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Zusammenfassung
Metabolische  Modelle  sind  wichtige  systembiologische  Werkzeuge,  um  den
Stoffwechsel von Zellen zu verstehen. Sie werden unter anderem zur Vorhersage von
Angriffspunkten  im  Stoffwechsel  von  pathogenen  Mikroorganismen  sowie  zur
Optimierung von mikrobiellen Produktionsstämmen eingesetzt. Mit der Flux-Balance-
Analyse und verwandten Methoden stehen Algorithmen zur Verfügung, mit denen das
Verhalten  metabolischer  Netzwerke,  sowohl  von  Wildtyp-Organismen  als  auch  von
Mutanten,  unter  verschiedenen  Umweltbedingungen  vorhergesagt  werden  kann.
Existierende  Implementierungen  dieser  mathematischen  Methoden  weisen  allerdings
verschiedene  Nachteile  auf,  u.a.  fehlende  oder  schwierige  Erweiterbarkeit  und  die
Zuweisung  von  unphysiologisch  hohen  zyklischen  Flüssen  in  der Flux-Balance-
Analyse.  Letztere  wird  meist  durch  sekundäre  Optimierungsstrategien  unter
zusätzlichem  Rechenaufwand  behoben.  Daneben  werden  Flussverteilungen  in
metabolischen  Netzwerken  bisher  überwiegend  unter  einer  rein  reaktionszentrischen
Sicht analysiert, obwohl einzelne Reaktionsflüsse für sich kaum interpretierbar sind.
In  der vorliegenden Arbeit  wird metano,  eine  Sammlung  von  mathematischen
Werkzeugen für die Analyse und Verfeinerung von metabolischen Modellen, vorgestellt.
metano enthält zunächst effiziente Implementierungen von etablierten Methoden (neben
der  Flux-Balance-Analyse  u.a.  Minimization  of  Metabolic  Adjustment  und  Flux
Variability  Analysis).  Die Flux-Balance-Analyse wurde dabei  so implementiert,  dass
das  Problem  biologisch  unplausibler  zyklischer  Flüsse  vollständig vermieden  wird.
Durch die Bereitstellung als  Open Source und die objektorientierte Implementierung
kann  metano leicht  erweitert  und  an  geänderte  Anforderungen  angepasst  werden.
Innerhalb  dieser  Plattform  wurde  eine  Reihe  von  neuen  Algorithmen  entwickelt,
darunter  die  automatische  Plausibilitätsprüfung  von  metabolischen  Modellen  sowie
Methoden  für  die  metabolitzentrische  Analyse  von  Flussverteilungen.  Durch  die
automatische  Plausibilitätsprüfung  wird  es  möglich,  im  Prozess  der  Erstellung  und
Verfeinerung von metabolischen Modellen Fälle zu erkennen, in denen Modifikationen
am Modell zu qualitativen Änderungen im metabolischen Verhalten führen.
Die in dieser Arbeit  entwickelten Methoden Split-Ratio-Analyse und Metabolitfluss-
Minimierung  etablieren  eine metabolitzentrische  Sicht  auf Flussverteilungen,  welche
die  klassische  reaktionszentrische  Sicht  komplementiert.  Durch  die  Analyse  von
Reaktionsflüssen  in  einem natürlichen  Kontext  erlaubt  die  metabolitzentrische Sicht
eine  tiefergehende  biologische  Interpretation  als  die  alleinige  Betrachtung  der
Reaktionsflüsse.  So  erlauben  diese  Algorithmen  die  Analyse  aller  Flüsse  in  einem
Metabolitpool  oder  einem metabolischen  Zyklus  auf  einen  Blick,  und  der  zelluläre
Energiestoffwechsel kann  durch  Analyse  der  Aufspaltungsverhältnisse  der  Flüsse  in
weniger  als  zehn  Knotenpunkten  des  Netzwerks  charakterisiert  werden.  Die  neu
entwickelten Methoden wurden auf publizierte genomweite metabolische Modelle  der
Bakterien Escherichia  coli und  Thermotoga  maritima angewendet.  Durch  die
metabolitzentrische  Analyse  konnten  mehrere Ansatzpunkte  zur  Optimierung  der
Modelle  hinsichtlich  ihrer  Vorhersagen  für  spezifische  Wachstumsbedingungen
identifiziert werden.
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Abstract
Metabolic  models  are  important  systems  biological  tools  for  understanding  cellular
metabolism. They are used, inter alia, for the prediction of drug targets in the metabolic
networks of  pathogenic  microorganisms  and  for  the  optimization  of  microbial
production  strains.  Flux  balance  analysis  and  related  mathematical  methods  allow
predicting  the  steady-state  behavior  of  the  metabolic  networks  of  both  wild-type
organisms  and  mutants  under  different  environmental  conditions.  Existing
implementations of these algorithms suffer from several drawbacks, among others the
lack or difficulty of extensibility and the assignment of unphysiologically high cyclic
fluxes  in  flux  balance  analysis.  The  latter  is  usually  corrected  via  secondary
optimization  strategies  at  the  cost  of  increased  computation  time.  To  date,  flux
distributions in metabolic networks are analyzed predominantly under a reaction-centric
framework, even though individual reaction fluxes do not have a clear interpretation by
themselves.
In this thesis, metano, a collection of mathematical tools for the analysis and refinement
of  metabolic  models,  is  introduced.  metano contains  efficient  implementations  of
established  computational  methods  (most  importantly  flux  balance  analysis,
minimization  of  metabolic  adjustment,  and  flux  variability  analysis).  Flux  balance
analysis  has  been  implemented  in  such  a  way  that  the  problem  of  biologically
implausible cyclic fluxes is avoided completely. As it is distributed as open source and
has  been  implemented  using  the  object-oriented  approach  of  software  engineering,
metano can  easily  be  extended  and  adapted  to  changed  requirements.  Within  this
software  framework,  several  new  algorithms  have  been  developed,  including  the
automated  plausibility  checking  of  metabolic  models  and  methods  for  the
metabolite-centric analysis of flux distributions. In the process of model construction
and refinement, the automated plausibility checking enables the identification of cases
where  a  modification  to  the  model  leads  to  qualitative  changes  in  the  metabolic
behavior.
The  methods  of  split-ratio  analysis  and  metabolite  flux  minimization,  which  were
developed in this work, establish a metabolite-centric view on flux distributions. This
view  complements  the  classical  reaction-centric  framework.  By  analyzing  reaction
fluxes  in  a  natural  context,  the  metabolite-centric  view  allows  a  more  profound
biological  interpretation  than  is  possible  from the  consideration  of  isolated  reaction
fluxes.  These  algorithms  allow the  analysis  of  all  fluxes  in  a  metabolite  pool  or  a
metabolic cycle at a glance, and the energy metabolism of the cell can be characterized
by considering the split ratios in less than ten branch points of the network. The newly
developed methods were applied to published genome-scale metabolic models of the
bacteria Escherichia coli and Thermotoga maritima. By performing a metabolite-centric
analysis, it was possible to identify several prospects for refinement of the models with
respect to their predictions for specific growth scenarios.
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1 Introduction
For more than two decades, genome-scale metabolic models have been used to predict
the  metabolic  capabilities  of  organisms,  both  wild  type  and  mutants,  in  different
environments.  The  genome-scale  reconstruction  of  metabolic  networks  has  been
enabled by advances in genome sequencing techniques, the  collection and  sharing of
omics data in electronic databases, and the development of computational tools for the
analysis of model structure and behavior.  Genome-scale metabolic  models have been
used,  inter  alia,  for  the  identification  of  novel  drug  targets  in  pathogenic  micro-
organisms  [1–4] and cancer cells [5], for predicting adverse side effects of drugs  [6],
and for optimizing microbial strains for the biotechnological production of chemicals of
industrial or medical importance [7–10]. Genome-scale models have further been used
to study robustness [11] and evolution [12] in metabolic networks.
Flux balance analysis (FBA) is one of the most widely used computational methods for
the  analysis  of  metabolic  models  [13,14].  It  predicts  the  metabolic  fluxes  in a
stoichiometric network model of the metabolism  of a cell  under certain biologically
motivated assumptions using linear programming  [15–17].  In the last decade, a large
number of additional algorithms have been developed for the analysis of genome-scale
metabolic  models  and  the  application  of  such  models  to  different  biological  and
biotechnological problems [18,19]. At the same time, a multitude of software programs
implementing FBA and related computational methods have been released (see [19] for
an overview).
Existing software solutions  for the analysis  of genome-scale metabolic models have
several drawbacks: While many programs are free for academic users, most are still
proprietary. Truly open-source software remains relatively rare in this field. In addition,
many implementations that are open source still depend on commercial software such as
MATLAB1,  CPLEX2,  LINDO3,  or  MOSEK4 for  solving  mathematical  optimization
problems.
Furthermore,  many  existing  software  tools  are  web-based.  Web-based applications
require  the user  to  upload their  (unpublished)  models  and data  to  the server  of  the
software’s  operator.  This is  clearly  unacceptable  in  commercial  research  and
development.  Moreover,  it  is  uncommon for  academic  research  groups that  are  not
formally collaborating to exchange substantial amounts of unpublished data, much less
entire models.
1 The MathWorks Inc., http://www.mathworks.com/products/matlab/
2 IBM Corporation, http://www-01.ibm.com/software/commerce/optimization/cplex-optimizer/
3 LINDO Systems Inc., http://www.lindo.com
4 MOSEK ApS, http://mosek.com/products/mosek/
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Closed-source  software  and  web-based  applications  limit  their  users  to  those
applications  envisioned by the  developers,  as the software’s  functionality  cannot  be
extended. For scientific software, which is used for extending the boundaries of current
knowledge, this is a severe, potentially crippling limitation.
This  drawback is shared to some extent with open-source software that  has not  been
designed from the start with the goal of extensibility. For instance, the software  tool
FASIMU  [20] is written in the parser language AWK1 and the shell  script  language
bash2.  Both  of  these  programming  languages  are  highly  specialized  –  AWK  for
processing text  files,  and bash for automatizing operating system  tasks.  Shell  script
languages  have  a  reputation  for  being  ‘write-only  languages’,  and  shell  scripts  are
notoriously hard to maintain. In addition, knowledge of these specialist languages is not
common among life scientists.
Finally, virtually all existing implementations of flux balance analysis assign extremely
large,  thermodynamically  infeasible  values  to  fluxes  in  stoichiometrically  balanced
reaction cycles  [21]. Some implementations report these values in the computed flux
distribution, leaving recognition and treatment of this problem to the user. Most existing
programs, however, offer a secondary optimization procedure, which finds or eliminates
the  problematic  cyclic  fluxes  automatically  at  the  cost  of  increased  computation
time [22].
Metabolic  models  and  predicted  flux  distributions  are  predominantly  analyzed  in  a
reaction-centric fashion [23]: To assess a model’s quality, predicted reaction fluxes are
compared to experimentally determined flux values, which are given either as absolute
values in mmol gDW−1 h−1 or as percentages of the substrate uptake rate [24,25]. Gene
knockouts  are  represented  in  the  model  by  constraining  the  fluxes  of  all  reactions
catalyzed by the gene product(s) to zero [26]. In the same way, gene expression data can
be incorporated by introducing or modifying constraints  on reaction fluxes  [27–30].
Finally, the most commonly employed computational strategies in metabolic engineer-
ing attempt to find a combination of gene knockouts and/or modify individual reaction
fluxes to boost production (and secretion) of a desired chemical compound [31–34].
Reaction fluxes are,  however,  hard to interpret in isolation.  To give an example,  no
insights can be gained from the fact that in Escherichia coli, a glutamate-producing flux
of  6.3 mmol gDW−1 h−1 through  glutamate  dehydrogenase  has  been  predicted  for  a
certain growth scenario.  Expressing this flux as a fraction of the glucose uptake rate
(57%) does not overcome this difficulty. A promising approach to the interpretation of
the flux through a given reaction may be to express the flux as a ratio of the total flux
through  each  of  the  reactants  and products  involved in  the  reaction.  For  glutamate
dehydrogenase,  e.g.,  the  relevant  questions  are  what  fraction  of  the  L-glutamate  is
produced and what fraction of the NADPH is consumed via this particular reaction.
1 GNU awk, The GNU Project, http://www.gnu.org/software/gawk
2 GNU Bash, The GNU Project, http://www.gnu.org/software/bash
2
1 Introduction
With  flux-sum  analysis  a  first  metabolite-centric  approach  for  the  analysis  of
genome-scale  metabolic  models  has  been  proposed  [11,35].  This  approach  has,
however,  remained  limited  to  the  analysis  of  network  robustness  [11,36].  The
examination of metabolic branch points and flux split ratios is very important in the
field  of  metabolic  engineering  [37–39].  Branch  points  and  split  ratios  have  been
considered  even  longer  in  wet-lab  metabolic  flux  analysis  [40–42].  However,  all
existing approaches use only small metabolic networks and look only at a small number
of  predefined  branch  points.  The  systematic  analysis of  genome-scale  metabolic
networks requires a non-targeted automated analysis of branch points and split ratios.
The  goals  of  this  work  were  threefold:  Firstly,  to  develop  an  easily  extensible
open-source toolkit implementing the most commonly used mathematical methods for
the analysis of genome-scale metabolic models. This software toolbox is named metano.
Secondly,  to  develop  an  implementation  of  flux  balance  analysis  that  avoids the
problem of thermodynamically forbidden cycles  entirely. And thirdly, to  develop and
implement  within  the  new framework a  set  of  new  computational  methods  for  the
analysis  and refinement of metabolic models.  The focus in the development of new
algorithms was placed on two areas  in  particular,  the  high-quality  reconstruction  of
metabolic networks and the metabolite-centric analysis of flux distributions.
This thesis is structured as follows: Chapter 2 introduces basic concepts and definitions
as well as the theoretical background of metabolic modeling.  Metabolic modeling is
presented within the context of the wider field of systems biology.  In addition,  this
chapter expounds on the problem of thermodynamically infeasible loops outlined above.
The  model  organisms  considered  in  this  work  are  also  introduced  in  Chapter 2.
Chapter 3 presents the methods implemented in  metano and the published metabolic
models to which these methods are applied in  the  subsequent chapters. In Chapters  4
and  5, the main results of this work are presented and discussed. Chapter 4 describes
metano and  gives  details  on  the  implementation.  In  addition,  the  validation  of  the
implementations  of  established  methods  in  metano is  presented  in  Chapter 4.  In
Chapter 5, the application of metano to the analysis of two published metabolic models
is  presented.  Results  are  described  and  discussed  in  the  same  chapter.  Chapter 6
describes, in more general terms, the applications of  metano in the reconstruction of
metabolic networks. Chapter 7 gives a summary and conclusion.
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2.1 Systems biology
Life is a hugely complex phenomenon that entails a plethora of interlocking processes
acting on vastly different size and time scales – from ångströms to meters and from
picoseconds  to  days. Traditionally,  researchers  have  examined  biological  processes
under a reductionist view, trying to gain as much knowledge as possible about isolated
components of biological systems. Both the fundamental building blocks of the cell and
the basic functional modules of the molecular machinery of the cell have been studied
extensively in this fashion. Cellular building blocks include, among others, DNA, RNA,
proteins, lipids, polysaccharides, and small molecules. The studied elementary cellular
processes  include  DNA replication,  transcription,  translation,  as  well  as  individual
metabolic and signaling pathways.
In  the  last  decades,  this  reductionist  view  has  gradually  been  replaced  by  a  more
systems-oriented approach, which has been termed systems biology [43]. This paradigm
shift has been necessitated by the realization that the components of living systems are
less  separable  than  initially  thought.  This  is  exemplified  by  inherently  systemic
phenomena such as  crosstalk between signal  transduction pathways  [44], the highly
complex protein-protein interaction networks at work in biological systems [45], and the
large number of ways in which transcription of a gene can be regulated, many of which
can be active at the same time [46,47]. The systems-oriented study of living systems has
been made possible by the advent of high-throughput techniques in the related –omics
disciplines [48]. These fields include genomics,  transcriptomics,  proteomics,  metabo-
lomics, and many more. The focus of systems biology is the integration of omics data
obtained  by  different  experimental  techniques  with  the  goal  of  obtaining  a  better
understanding of biological systems.
Systems biologists use mathematical modeling to generate a functional description of
the system under consideration  [49]. Computational models can be used to simulate
processes that underlie measurable phenomena but cannot be observed directly. Models
are valuable tools for generating hypotheses, which can then be used to guide wet-lab
experiments  [50]. Experimental results can in turn be used to refine the model. The
resulting cycle of data- and hypothesis-driven modeling and hypothesis-driven design
and execution of experiments is shown schematically in Figure 1. It should be noted that
the early stages of model refinement do not usually entail wet-lab experiments. If the
model  is  still  internally  inconsistent  or  if  its  predictions  are  in  disagreement with
published experimental data, these conflicts have to be resolved first before the model’s
predictions can be used to guide new experiments. This approach is highly economic, as
wet-lab experiments are usually much more costly in time, space, energy, and material
requirements than computer simulations.
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Figure 1: Cycle of hypothesis-driven research in systems biology. Figure taken from [49].
The  analysis  of mathematical  models  requires  computational  methods.  The
development of a wealth of new computational tools and the continuous increase in
computing power have strongly contributed to  the success  of systems biology  [51].
Recent  years  have  seen  the  development  of  computational  methods  supporting  or
partially automatizing the process of model generation (e.g. [52–54]).
2.2 Metabolism as determinant of phenotype
The biochemical processes inside the cell can be described by a hierarchical scheme:
Based on the static genome, the cell’s transcription and translation machinery produces
RNAs and proteins [55]. The set of all RNAs that are present in the cell at a given time
is called the transcriptome, and the set of all proteins is called the proteome. A large
number  of  proteins  are  enzymes,  which  catalyze  the  conversion  of  substrates  to
products  in  chemical  reactions.  The  set  of  all  these  chemical  reactions  forms  the
metabolism of the cell, and the set of all metabolites present at a given time is called the
metabolome. Figure 2 shows this hierarchical organization schematically along with the
most important types of interactions between the three dynamic layers.
The  three  layers  differ  in  their  response  time  to  perturbations:  Changes  in  gene
expression take between hours and days to produce an effect on the phenotype [56,57],
protein-protein interactions act on an intermediate scale  of seconds to minutes  [58],
while changes on the metabolic level alone can alter the phenotype very rapidly  [59].
As  nearly  all  changes  in  gene  expression  or  protein  modulation  ultimately  act  by
altering the cell’s metabolism, metabolism is the most immediate determinant of the
cellular phenotype [60].
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Figure  2:  The  biochemical  interaction  network  of  the  cell  has  a  hierarchical  organization,  which
comprises  the  static  genome  and  the  three  dynamic,  mutually  interdependent  layers  transcriptome,
proteome,  and  metabolome.  The  following  types  of  interactions  are  shown:  (1) enzyme  catalysis,
(2) post-transcriptional  control  of  gene  expression,  (3) effect  of  a  metabolite  on  gene  transcription
mediated  by  a  protein,  (4) protein-protein  interaction,  (5) effect  of  a  downstream  metabolite  on
transcription via binding to a protein, (6) feedback inhibition or activation of an enzyme by a downstream
metabolite, and (7) transport of a metabolite into or out of the cell. Figure taken from [48].
2.3 Metabolic modeling
A metabolic model is a network of chemical reactions transforming sets of chemical
compounds  into  one  another.  In  this  thesis,  all  chemical  compounds  involved  in
metabolic  reactions  are  referred  to  as  metabolites,  regardless  of  size  or  subcellular
localization.  Metabolic  networks  have  been  modeled  on  three  levels  of  detail:
graph-based, stoichiometric, and kinetic.
Firstly, a metabolic network can be represented as a bipartite graph, where reactions and
metabolites are modeled as distinct types of nodes. A reaction is described in the graph
by a reaction node and the edges connecting it to the metabolite nodes corresponding to
the compounds involved in the reaction. Panels A and B of Figure 3 show an example
network  comprising  four  reactions  and  three  metabolites  as  chemical  reaction
equations (A) and as a bipartite graph (B). Graph-based approaches focus on the study
of topological properties of metabolic networks [61,62]. Within a purely graph-theoretic
framework, reaction stoichiometry cannot be represented, and graph-based approaches
are not suitable for studying dynamic system behavior [63]. Graph-theoretic algorithms
have, among other applications, been used to study redundancy and robustness [64], to
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decompose  networks  into functional  modules  [65],  and to  identify critical  points  in
metabolic networks [66].
Figure 3: Four representations of a small example metabolic network: (A) Chemical reaction equations.
(B) Bipartite graph (dashed lines represent the system boundary). (C) System of ordinary differential
equations describing the time derivatives of the concentrations as functions of the reaction fluxes (v 1 is
the flux through reaction r1, v2 through reaction r2, etc.). (D) Stoichiometric matrix.
Secondly, metabolic networks can be modeled in kinetic detail. Kinetic models repre-
sent the network as a system of ordinary differential equations [67]. An example of this
is shown in Figure 3C: The time derivatives of the metabolite concentrations are linear
functions of the fluxes v1 through v4 corresponding to the reactions r1 through r4 shown
in Figure 3A. Kinetic models can, in principle, predict the system’s dynamic response to
perturbations and the time-dependent behavior of other non-steady-state processes [68].
Their greatest limitation lies in the availability of kinetic parameters, which are required
for all reactions in the network. In general, kinetic parameters are available for only a
small number of enzymes in the network, and in-vivo reaction rates may be substantially
different  from  those  observed  in  vitro for  isolated  enzymes  [69,70].  Hence,  the
construction of fully kinetic metabolic models on a genome-wide scale seems infeasible
at present [71]. Despite their limitations, kinetic models are valuable tools for studying
non-steady-state  processes,  most  importantly  signal  transduction  [72,73] and  the
cellular  response to  environmental  stress  [74].  Moreover,  approaches  for  combining
stoichiometric and kinetic models have been proposed towards the goal of building an
integrated whole-cell model [75].
In the third commonly used approach to metabolic modeling, the network is represented
by a set of reaction equations, such as that shown in Figure 3A. Stoichiometric models
are characterized by the condition of mass balance, where in each reaction, each kind of
atom appears in the same number on the left-hand side as on the right-hand side. The
only  exception  to  this  condition  are  reactions  transporting  matter  over  the  system
boundary  into  or  out  of  the  system under  consideration.  As  stoichiometric  models
incorporate reaction stoichiometry but do not require knowledge of kinetic parameters,
this  level  of  detail  is  well  suited for  the reconstruction of whole-genome metabolic
networks  [7]. In  fact,  all  genome-scale  metabolic  models  published  to  date  are
stoichiometric  models  [18].  Stoichiometric  models  do  not  allow  the  analysis  of
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non-equilibrium dynamics,  but have proven very useful for predicting the metabolic
capabilities in steady state [76–79]. The remainder of this thesis will focus exclusively
on stoichiometric metabolic models.
Kinetic  and  stoichiometric  metabolic  models  allow  the  prediction  of  fluxes  under
certain  assumptions.  This  allows  the  identification  of  essential  reactions  (and  thus
essential genes) and the characterization of the split ratios of metabolic fluxes in the
network.  By  examining  the  variability  of  reaction  fluxes,  it  is  possible  to  identify
alternative  metabolic  pathways.  As  both  are  deterministic  models,  a  kinetic  or
stoichiometric model does not represent an individual cell but rather an ‘average’ cell in
a larger population [80].
2.3.1 Stoichiometric matrix and steady state
A stoichiometric model with n reactions and m metabolites is represented mathematical-
ly by an m × n stoichiometric matrix S. Each row of S corresponds to one metabolite,
and each column corresponds to one reaction. The entry  sij of  S is the stoichiometric
coefficient of metabolite  i in reaction  j. It is positive if the metabolite occurs on the
right-hand side of reaction j, negative if it occurs on the left-hand side, and zero if it is
not  involved in  the  reaction.  Figure  3D  on page  8 shows the stoichiometric  matrix
corresponding  to  the  network  defined  by  the  reactions  shown  in  Figure  3A.  The
stoichiometric  matrix  transforms the  n × 1 vector  of  reaction  fluxes  v into  a  vector
containing the time derivatives of the metabolite concentrations [81]:
S⋅v = dc
dt
. (1)
See Figure 3C for an example of such a system of ordinary differential equations. The
flux  vj through reaction  j is  positive  if  the  reaction proceeds from left  to  right  and
negative if the reaction proceeds in the reverse direction.
The metabolic steady state is a flux equilibrium, in which all metabolite concentrations
are constant [82]. This means that for each metabolite node in the system, the sum of all
incoming  (i.e. producing)  fluxes  is  equal  to  the  negative  sum  of  the  outgoing
(i.e. consuming)  fluxes.  In  other  words,  all  metabolites  produced  by  fluxes  in  the
network have to be consumed at the same time by other fluxes. The steady state is
thought to exist for every metabolic network under constant external conditions, and
most biochemical systems in nature are known to operate close to a steady state [83].
All analyses of stoichiometric metabolic networks inherently assume that the system
under  consideration  is  in  steady  state.  The  steady-state  condition  is  expressed
mathematically as
S⋅v = 0. (2)
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In steady state,  the  system of  ordinary  differential  equations  defined by Equation 1
simplifies to a system of linear equations (Equation 2). As metabolic networks contain
more reactions than metabolites, this system is underdetermined [84]. This means that
the  solution  space  of  Equation 2 (i.e.  the  null  space  of  S)  is  infinitely  large.
Computational methods for the analysis of metabolic models either try to explore the
shape of the solution space or to find a particular solution that is most biologically
meaningful under certain conditions.
2.3.2 Genome-scale metabolic models
With  the  availability  of  rapid  sequencing  technologies,  electronic  databases  for  the
collection and sharing of  omics data, and suitable computational tools, it has become
possible to develop whole-genome reconstructions of metabolic networks.
Firstly, a genome-scale metabolic model is a structured knowledge base that integrates
data about the metabolism of the organism under consideration from different sources,
including  databases,  primary  literature,  and  expert  knowledge  [85].  Secondly,
genome-scale models allow the prediction of cellular phenotypes. Among other things,
this allows the in-silico prediction of the effects of genetic or regulatory modifications
or growth in different environments on the phenotype  [23]. The predicted metabolic
capabilities of a genome-scale network in a certain scenario can be used for hypothesis-
driven planning and execution of wet-lab experiments and for providing context for the
interpretation of experimental data.
Important  applications  of  genome-scale  metabolic  models  include  the  prediction  of
potential  drug  targets  in  pathogenic  microorganisms  [2] and  the  study  of
environmentally triggered phenotypic changes. Examples of such transitions that have
been studied  using metabolic  models  are  a  pathogen or  parasite  switching from an
insect vector to a mammalian host [86] and a non-pathogenic soil bacterium becoming
pathogenic  inside  a  mammalian  host  [87].  Studying  the  metabolism  of  pathogenic
organisms in comparison with host cell  metabolism can lead to the identification of
novel drug targets [88]. Furthermore, an accurate model of cellular metabolism allows
metabolic  engineering,  the  directed  modification  of  the  organism with  respect  to  a
metabolic  goal,  such as  overproduction  and  export  of  a  medically  or  commercially
relevant chemical compound [89].
2.3.3 System boundary and compartments
In a genome-scale metabolic model, the system under consideration usually includes the
part  of  the  extracellular  space  immediately  surrounding  the  cell.  Hence,  the  model
contains at least two compartments: intracellular and extracellular. In general, there is
one compartment in the model for each membrane-enclosed compartment in the cell. In
addition,  virtual  compartments  may be used to  represent  other  reaction spaces  with
limited accessibility, such as for membrane-bound reactions, or reactions with unknown
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subcellular  localization  [90].  Figure  4 schematically  shows  a  system  with  three
compartments.
Figure 4: A system with two nested cellular compartments and one extracellular compartment.
Compartments are modeled by duplication of metabolite nodes, which means that pools
of the same metabolite occurring in different compartments are represented by separate
entities (metabolite nodes). For instance, a model of a Gram-negative bacterium might
contain  metabolite  nodes  labeled  ‘glucose[extracellular]’,  ‘glucose[periplasm]’,  and
‘glucose[cytosol]’ for representing pools of D-glucose in the respective compartments.
The transport  of  metabolites  between compartments  is  modeled  by  virtual  transport
reactions,  which  convert  between  a  metabolite  in  one  compartment  and  the  same
metabolite in another compartment. Table 1 shows examples of these virtual reactions.
Table 1: Examples of virtual reactions representing the transport of metabolites between compartments.
(Unmarked metabolites are localized in the cytosol.)
Type of transport Example
Passive diffusion O2[extracellular]  O⇌ 2
Passive uniporter glucose[extracellular]  glucose⇌
Symporter (active or passive) acetate[periplasm] + H+[periplasm]  acetate + H⇌ +
Antiporter (active or passive) succinate + citrate[periplasm]  citrate + succinate[periplasm]⇌
Primary active transport (ABC 
transporter)
L-alanine[extracellular] + ATP + H2O → L-alanine + ADP + 
phosphate + H+
Group translocation 
(phosphotransferase system)
glucose[extracellular] + phosphoenolpyruvate → glucose 6-phosphate 
+ pyruvate
In steady state, the system is regarded as surrounded by an infinite environment with
constant  composition.  This  condition  corresponds  best  to  exponential  growth  in  a
bioreactor in continuous mode, where fresh medium is supplied at a constant rate. The
exchange of metabolites with a larger environment is represented in the model by a set
of  exchange  reactions,  which  transport  metabolites  from  the  environment  to  the
modeled part of the extracellular space and vice versa. The exchange reactions are not
stoichiometrically balanced: They contain the transported metabolite on one side, while
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the other side is empty. In the toy example shown in Figure 3 on page 8 (which has only
a single compartment), reactions r1, r2, and r4 are exchange reactions, while reaction r3
is an internal (i.e. metabolic) reaction.
2.3.4 Constraint-based modeling
The construction of stoichiometric metabolic models is an instance of constraint-based
modeling, where the solution space of a mathematical problem is defined via a set of
equality and inequality constraints  [91]. This is in contrast to theory-based modeling,
which has the goal of determining a single ‘exact’ solution  [81].  For stoichiometric
models,  the  relevant  equality  constraints  are  given  by  the  steady-state  condition
(Equation 2 on page 9), while the most common type of inequality constraints has the
form
lb ≤ v ≤ ub . (3)
This means that the reaction fluxes v are constrained via two n × 1 vectors lb and ub of
lower and upper bounds.
Inequality constraints are used to model the following, among others:
• Irreversibility of reactions (lower or upper bound set to zero),
• measured flux values (e.g. bounds = mean  standard error),∓
• known uptake or secretion rates, and
• known split ratios of fluxes.
The solution space defined by the equality and inequality constraints is the set of all
feasible metabolic states. It does not contain an intrinsic measure of the likelihood of
any particular flux distribution in a given environmental scenario [92].  Therefore, any
computational  method  for  predicting  the  metabolic  capabilities  of  a  stoichiometric
model needs to make additional assumptions to further constrain the solution space in
order to produce biologically meaningful predictions.
2.3.5 Biomass reaction, units, GAM, and NGAM
The growth of the cells is modeled as flux through a virtual biomass reaction. This flux
will hereafter be referred to as biomass flux for short. The biomass reaction contains on
the left-hand side all metabolites that are known biomass components of the modeled
organism in correct molar ratios. In the case of polymers, monomer precursors are given
instead. The molar ratios of the biomass components are given as absolute values in
millimoles per gram dry weight. The use of absolute ratios leads to a normalization of
the biomass such that one millimole of the virtual biomass metabolite produced by the
biomass reaction corresponds to one gram dry weight. While all other reaction fluxes
are in mmol gDW−1 h−1, the unit of the biomass flux is h−1 because of the normalization.
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In steady state, the produced biomass leaves the system under consideration, which is
often modeled in practice by omitting the virtual biomass metabolite on the right-hand
side of the biomass reaction.
The energy requirement for cellular growth and reproduction also has to be considered
in the model. It is included in the form of an ATP hydrolysis reaction whose flux is
coupled to the biomass flux. The amount of ATP in millimoles that is required for the
formation  of  one  gram  of  dry  biomass  is  called  growth-associated  maintenance
requirement (GAM)  [93]. Most  of  the  GAM  is  accounted  for  by  the  synthesis  of
macromolecules such as DNA, RNA, and proteins. Usually, the GAM is included in the
biomass reaction. This is achieved by adding  z ATP + z H2O to the left-hand side and
z ADP + z phosphate + z H+ to the right-hand side.
Certain  cellular  processes  consume energy  but  are  not  associated  with  cell  growth.
These  include,  among  others,  DNA repair  and  maintaining  osmotic  pressure  and
membrane potential. They are modeled as a combined ATP hydrolysis reaction  with a
fixed flux. The flux through this reaction is called non-growth-associated maintenance
requirement (NGAM) [94].
2.4 Thermodynamically infeasible loops
An infeasible loop, also called an internal cycle, a stoichiometrically balanced cycle, or
a type III extreme pathway, is a set of reactions that is capable of transforming a group
of  metabolites  into  itself  via  a  series  of  conversions  without  any  loss  or  gain  of
matter [95,96]. In the example shown in Figure 5, the sequence of reactions 2–3–4–1 is
capable of transforming metabolite C back into itself.
R1 : A + B  C⇌
R2 : C + ATP  CP + ADP⇌
R3 : CP + ADP  B + D + ATP + H⇌
R4 : D + H  A⇌
Figure  5: A thermodynamically infeasible loop (left:  reactions,  right: network).  Metabolite C can be
converted back to itself in four reaction steps.
In steady state, biochemical reactions can only proceed in the direction of decreasing
free energy [95]. As the net change in free energy associated with any stoichiometrically
balanced  cycle  of  chemical  reactions  is  zero,  cyclic  fluxes  are  thermodynamically
forbidden. If any reaction in the network is known to proceed in the direction converting
a set of substrates S to a set of products P in the scenario under study, then it follows
from Hess’s law  [97] that there can be no net flux through a sequence of reactions
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transforming P to S without consumption of energy. If,  in the example of  Figure 5,
reaction 2 is known to proceed in the direction producing CP and ADP, at least one of
the reactions 1,  3, and 4 must have a non-positive flux (i.e.  either R1 : A + B ← C,
R3 : CP + ADP ← B + D + ATP + H, or R4 : D + H ← A).
As the reactions forming an infeasible loop are stoichiometrically balanced, cyclic flux
through the loop does not result in any net production or consumption of metabolites.
Therefore,  adding any amount  of such cyclic  flux to  a steady-state flux distribution
preserves the steady-state condition. Restricting the solution space further by adding
inequality constraints can only partially eliminate this ambiguity. For instance, in the
example  above,  reaction 2  might  proceed  in  one  direction  in  some  environmental
conditions and in the opposite direction in others. Furthermore, it might not be known
which other reaction in the cycle must necessarily proceed in the opposite direction.
In  particular,  flux  distributions  in  metabolic  networks  predicted  via  mathematical
optimization  strategies  frequently  contain  arbitrarily  large  cyclic  fluxes  through
infeasible loops, as the objective functions commonly employed are blind to such cyclic
fluxes. A trivial workaround would be to secondarily minimize the total flux through the
network  [98] or the total number of reaction steps  [99]. In addition, a large body of
work has been published in the last decade on identifying and eliminating infeasible
loops in metabolic models (e.g. [22,95,96,100–103]).
2.5 Comparability of model predictions and experimental observations
2.5.1 Experimental data that can guide model validation and refinement
Several  types  of  high-throughput  omics data  can  be  used  in  the  process  of  model
construction,  validation,  and  refinement.  These  include  genome,  transcriptome,
proteome, protein-protein interaction, metabolome, fluxome, and phenotypic data [23].
The process of metabolic modeling always starts from a genome annotation [104,105].
All  enzyme functions that have been described for the studied organism have to be
included in the model. Usually, all enzymes identified in the genome with a high confi-
dence score are added in an automatic step. Commonly used annotation sources include
biochemical  databases  such as  BRENDA  [106],  KEGG  [107],  or  UniProtKB  [108];
pattern-based similarity searches [109]; and BLAST-based homology searches [105].
The information obtained from genome annotation data can and should be refined by
incorporating gene expression data.  This  ensures  that  only genes  (and the  reactions
catalyzed by their  products)  are included that are  actually  expressed in the scenario
under consideration. When comparing metabolic behavior in different growth scenarios
or  between wild-type and perturbed networks,  differential  gene expression data  can
further be used to formulate scenario-specific constraints. For instance, if the expression
of an enzyme is  reduced by 50% in the studied scenario compared to the reference
condition and the reaction catalyzed by that enzyme is known to be the rate-determining
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step in a biosynthetic pathway, an upper bound of 50% of the value for the reference
scenario  can  be  set  for  the  flux  through  the  reaction.  Data  on  gene  regulation  or
regulatory protein-protein interactions can be incorporated in a similar fashion.
Metabolome data can be employed for model refinement. In an untargeted metabolomic
analysis, it is routinely possible to detect several hundred metabolites, of which about
100 to 150 can be identified  [110,111]. First of all, for each metabolite detected in a
specific growth scenario,  the model  must predict  at  least  one reaction involving the
metabolite to be active. Furthermore, absolute metabolite concentrations can be used in
conjunction  with  Gibbs  energies  of  formation  to  predict  the  directions  in  which
reversible reactions operate in the scenario under study [112,113].
The  primary  variables  in  a  metabolic  model  are  reaction  fluxes,  which  are  directly
comparable to fluxome data. The most common method of determining fluxes in vivo is
tracer analysis, where the organism is grown on stable-isotope-labeled substrates for a
defined period of time, after which the distribution of the label in the metabolome is
analyzed.  The label distribution is determined  using  either  mass spectrometry, usually
after  a  chromatographic  separation  step,  or  nuclear  magnetic  resonance  spectros-
copy [114]. The isotopes employed in tracer experiments include 2H, 13C, 15N, 18O, and
31P [114,115], with  13C studies being by far the most common  [116–118]. Traditional
approaches to fluxomics are based on targeted metabolomics, studying only the labeling
patterns  of  a  defined set  of  metabolites,  such as  amino acids  [119].  A more  recent
strategy employs untargeted metabolomics  and evaluates  the labeling patterns  of all
detectable  compounds  [120].  As all  fluxomics  approaches  depend on metabolomics,
only  those  reactions  can  be  studied  that  involve  metabolites  with  sufficiently  high
concentrations. Therefore, 13C tracer experiments can, in general, only determine fluxes
in or close to the central carbon metabolism [117,118,121].
Finally,  phenotypic  data  can  be  used  to  qualitatively  validate  model  predictions  for
different growth scenarios. Among the most important experimental tools for obtaining
high-throughput  phenotypic  data  are  phenotype  microarrays  [122]:  Non-selectively
precultured cells  are transferred to a microtiter  plate,  each well  of which contains a
different cultivation medium and a redox dye. The originally colorless dye is reduced by
enzymes of the electron transfer chain of the cell using NADH as electron donor [123],
provided that the cell is capable of respiration in the medium. Thus, a color change is
observed for  each usable medium.  By taking photographic  measurements  at  regular
intervals, kinetic curves can be obtained [123]. Phenotypic data are usually incorporated
in the model validation process in the form of binary variables (growth/ no growth on a
particular substrate or combination of substrates) [23]. It should be noted that phenotype
microarrays  do  not  measure  growth  but  respiration,  which  are  not  necessarily
proportional.
2.5.2 Quantitative prediction of cell growth
If the biomass reaction reflects the correct biomass composition and is normalized (as
described in Section 2.3.5) and the values of substrate uptake rate, GAM, and NGAM
15
2 Background
(see  Section  2.3.5)  have  been  fitted  to  experimentally  determined  values,  the  flux
through the biomass reaction corresponds to the specific growth rate µ of exponentially
growing cells. Exponential (unlimited) growth occurs, e.g., in a bioreactor in continuous
mode or during the exponential phase of growth in a limited environment. The specific
growth  rate is  defined  as  the  increase  in  cell  mass  x per  unit  time  per  gram cell
mass [124,125]:
μ = dx
dt
⋅ 1
x
. (4)
As the unit of 
dx
dt  is [unit of  x] per hour, the unit of  x cancels out, and the unit of µ
is h−1.  As  cell  mass  is  hard  to  determine  experimentally  (impossible  in  vivo),  other
measures are routinely used, which are proportional under certain assumptions. These
are biomass concentration (g L−1; for constant volume (such as in a bioreactor or shaker
flask)), cell number (if cell size is constant), and optical density (if cell size, cell shape,
and cell envelope composition are constant). The specific growth rate can be calculated
from an experimentally determined growth curve by measuring cell mass  x (or, more
commonly, a proportional measure such as optical density) at two points in time t1 and t2
during a period of exponential growth:
μ =
ln x2−ln x1
t2−t1
, (5)
where x1 and x2 denote cell mass at time t1 and t2, respectively [124].
The equivalence of biomass flux and specific growth rate during exponential growth is
obtained from the following consideration:
The  stoichiometric  matrix  S of  the  model  transforms  a  flux  vector  v into  the
corresponding  vector  of  the  time  derivatives  of  the  metabolite  concentrations
(Equation 1 in  Section 2.3.1).  The components  of  this  vector  are  normalized  to  one
gram of dry biomass,  like the reaction fluxes.  They are not  time derivatives  of the
absolute concentrations in mmol L−1.
In particular, this also applies to the time derivative of the concentration of the virtual
biomass  metabolite  (see Section 2.3.5),  which is  determined by the biomass  flux as
follows:
dcBM
dt
= vBM . (6)
This normalized derivative is obtained from the time derivative of the absolute biomass
concentration (or cell mass) x by dividing the latter by the current value of x:
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dcBM
dt
= dx
dt
⋅ 1
x
. (7)
The right-hand sides of Equations  4 and  7 are identical. Therefore,  with Equation  6
follows:
dcBM
dt
= vBM =μ . (8)
2.6 Escherichia coli
Escherichia coli is a Gram-negative bacterium in the family Enterobacteriaceae in the
class Gammaproteobacteria. The bacterium is rod-shaped and facultatively anaerobic.
E. coli occurs  as a  commensal  organism in the gut  flora of birds  and mammals.  In
addition, several human-pathogenic strains of  E. coli exist, and commensal strains can
become pathogenic in immunocompromised patients [126].  E. coli has long been used
as a model organism in the life sciences, and it is by far the best-studied prokaryote.
Many  metabolic  enzymes  and  pathways  were  originally  discovered  in  E. coli
(e.g. [127–130]), and its metabolism has been modeled in increasing scopes and levels
of detail since the mid-1980s  [76,131,132].  E. coli can easily be cultured in defined
high-glucose minimal media. During rapid aerobic growth on glucose,  E. coli secretes
acetate. This phenomenon has been termed overflow metabolism [133]. The overflow
effect is associated with transcriptional regulation of genes in the TCA cycle and the
electron transport chain [134].
MG1655 is a laboratory strain of E. coli derived from the wild-type strain K-12, which
was isolated  in  1922 from human feces.  MG1655 was the  first  E. coli strain  to  be
sequenced; the genome sequence was published in 1997 [135].
2.7 Thermotoga maritima
Thermotoga  maritima is  a  rod-shaped  hyperthermophilic  bacterium  in  the  order
Thermotogales,  which  is  considered  one  of  the  deepest  branches  within  the
Bacteria [136]. The cell membrane of  T. maritima is a lipid monolayer, and the cells
exhibit  Gram-negative  staining  [137].  T. maritima is  an obligately anaerobic  hetero-
troph, obtaining the energy required for growth via fermentation of carbohydrates [138].
Its optimal growth temperature is 80°C [139], and it is a model organism for the study
of hyperthermophilia and of phylogenetically ancient bacteria [140,141].
MSB8 (DSM 3109) is the type strain of T. maritima. It was isolated from geothermally
heated marine sediment at Vulcano, Italy and first described in 1986 [142]. The genome
sequence was published in 1999 [143].
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2.8 Pseudomonas aeruginosa
Pseudomonas  aeruginosa is  an  obligately  respiring  bacterium  [144] in  the  family
Pseudomonadaceae in the class Gammaproteobacteria, which can thrive in a wide range
of environments.  Cells  are  rod-shaped and stain Gram-negative.  P. aeruginosa is  an
opportunistic  human pathogen that  can  cause,  among others,  lung and urinary  tract
infections [145]. Of biotechnological interest is its capability to produce biofilms [146].
PAO1, a wound isolate first described in 1955 [147], is the most widely used laboratory
strain of P. aeruginosa. Its genome sequence was published in 2000 [148].
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3 Materials and methods
3.1 Genome-scale metabolic models
The computational methods and software implementations presented in this thesis were
first  validated  against  the  whole-genome  metabolic  reconstruction  iAF1260  of
Escherichia coli [24]. The software was then used for detailed analyses of the published
genome-scale  metabolic  models  of  two  bacteria:  Escherichia  coli and  Thermotoga
maritima.
3.1.1 Escherichia coli K-12 MG1655
Two  published  genome-scale  metabolic  models  of  E. coli were  used  in  this  work:
iAF1260,  published in  2007  [24],  and the  more  recent  version  designated  iJO1366,
which was published in 2011 [149]. As an updated version of the same model, iJO1366
was used for all  actual  in-silico analyses of metabolic phenotypes performed in this
work. However, as the authors of iAF1260 provided flux distributions obtained using
their model, this model was used for the validation of the implementation of established
tools in metano.
3.1.1.1 iAF1260
The model iAF1260 covers 1,260 open reading frames of the genome of  Escherichia
coli K-12 MG1655. The model is an extension of the earlier model iJR904, which was
published in 2003 by the same research group [77]. iAF1260 is based on the genome
sequence  published  by  Blattner  et al.  [135],  a  published  functional  annotation  of
E. coli   [150], the  EcoCyc  database  [151],  and  a  global  thermodynamic  analysis  of
E. coli metabolism [152]. The model comprises three compartments (cytosol, periplasm,
and  extracellular  space),  2,382  reactions  (1,387  metabolic  reactions,  690  transport
reactions, 304 exchange reactions, and 1 biomass reaction), and 1,668 metabolite nodes
(951  cytoplasmic,  418  periplasmic,  and  299  extracellular).  The  growth-associated
maintenance  requirement  (GAM)  is  59.81 mmol ATP gDW−1,  while  the  non-growth
associated maintenance requirement (NGAM) is 8.39 mmol ATP gDW−1 h−1.
The  model  was  downloaded  from the  supplementary  material  of  the  corresponding
publication  [24] in  the SBML format  [153].  The two downloaded SBML files  both
contain the complete model, but the files differ in the lower and upper bounds set for the
reaction  fluxes.  The  different  sets  of  flux  bounds  represent  two  different  growth
scenarios. Both scenarios correspond to growth in defined media with glucose as the
sole carbon source, ammonium as the sole nitrogen source, phosphate as the source of
phosphorus, and sulfate as the sulfur source.
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In  scenario 1 (SBML file  Ec_iAF1260_flux1.xml),  glucose  uptake  is  limited  to  a
maximum  rate  of  8 mmol gDW−1 h−1,  and  the  oxygen  uptake  rate  is  limited  to
18.5 mmol gDW−1 h−1.
In scenario 2 (SBML file Ec_iAF1260_flux2.xml), 152 reactions known to be inactive
during growth on glucose are deactivated, and  the ratio between proton-translocating
and non-proton-translocating NADH dehydrogenase is set to 1:1. The latter constraint is
not present in the SBML file, but is described in the publication [24]. In this scenario,
the glucose uptake rate is limited to 11.0 mmol gDW−1 h−1, and the maximum oxygen
uptake rate is set to 18.2 mmol gDW−1 h−1.
3.1.1.2 iJO1366
The model  iJO1366 is  an updated  version of  iAF1260,  published in  2011  [149].  It
covers  1,366  open  reading  frames  of  the  genome.  The  model  encompasses  2,583
reactions (1,473 metabolic reactions, 778 transport reactions, 330 exchange reactions,
and  2  biomass  reactions)  and  1,805  metabolite  nodes  (1,039  cytoplasmic,  442
periplasmic, and 324 extracellular). Both growth-associated and non-growth-associated
maintenance requirements are considerably lower than the values used in the earlier
model  iAF1260:  The  GAM  is  53.95 mmol ATP gDW−1,  and  the  NGAM  is
3.15 mmol ATP gDW−1 h−1.  The  model  was  downloaded  as  an  SBML file  from the
supplementary material of the corresponding publication [149]. This file only contains
universally valid lower and upper bounds on the reaction fluxes.
The following scenario, which will be referred to as the original scenario, was used to
simulate aerobic growth in a bioreactor in continuous mode in a high-glucose minimal
medium:  The  glucose  uptake  rate  was  limited  to  11.0 mmol gDW−1 h−1,  and  acetate
secretion was added at a forced rate of 6.4 mmol gDW−1 h−1. These values were reported
for exponential growth in a bioreactor  [154], the scenario that corresponds best to the
infinite environment assumed implicitly in steady-state analyses of metabolic models.
In addition, the constraints described for iAF1260 specifically for aerobic growth on
glucose  [24],  which  are  included  in  the  second  scenario  described  in  the  previous
section,  were  adapted  to  this  model.  The  adaptations that  were  performed  include
disabling the reactions known to be inactive for this scenario (transferred from iAF1260
scenario 2)  and  setting  the  ratio  between  proton-translocating  and  non-proton-trans-
locating NADH dehydrogenase to 1:1. The latter was implemented by combining the
two  NADH  dehydrogenase  reactions,  one  translocating  3  protons  per  molecule  of
NADH and the other not translocating any protons, into one reaction that translocates
1.5  protons  per  molecule  of  NADH.  The  uptake  of  any  other  carbon  source  was
disallowed,  and  ammonium,  phosphate,  and  sulfate  were  used  as  sole  sources  of
nitrogen, phosphate, and sulfur, respectively.
As simulations with the set of bounds described by the above scenario displayed some
discrepancies  between  model  predictions  and  experimental  data,  an  alternative
scenario was employed in an attempt to resolve these discrepancies. This scenario was
derived  from  the  original  scenario  described  above  by  adding  a  forced  flux  of
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5 mmol gDW−1 h−1 through  the  following  reaction,  which  is  catalyzed  by  proton-
translocating transhydrogenase (EC 1.6.1.2):
1 NADH + 1 NADP+ + 2 H+[periplasm] → 2 H+ + 1 NAD+ + 1 NADPH
(unmarked metabolites represent cytoplasmic pools).
3.1.2 Thermotoga maritima DSM8: Model iTZ478
A whole-genome  metabolic  reconstruction  of  T. maritima,  designated  iTZ478, was
published  in  2009  [155]. To  the  author’s  knowledge,  it  remains  the  most  current
metabolic model of  T. maritima.  The model was downloaded from the supplementary
material of the publication  [155] in the SBML format.  It covers 478 metabolic genes
and encompasses two compartments (cytoplasmic and extracellular), 645 reactions (562
metabolic or transport reactions, 82 exchange reactions, and 1 biomass reaction), and
564 metabolite nodes (491 cytoplasmic and 73 extracellular).  It  employs a GAM of
45.56 mmol ATP gDW−1. The model does not include an ATP hydrolysis reaction for
modeling the energy requirement of non-growth-associated processes.
Owing to the lack of experimental data on the biomass composition of T. maritima, the
modelers adapted  the  biomass  reaction  from  an  earlier  metabolic  reconstruction  of
E. coli, iJR904 [77], the predecessor of iAF1260, with the following modifications: The
specific  peptidoglycan  composition  of  T. maritima is  represented  in  the  model,  and
specific lipids were incorporated, as far as quantitative information was available. The
proteinogenic amino acid L-asparagine does not occur in the model. As its biosynthesis
in T. maritima is thought to occur in a tRNA-bound state [156] and tRNAs were judged
by  the  authors  of  iTZ478  to  lie  outside  the  scope  of  the  model,  L-asparagine  was
replaced with L-aspartate in the biomass reaction. The authors state that the model is not
suitable for quantitative predictions, but should be able to make qualitatively correct
predictions on gene essentiality and growth capability on different carbon sources [155].
In the studied scenario (defined  by  the  lower and  upper  flux  bounds  present in  the
SBML file), glucose uptake is limited to a rate of 10 mmol gDW−1 h−1. This value does
not  seem  to  be  based  on  experimental  measurements. The  sole  nitrogen  source  is
ammonium, the source of phosphorus is phosphate, and sulfur is imported exclusively in
the form of elemental sulfur. All of these can be taken up at arbitrary rates. In the model,
no distinction is made between ammonia and ammonium.
3.1.3 Pseudomonas aeruginosa PAO1: Model iMO1056
The model iMO1056 was published in 2008 [79]. It contains 874 metabolite nodes and
883 reactions  (1,005 including artificial biomass and exchange reactions), accounting
for 1,056 genes. The model was downloaded from the supplementary material of the
corresponding publication [79]. The minimal medium constraints supplied in the same
file as the model (aerobic growth on glucose, glucose uptake rate: 10 mmol gDW−1 h−1)
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were used for all simulations. In this scenario, the sole  nitrogen source is ammonium,
phosphorus is taken up in the form of phosphate, and the sole sulfur source is sulfate.
3.2 Flux balance analysis (FBA)
Flux balance analysis (FBA) is a mathematical method for predicting the fluxes in a
stoichiometric  metabolic  network  in  steady  state  [15–17].  The  key  assumption
underlying FBA is that the organism under consideration has been optimized through
evolution  for  a  biological  goal,  usually  maximum  growth  at  optimal  utilization  of
available resources. FBA thus solves the following mathematical optimization problem:
Algorithm 1 (Flux balance analysis):
Maximize or minimize an objective function Z (v )
in steady state: S⋅v = 0
with linear inequality constraints: lb ≤ v ≤ ub .
Figure 6: Principle of flux balance analysis: FBA uses mathematical optimization to select a particular
solution from an allowable solution space defined by a set of linear equality and inequality constraints.
Figure taken from [77].
The most commonly used objective function is maximization of biomass production,
which  corresponds  to  the  flux  through  the  biomass  reaction  in  the  model  (see
Section 2.3.5):
Z (v) = v BM. (9)
This is a linear function in v, i.e. a special case of
Z (v) = cT v , (10)
where c is an n × 1 coefficient vector.
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In this case, the optimization problem can be solved using linear programming [157], as
the objective function and all equality and inequality constraints are linear in v. Figure 6
illustrates the principle of FBA schematically.
Other objective functions that have been examined include maximization of ATP yield,
biomass yield per flux unit, or ATP yield per flux unit and minimization of total flux or
glucose  consumption  [158].  Some  of  these,  such  as  ATP yield  per  flux  unit,  are
nonlinear  functions,  which  require  nonlinear  programming.  In  contrast  to  nonlinear
programming, linear programming is always guaranteed to find a global optimum of the
objective function [157].
The reaction fluxes predicted by FBA are net fluxes. Hence, a flux of zero does not
necessarily mean that the reaction is inactive, but merely that the effective rates of the
forward and reverse reactions cancel each other out.
It should further be noted that the solution of the optimization problem is usually not
unique and that out of all optimal solutions, FBA will return an arbitrary one. Seemingly
insignificant changes in the input, such as changing the order of the reactions in the
model, can lead to a different, but also optimal solution. The subregion of the solution
space where the objective function assumes the optimum will be referred to as optimal
solution space from this point on.
3.3 Dead-end analysis
A metabolic  dead  end is  a  metabolite  that  cannot  be  consumed  and  produced  via
separate reactions in the network  [77]. There are two classes of dead ends, those for
which no consuming or no producing reactions exist and those involved in only a single
reversible reaction. In steady state, where the consuming and producing fluxes of each
metabolite  have  to  cancel  each  other  out,  all  reactions  that  involve  a  dead-end
metabolite necessarily have a flux of zero. The reactions that are blocked due to dead
ends can, in turn, induce further dead ends. If, e.g., a reaction producing a dead-end
metabolite is also the only reaction to consume another metabolite, that metabolite is a
dead end as well. This can result in cascades of blocked reactions and induced dead
ends  [159].  Dead  ends  (primary  or  induced)  can  be  identified  exhaustively  by  the
following iterative algorithm:
Algorithm 2 (Iterative dead-end analysis):
Preprocessing: Compile sets producingReactions[i], 
consumingReactions[i] for each metabolite i
deadEnds := ∅
repeat
  newDeadEnds := ∅
  for each metabolite i not in deadEnds
    if (producingReactions[i] = ∅ or consumingReactions[i] =  ∅ or
        | producingReactions[i] ∩ consumingReactions[i] | < 2)
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      newDeadEnds := newDeadEnds  {i}∪
      Mark all reactions involving metabolite i as blocked
    end if
  end for
  deadEnds := deadEnds  newDeadEnds∪
  for each reaction j newly marked as blocked
    for each metabolite i not in deadEnds
      producingReactions[i] := producingReactions[i]  {j}∖
      consumingReactions[i] := consumingReactions[i]  {j}∖
    end for
  end for
until newDeadEnds = ∅
In Algorithm 2,  denotes the empty set;∅  , ∩, ∪ and  are the usual set operators; and∖
| x | denotes the cardinality of set x.
Dead ends can indicate gaps or errors in the network [85]. As the medium composition
is  represented  in  the  model  in  the  form of  restrictions  (i.e. bounds)  on  transport  or
exchange reactions, dead ends occur regularly in degradation pathways for compounds
that are not present in the medium.
For any analysis under steady-state conditions, all dead ends (primary or induced) can
be removed from the network along with all reactions in which they are involved [160].
This reduces the dimension of the stoichiometric matrix S and thus the dimension of the
solution space of the steady-state equation (Equation 2; see Section 2.3.1), which can
greatly reduce the running times of algorithms operating in that solution space.
3.4 Flux variability analysis (FVA)
Figure 7: Flux variability analysis determines a pair of bounds (v i
min , vi
max) for each flux variable v i
of the network within which a (sub)maximal biomass flux is possible. Figure taken from [162].
When using a linear objective function, FBA is guaranteed to find an optimal solution if
the solution space is not empty. However, this solution is not necessarily unique [161].
In  genome-scale  networks,  there  usually  exist  alternative  pathways,  which  are
equivalent with respect to the objective function.  Flux variability analysis (FVA) is a
method for exploring the shape of the optimal solution space [162]. It is only applicable
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to  linear  problems. FVA determines  minimum  and  maximum  values  for  each  flux
variable under the added constraint that the objective function of the FBA be optimal or
near optimal. In geometric terms, FVA finds a hyperrectangle (box) in  n-dimensional
space within which all (sub)optimal solutions lie. This is illustrated for two dimensions
in Figure 7.
The difference between the maximum and minimum values for each flux is called flux
variability.  It  is  a  measure  for  how  strongly  a  flux  is  restricted  by  the  additional
constraint of (sub)optimal biomass flux. Fluxes with low variability are essential for the
formation of biomass, while highly variable fluxes can be replaced by other fluxes in
the network.
FVA consecutively solves two linear optimization problems per reaction in the network.
This is described more formally below.
Algorithm 3 (Flux variability analysis):
For each reaction j:
Minimize v j
in steady state: S⋅v = 0
with linear inequality constraints: lb ≤ v ≤ ub
and the additional constraint ∣Z (v)∣≥ γ⋅∣Z opt, FBA∣.
Repeat the above with maximization instead of minimization (or, equivalently, 
minimization of −v j  instead of v j ).
In Algorithm 3, Z(v) denotes the objective function of the FBA (usually biomass flux),
Zopt, FBA is the FBA optimum, and γ is a threshold parameter between zero and one. This
parameter determines how much the optimality constraint is to be relaxed (as a fraction
of Zopt, FBA). For instance, a value of 0.95 signifies that the objective function value may
differ by up to 5% from the optimum. If γ is set to one, only truly optimal solutions are
explored.
It is worth noting that a solution exists for each linear optimization problem considered
in FVA, because any FBA solution lies within the solution space. The running time of
FVA can be improved in practice by launching each optimization from the previous
optimal solution instead of starting from a fix or random point in the solution space or,
worse, starting over every time by generating an initial feasible solution  [163]. This
improvement  is  based  on  the  observation  that  the  solutions  of  linear  optimization
problems with slightly changed objective functions tend to be located near each other in
the search space [163].
In the interpretation of FVA results it is important to note that a very large or infinite
flux  variability  does  not  usually  signify the  presence of  true  biological  alternatives,
25
3 Materials and methods
where flux can be distributed arbitrarily between alternative metabolic routes. Indeed, a
state where two pathways with exactly the same function are present would likely be
unstable  over  time.  Without  strong conservative selection,  one of  the two pathways
would be free to degenerate or to evolve a new function, as is the case with duplicated
genes [164,165]. Rather, infinite variability is an indicator of uncertainty in the model,
e.g.  regarding  cofactor  specificity  or  reaction  directionality  [103].  Moreover,  the
duplication of any reaction with unbounded flux in the model results in two reactions
with infinite flux variability.
3.5 Minimization of metabolic adjustment (MOMA)
The core assumption of FBA, that the studied organism has been optimized through
evolution for optimal growth (or a different biological goal), is only valid for wild-type
organisms growing in natural or near-natural conditions.  Artificially created mutants
have  not  had  the  time  to  undergo  evolutionary  optimization.  Major  rerouting  of
metabolic  fluxes,  e.g.  in  response to  the knockout  of  a metabolic  enzyme,  is  likely
impeded by regulatory mechanisms, including gene regulation and enzyme inhibition,
which are still the same as in the wild type. Similarly, the evolutionary assumption is
not valid for the wild type growing in a medium with a very different composition from
the organism’s natural habitat or in other non-natural conditions.
Figure 8: Minimization of metabolic adjustment (MOMA) projects the flux distribution of the wild type
(a) onto the allowable solution space of the mutant (yellow). The solution (c) can differ strongly from the
FBA solution of the mutant (b). Figure taken from [166].
Minimization of metabolic adjustment (MOMA) is based instead on the assumption that
the flux distribution in a perturbed network will be as close to that of the unperturbed
(wild-type) network as is still possible within the modified solution space [166]. It uses
the same equality and inequality constraints as FBA (aside from constraints defining the
genetic or environmental modification)  but a different objective function.  While FBA
maximizes the  biomass  flux,  MOMA minimizes  the  Euclidean distance  of  the  flux
vector  to  the  flux  distribution  of  the  unperturbed  network.  Geometrically,  this
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corresponds to a projection of the wild-type flux vector onto the solution space of the
perturbed network, as shown schematically in Figure 8.
Given  a  reference  flux  distribution  vWT,  MOMA solves  the  following  optimization
problem:
Algorithm 4 (Minimization of metabolic adjustment):
Minimize D(v) = (v−vWT)
T(v−vWT)
in steady state: S⋅v = 0
with linear inequality constraints: lb ≤ v ≤ ub .
In  practice,  the  square  of  the  Euclidean distance  is  used  as  objective  function  (see
Algorithm 4). This is possible because squaring is a monotonically increasing function,
so that minimizing the original or the squared objective function will yield the same
solution [166]. Similarly, any constant offset or factor can be omitted from the objective
function in mathematical optimization. The squared objective function is quadratic in v.
Hence,  the  optimization  problem  can  be  solved  using  convex  quadratic
programming [167].
While FBA allows the prediction of network behavior from network topology, network
stoichiometry, and a set of constraints on the fluxes alone, MOMA requires a reference
flux distribution. This limitation is shared by regulatory on/off minimization (ROOM), a
related method for predicting the flux distribution of perturbed networks. In contrast to
MOMA, ROOM minimizes the number of changed fluxes rather than the total amount
of flux change compared to a reference flux vector  [168]. In both methods, an FBA
solution for the unperturbed network is usually employed as reference.
3.6 Weighted MOMA (wMOMA)
The solutions returned by MOMA and related methods are only as good as the reference
vector. Using an experimentally determined flux distribution would be ideal. However,
while  13C tracer experiments can resolve the high-magnitude fluxes in central carbon
metabolism and in  amino acid  biosynthesis  pathways  [119,169],  it  is  impossible  to
determine  the  in-vivo fluxes  through  all  reactions  in  the  network.  Because  of  this
limitation, in-silico predictions obtained via FBA are used instead.
If the metabolism of the modeled organism is not well understood, a high degree of
uncertainty may remain in the use of cofactors and alternative reaction sets. Hence, the
difference between extreme FBA solutions from opposite ends of the optimal solution
space may be substantial. MOMA predictions for a perturbed network can consequently
differ widely depending on the FBA solution used as reference. Weighted MOMA, a
method developed in the present work, uses a weighted Euclidean distance as objective
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function,  with weights based on the degree of uncertainty in the FBA solution.  The
degree of uncertainty for each flux variable is assessed via FVA.
Weighted  MOMA thus  performs  the  following  optimization,  based  on  the  given
reference flux distribution vWT:
Algorithm 5 (Weighted MOMA):
Perform FVA for wild type  → v i
min , v i
max .
Compute weights from flux variability:
w i = α + exp(−β(v i
max−v i
min)).
Minimize D(v) = (v−vWT)
T diag(w)(v−vWT)
in steady state: S⋅v = 0
with linear inequality constraints: lb ≤ v ≤ ub .
In Algorithm 5, w is an n × 1 vector of weights. The optimality parameter γ for FVA is
an additional input of the algorithm, as are the values of the positive parameters α and β.
Figure 9: The exponentially decreasing weight function used in weighted MOMA: Weight w i as function
of the variability of flux vi. Flux variability is determined via FVA. A value of α = 10−6 was used for all
three curves.
The decreasing exponential function that was chosen for the computation of the weights
assigns a weight of one to fluxes that are restricted to a single value by the constraint of
(sub)optimal  biomass.  This  function  was chosen because  it  is  most  sensitive in  the
relevant region near zero and assigns a very low weight (close to the base value of α) to
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highly  variable  fluxes.  The  parameter  β determines  the  steepness  of  the  function.
Figure 9 shows the weight function for three different values of β.
This weight function ensures that fluxes that are sharply restricted by the constraint of
optimal biomass are weighted up, while unrestricted fluxes are weighted down.
3.7 Split-ratio analysis
The following algorithm was developed in the course of this work for the computation
of metabolite fluxes and split ratios from reaction fluxes. It was first described in [170].
Algorithm 6 (Split-ratio analysis):
Given a stoichiometric matrix S and a flux vector v,
For each metabolite i:
Compute partial fluxes ρij = s ij⋅v j  for all reactions j and group into 
positive (producing) and negative (consuming):
P i = { j ∣ρij > 0}, C i = { j ∣ρij < 0}.
Compute Φi =∑
j∈Pi
ρij =−∑
j∈C i
ρij  and divide partial fluxes by this sum:
ρij
* =
ρij
Φi
.
The ρij
*  computed by Algorithm 6 are collectively called the split ratios of metabolite i.
If positive,  ρij
*  is the fraction of metabolite i produced via reaction j. If negative, it is
the fraction consumed via that reaction. The ρij
*  are usually expressed as percentages of
Φi ,  the total  flux through metabolite  i.  Φi  is  also called the flux sum of metabo-
lite i [11].
Based on split ratio analysis, metabolite nodes can be divided into three classes for the
growth  scenario  under  consideration:  Inactive  metabolite  nodes,  intermediates,  and
branch  points.  A metabolite  is  inactive  if  it  does  not  occur  in  any  reaction  with  a
non-zero flux, which results in a flux sum of zero. A pure intermediate or transitory
metabolite node is a metabolite that is produced by exactly one reaction and consumed
by exactly one reaction. Branch points are metabolite nodes where fluxes branch or join,
i.e. metabolites involved in more than two active reactions.
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3.8 Branch point analysis (BPA)
Branch  point  analysis  (BPA)  is  a  graphical  extension  of  split-ratio  analysis,  which
allows the visual analysis of the extended metabolic context of a selected metabolite or
reaction or sets of metabolites and reactions. The method was developed in our group
by René Rex [170].
Figure 10: The algorithm of branch point analysis proceeds in four steps: (A) The full bipartite graph is
generated via split-ratio analysis. In the example, R1 has been selected as hub, X is to be disconnected,
and Y is to be removed. (B) Selected nodes are disconnected (X) and removed (Y), respectively. (C) Each
sequence of transitory nodes  (–B–R2–C–) is bridged by a combined edge. (D) Nodes with a distance
from the hub of more than the selected maximum depth (2) are removed. (E) Output graph. Figure taken
from [170].
Figure 10 illustrates the algorithm for a small example network. In the simplest case, the
inputs of the algorithm are a flux distribution (e.g. an FBA solution), a hub node, a list
of nodes (reactions or metabolites) to be excluded, a list of nodes to be disconnected,
and a parameter maxDepth. The hub is the reaction or metabolite node whose metabolic
context  is  to  be  displayed.  By excluding  or  disconnecting  certain  nodes,  the  graph
output can be made clearer. Typical candidates for exclusion are metabolites that are
ubiquitous but not of interest in most conditions, such as H+, H2O, and phosphate. Other
promiscuous  metabolites,  i.e.  metabolites  participating  in  a  large  number  of  active
reactions, such as ATP, NADH, and coenzyme A, should be disconnected in order to
prevent crowding of the graph.
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BPA overlays the split ratios and metabolite fluxes computed by split-ratio analysis on a
bipartite graph representation of the metabolic network (see Section 2.3) reduced to the
selected metabolic context. The algorithm is described in detail below.
Algorithm 7 (Branch point analysis):
Perform split-ratio analysis on the given flux distribution.
Construct the bipartite graph from the active reactions and metabolites; set edge
directions from the signs of the reaction fluxes.
Label  edges  with  split  ratios  (as  percentage  of  the  flux  through  the  adjacent
metabolite node) and metabolite nodes with the respective flux sums.
Remove each node to be excluded from the graph, along with the adjacent edges.
Replace  each  node  to  be  disconnected  by  separate  instances  for  each  edge
involving the node.
While the graph contains nodes with exactly one incoming and one outgoing edge
(transitory nodes):
Pick a transitory node T. Let P→T and T→N denote the incoming and 
outgoing edges, respectively.
Remove T, P→T, and T→N from the network.
Introduce a new combined edge P→N.
Remove all nodes from the graph that have a distance of more than  maxDepth
from the hub node.
Note that the final graph contains only metabolic branch points, i.e. nodes where fluxes
join or split, except for the hub, which is included in the graph even if it is a transitory
node.
By selecting more than one hub for the analysis, it is possible to use BPA for the visual
analysis of larger metabolic contexts, such as metabolic pathways or metabolite pools.
In our implementation, only the largest connected component is displayed in case the
resulting graph is disconnected.
BPA was implemented by René Rex as an optional extension of  metano,  the software
toolkit presented in this thesis. The resulting program, AMEBA (Advanced MEtabolic
Branchpoint  Analysis),  can  be  downloaded  from  http://metano.tu-bs.de/  ameb  a  .  Like
metano, it is implemented in the Python programming language and distributed under
the GNU General Public License version 3.
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3.9 Metabolite flux minimization (MFM)
The following algorithm computes the minimum flux through each metabolite node
under the added constraint that the objective function of the FBA be (sub)optimal. Like
FVA,  it  is  only applicable  to  linear  problems. The algorithm was developed in the
course of this work and first described in [170].
Metabolite  flux  minimization  (MFM)  operates  on  flux  variables  that  are  split  into
non-negative components:
v j = v j
+ − v j
− , where v j
+ ≥ 0 and v j
− ≥ 0.
This  splitting  is  achieved  by  adding  negative  copies  of  the  columns  of  the
stoichiometric matrix  S to the matrix. Lower and upper bounds have to be adjusted
accordingly. In practice, flux variables constrained to zero, e.g. because the original flux
variable was constrained to be non-negative or non-positive, can be removed along with
the corresponding columns of S.
Algorithm 8 (Metabolite flux minimization):
Transform the flux vector v into a vector of non-negative flux variables and adapt
the stoichiometric matrix S and the bounds vectors lb and ub accordingly.
For each metabolite i:
Minimize ∑
j
sij
+⋅v j , where sij
+={sij , sij ≥ 00, else
in steady state: S⋅v = 0
with linear inequality constraints: lb ≤ v ≤ ub
and the additional constraint ∣Z (v )∣≥ γ⋅∣Zopt, FBA∣.
MFM solves one linear optimization problem per metabolite node in the network. In
Algorithm 8, Z(v), Zopt, FBA, and γ have the same meanings as in FVA (see Section 3.4).
γ  is again a threshold parameter between zero and one determining how much the opti-
mality constraint is to be relaxed. The algorithm successively minimizes the producing
flux for each metabolite node.
3.10 Automated plausibility checking of metabolic models
When reconstructing the metabolic model of a particular organism, certain metabolic
behaviors will be expected, e.g. based on the organism’s taxonomy and ecology. For
instance, in an organism known to be strictly aerobic, the model should not allow for
growth without uptake of oxygen. To give another example, in all organisms in which
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both  glycolysis  and  gluconeogenesis  are  present,  a  strong  glycolytic  flux  is  to  be
expected for growth on carbohydrates,  while gluconeogenesis can be expected to be
active for most other substrates that can be utilized.
Such expectations can be used to automatically check a metabolic model for biological
plausibility in a given growth scenario or set of scenarios. Any such expectation can be
formalized as a set of assertions, i.e. expressions that can be evaluated to True or False,
where  the  expected  result  evaluates  to  True [171].  The assertions  contain  variables
representing, e.g., reaction fluxes, metabolite fluxes, split ratios, and the minimum and
maximum values for reaction fluxes determined by FVA.
The following algorithm automatically processes a list of assertions and reports those
that are violated in the scenario under consideration:
Algorithm 9 (Evaluation of model assertions):
Given a reaction file, scenario file, FVA threshold parameter, and list of assertions:
Perform FBA
Compute metabolite fluxes and split ratios from FBA solution
Perform FVA with the given threshold parameter
Evaluate all assertions
Report all assertions that failed or could not be evaluated
3.11 Prediction of reaction directionality from Gibbs free energies
In principle, all chemical reactions are reversible [172]. Under physiological conditions,
however,  a  reaction may very well be irreversible, depending on the change in Gibbs
free energy associated with that reaction. For any reaction j, the difference in Gibbs free
energy between reactants and products can be computed from the Gibbs energies of
formation of each reactant and product as follows:
Δ rG j=∑
i
s ijΔ f Gi
0 + RT ln(∏
i
ci
sij)  [101]. (11)
In Equation  11, s ij  is  the stoichiometric  coefficient  of metabolite  i in  reaction  j as
defined in Section 2.3.1, c i  is the concentration of metabolite i, Δ f Gi
0  is the standard
Gibbs energy of formation of metabolite i, T is the absolute temperature in Kelvin, and
R is the gas constant (≈ 8.314 J mol−1 K−1). The  (transformed)  standard Gibbs energies
of  formation  Δ f Gi
0  are  approximately  constant  for  given  ionic  strength  and  pH
values [173]. They have been experimentally determined [174] or estimated using group
contribution methods [175] for many biomolecules [176].
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The net reaction proceeds from left to right if Δ rG j  is negative, else from right to left.
It is obvious from Equation 11 that the direction of a biochemical reaction depends only
on  the  temperature  and  the  concentrations  of  the  reactants  and  products.  As  the
temperature is constant in steady state, the directionality of biochemical reactions can be
predicted from the physiological ranges of the metabolite concentrations [101,113]:
A lower bound for  Δ rG j  can be computed via Equation 11 by setting the concentra-
tions of the products (which have positive coefficients s ij ) to their lower bounds and
those  of  the  reactants  (which  have  negative  coefficients sij )  to  their  upper  bounds.
Similarly,  an  upper  bound  is  obtained  by  using  the  upper  bounds  of  the  product
concentrations and the lower bounds of the reactant concentrations.
If the lower and upper bounds of Δ rG j  computed in this way have the same sign, the
reaction is irreversible for the given physiological concentration ranges. If the sign is
negative, the reaction proceeds in the forward direction, else in the backward direction.
If the lower and upper bounds have opposite signs, the reaction is reversible.
Obviously, if the measured  physiological  ranges  for the metabolite concentrations  are
too broad, nearly all reactions will be classified as reversible, which reduces the utility
of this approach. If, on the other hand, the measured ranges  underestimate the actual
variability,  reactions may falsely be assumed to be irreversible,  which may exclude
physiological metabolic capabilities.
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4 Implementation and validation
4.1 Overview
metano is a collection of algorithmic tools for analyzing the capabilities of metabolic
networks and for assisting in metabolic reconstruction. It has been implemented in the
Python programming language1 and is designed to be easy to use and run reasonably
fast.  metano is  distributed  as  open  source  under  the  GNU  General  Public  License
version 3 (http://www.gnu.org/licenses/gpl.html). Source code and documentation are
provided via the website  http://metano.tu-bs.de. An object-oriented approach has been
chosen for the design and implementation in order to ensure long-term maintainability
and easy extensibility of the software.
All tools in metano are available in two forms, as stand-alone programs and as Python
classes. The stand-alone programs are designed to run in any Linux environment. They
can be run from the Linux console and require neither a graphical display nor a database
connection, which makes them well-suited for batch execution in a massively parallel
computing environment.  The stand-alone scripts  use plain ASCII files  for input and
output. The scripts require no adjustment of numerical parameters so as to be easy to
use by metabolic modelers with little or no programming experience. On the other hand,
the Python classes and functions of metano have been designed in such a way that they
can be directly included in any Python software project. The interfaces (constructors and
parameter  lists)  have  been  designed  with  the  goal  of  easy  reuse,  requiring  as  little
context as possible.
The  computational  methods  implemented  in  metano fall  into  three  categories:
(i)  Prediction of flux distributions and reaction-centric analyses (FBA, FVA, MOMA,
wMOMA), (ii) assistance in the construction of metabolic models (dead-end analysis,
automated  plausibility  checking,  prediction  of  reaction  directionality),  and
(iii)  metabolite-centric analyses (split-ratio analysis, metabolite flux minimization). In
addition,  metano features parsers and writers for both its native file formats and the
Systems Biology Markup Language (SBML), a standard for the exchange of biological
network models [153,177].
Algorithms with a long running time have been parallelized using the Message-Passing
Interface  (MPI)  [178] via  the mpi4py interface2,  so  that  they  can be  run on cluster
computers without modification of the code.
metano includes  interfaces  to  a  number  of  solvers  for  mathematical  optimization
problems, most of which are also open source software: For linear programming, the
1 Python Software Foundation, http://www.python.org
2 MPI for Python, L. Dalcin, http://mpi4py.scipy.org
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supported  solvers  are  lp_solve1 and  the  GNU  Linear  Programming  Kit  (GLPK)2,
interfaced  via  OpenOpt3 and  PyMathProg4,  respectively,  which  provide  Python
bindings. For quadratic programming,  metano uses the quadratic cone program solver
implemented in CVXOPT5, accessed via the CVXMOD modeling interface6. For non-
linear programming, the ALGENCAN solver  [179] is used, which is available free of
charge for academic users7. ALGENCAN is also accessed via the OpenOpt interface.
4.2 Class structure
The  design  of  metano follows  the  object-oriented  paradigm  of  software  develop-
ment [180]. The classes of metano fall into three categories: classes for data storage and
exchange, input/output classes, and algorithmic classes.
The central data storage classes of metano are MetabolicModel and MetabolicFlux. The
first  is  used  to  represent  a  metabolic  model,  while  the  latter  is  used for  the  repre-
sentation  of  a  flux  distribution  in  a  network,  i.e.  a  flux  vector.  A MetabolicModel
encompasses not only the network itself, but also network-associated parameters such
as flux bounds. The MetabolicModel class stores the biochemical reactions forming the
network as a list of objects of the class Reaction. The Reaction class stores the reaction
name, the reaction equation in the form of lists of (coefficient, metabolite) pairs for the
two sides of the reaction,  and the lower and upper bounds for the flux through the
reaction. The special value inf is used to denote the absence of a bound (+inf for upper
and −inf for lower bounds). The (coefficient, metabolite) pairs are stored as instances
of the class Reactant instead of simple tuples, which allows addressing the values by
name rather than by index. The MetabolicModel class was designed in cooperation with
René Rex.
The  member  functions  of  the  MetabolicModel  class  include  functions  for  filling  a
MetabolicModel  with  data  read  from files  (via  the  ReactionParser  and ParamParser
classes described below) and for writing a metabolic model to ASCII files in metano’s
native reaction file format. Furthermore, the class provides functions for extracting sub-
networks (also represented as instances of MetabolicModel) according to user-provided
criteria and for constructing the stoichiometric matrix from the list of reactions. Finally,
MetabolicModel  implements  topology-based  analyses,  including  the  automatic
detection  of  boundary  reactions  and  the  identification  of  duplicate  reactions  in  the
network. As the presence of dead ends is a network property, dead-end analysis (see
1 lp_solve 5.5, http://lpsolve.sourceforge.net
2 The GNU project, http://www.gnu.org/software/glpk
3 National Academy of Sciences of Ukraine, http://www.openopt.org
4 http://pymprog.sourceforge.net
5 M. Andersen, J. Dahl, and L. Vandenberghe, http://abel.ee.ucla.edu/cvxopt
6 J. Mattingley, Stanford University, http://cvxmod.net
7 TANGO project, http://www.ime.usp.br/~egbirgin/tango/downloads.php
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Section  3.3) has also been implemented as a member function of the MetabolicModel
class.
The MetabolicFlux class represents a flux distribution as a Python dictionary assigning
a flux value to each reaction by name. In addition, it can optionally store the effective
flux bounds in a similar dictionary. It provides functions for reading and writing flux
distributions  in  metano’s  native  ASCII  file  format  and  for  the  conversion  between
different representations of flux distributions. The most important of these conversions
are  from and  to  a  flat  vector,  represented  as  a  Python  list,  where  flux  values  are
addressed  by  index  rather  than  by  reaction  name.  In  these  conversion  functions,  a
MetabolicModel can be supplied for providing the association between reaction names
and indices. In addition, the MetabolicFlux class implements different semimetrics for
computing the distance between two flux vectors (currently Manhattan distance and
squared  Euclidean  distance).  Finally,  split-ratio  analysis  (see  Section  3.7)  has  been
implemented as a member function of the MetabolicFlux class.
The dedicated input/output classes are ReactionParser,  ParamParser,  SbmlParser,  and
SbmlWriter.  metano natively uses  plain  ASCII  formats  for  storing lists  of  reactions
(reaction files), scenario-specific parameters (scenario files), and flux distributions (flux
files).  Detailed  descriptions  of  these  file  formats  can  be  found  online  under
http://metano.tu-bs.de/quickref.html#fileform.  A  parser  for  reaction  files  has  been
implemented  in  the  class  ReactionParser.  As  mentioned  above,  instances  of
MetabolicModel  can  be  constructed  directly  from reaction  files.  The  corresponding
function  internally  calls  a  ReactionParser  to  generate  a  list  of  Reaction  objects.
Similarly, the ParamParser is used for parsing a scenario file, which most importantly
contains explicit  definitions of flux bounds to  be applied in addition to the implicit
bounds imposed by the irreversibility of reactions. The resulting lists of explicit (finite)
bounds can then be used to update the bounds stored in a MetabolicModel in order to
adapt the MetabolicModel to the simulation scenario.
Besides  its  native  file  formats,  metano also  supports  the  SBML format  (Systems
Biology  Markup  Language).  The  classes  SbmlParser  and  SbmlWriter  implement  a
parser  and  an  export  filter,  respectively,  for  SBML files.  The  two  classes  and  the
associated stand-alone Python scripts  for the conversion between the file formats of
metano and SBML were originally developed by Alexander Krause in the course of a
3-week internship under supervision of the present author. All elements represented in
one MetabolicModel and one MetabolicFlux object can be represented in one SBML
file. However, owing to the great flexibility of the language, most elements in SBML
are  optional.  Hence,  an  SBML file  from a  third  party  will  usually  not  contain  all
elements necessary for constructing a MetabolicModel or for performing flux balance
analysis on the model.
The  most  important  algorithmic  classes  of  metano are  FbAnalyzer,  FvAnalyzer,
MomaAnalyzer,  MfmAnalyzer,  and  ModelWatcher.  They  implement  FBA  (see
Section  3.2),  FVA (see  Section  3.4),  MOMA/wMOMA (see  Sections  3.5 and  3.6),
metabolite flux minimization (see Section 3.9), and the automated plausibility checking
described in Section  3.10, respectively. FbAnalyzer, FvAnalyzer, MomaAnalyzer, and
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MfmAnalyzer  internally  use  the  following  classes  for  representing  and  solving  the
mathematical  optimization  problems  arising  in  the  analyses:  LinearProblem,
QuadraticProblem, MomaProblem, and NonLinearProblem. The inheritance schema of
these classes is shown in Figure 11.
Figure  11:  Inheritance  schema  for  the  metano classes  for  representing  and  solving  mathematical
optimization problems.
LinearProblem  is  used  to  represent  linear  programs,  QuadraticProblem  represents
quadratic  programs,  and  NonLinearProblem  represents  general  nonlinear  programs.
MomaProblem is a specialization of QuadraticProblem for representing and efficiently
solving  the  specific  problem  occurring  in  MOMA,  i.e.  minimization  of  Euclidean
distance, which is a convex quadratic program.
4.3 Flux balance analysis
Virtually all existing implementations of FBA assign arbitrary large lower and upper
bounds  (e.g.  −10,000  and  +10,000)  to  all  flux  variables  for  which  no  biological
restrictions are known [14,103,181–183]. In these implementations, each flux variable
vi has a finite lower bound lbi and a finite upper bound ubi. A notable exception is the
recently-published CoPE-FBA [21]. The introduction of artificial bounds amounts to a
modification of the solution space: The original flux cone, which is unbounded in some
dimensions, is replaced by a polytope, which is bounded in all dimensions  [21]. This
modification  introduces  additional  vertices  to  the  optimal  solution  space.  This  is
illustrated schematically in Figure 12.
Linear optimization problems such as those occurring in FBA are usually solved using a
variant of the simplex method [94,184]. The simplex method solves a linear program on
a solution space defined by sets of equality and inequality constraints by finding a basis
of the solution space (i.e. an initial solution) and subsequently performing a series of
basis transformations [157]. In each iteration, all optimization variables that are not part
of the basis are set to extreme values defined by the given inequality constraints (either
the  lower  or  the  upper  bound).  Consequently,  the  simplex  method  only  considers
vertices of the solution space when looking for an optimal solution.  As the simplex
algorithm operates on non-negative variables, zero is assigned as default value to all
non-basis  variables  that  are  not  otherwise  constrained.  In  FBA,  the  non-negative
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optimization variables are obtained from the flux variables by splitting the latter into
non-negative components (as described in Section 3.9). This is equivalent to modeling
the  forward  and  backward  fluxes  through  each  reaction  by  separate  non-negative
variables.
Figure  12:  The  introduction  of  arbitrary  large  bounds  on  reaction  fluxes  with  no  known biological
restriction (exemplified by upper bound ub in panel B) introduces spurious vertices to the solution space
of flux balance analysis. These vertices can appear as possible solutions when solving the linear program
with a variation of the simplex algorithm. Shown in gray is the solution space of FBA (A) without and
(B) with an artificial large bound ub. Z is the (linear) objective function.
As all optimal solutions returned by the simplex algorithm are vertices of the solution
space,  introducing  artificial  large  bounds  and  thus  additional  vertices  increases  the
number  of  possible  optimal  solutions  (see  Figure  12).  The  additional  vertices
correspond to flux distributions in which a subset of the artificial, non-biological large
bounds is actually assumed. In this way, arbitrary large cyclic fluxes are assigned to
reactions in thermodynamically infeasible loops, as such fluxes do not affect the value
of the objective function (see Section 2.4). An example can be seen in the flux distri-
bution predicted by the object-oriented open-source implementation SurreyFBA [185]
for  the  E. coli model  iAF1260  under  scenario 1  (see  Section 3.1.1.1).  Table  21 in
Appendix A shows the relevant excerpt from this flux distribution. The flux distribution
contains 19 fluxes with an absolute value of more than 999,000 mmol gDW−1 h−1.
As  mentioned  in  Section 2.4,  several  widely  used  implementations  of  FBA employ
artificial large bounds when formulating the linear program and remedy the problem of
cyclic fluxes through infeasible loops by secondary corrections.  These often involve
nested  optimization  strategies  or  the  exhaustive  identification  and  elimination  of
infeasible loops. Among these implementations is the COBRA toolbox [14,186], which
is possibly the most popular software tool for performing FBA. In contrast, the metano
implementation of FBA applies only explicit bounds and lower or upper bounds of zero
implied by the irreversibility of reactions.  metano thus allows flux variables that are
unbounded on one or both sides. If the flux through the biomass reaction is used as
objective function and fluxes with no known biological restrictions are left unbounded,
non-productive fluxes (i.e. those not contributing to biomass formation) do not occur in
FBA. In particular,  cyclic fluxes through thermodynamically  infeasible loops do not
occur. While the exhaustive identification of stoichiometrically balanced cycles may be
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a worthwhile goal in itself, special treatment of infeasible loops is not required when
performing FBA on the unmodified solution space.
FBA has  been  implemented  in  metano with  the  following  features:  Firstly,  flux
variables are split into non-negative components, as described in Section 3.9. While the
simplex method only works on non-negative variables, virtually all existing solvers for
linear programs include a presolver, which automatically performs such preprocessing.
However, the advantage of explicitly working with split flux variables is that the total
flux through the network can be computed easily as the sum of all flux variables.
Secondly,  the  implementation  of  FBA in  metano includes  dead-end  analysis  as  a
preprocessing step, which is performed before flux variables are split. In this step, the
stoichiometric matrix  S is reduced by iterative removal of all  dead ends and blocked
reactions  from the  network.  FBA is  then  performed  on the  resulting  stoichiometric
matrix  with  reduced  dimension.  The  reactions  removed  in  preprocessing  are  added
again to the returned solution with a flux of zero. The effect of reducing the dimension
of the problem before optimization is a considerable speedup. For instance, the model
iAF1260 can be reduced from 2,382 reactions and 1,668 metabolites to 2,148 reactions
and 1,452 metabolites, which amounts to a decrease in the number of entries of the
stoichiometric matrix by 22%. It should be noted that if an inequality constraint exists
forcing a blocked reaction to assume a non-zero flux, the problem is infeasible.
Thirdly, metano FBA supports alternative objective functions besides the biomass flux.
Any linear or general nonlinear function can be used: A linear function can be specified
by its coefficient vector, while a nonlinear function can be given directly as a Python
function  and,  optionally,  a  second  Python  function  for  the  gradient.  As  detailed  in
Section 4.1,  metano includes interfaces to  a number of linear  and nonlinear solvers.
Since it is generally impossible to identify the global optimum of an arbitrary nonlinear
function or even to determine with certainty whether the function is bounded, nonlinear
optimization  is  repeated  a  user-specified  number  of  times  from  randomly  chosen
starting  points.  In  this  case,  the  optimum  of  all  runs  is  returned  along  with  the
corresponding flux distribution. Of course, this is still not guaranteed to be the global
optimum.
Finally,  metano provides the option to secondarily minimize the total flux through the
network, i.e. the sum of the absolute flux values. This secondary optimization has been
implemented as a binary search for the lowest possible value of an additional upper
bound on the sum of all non-negative flux variables that still leads to an optimal FBA
solution.
To demonstrate the correctness of the present implementation,  it  was applied to the
E. coli model iAF1260 for scenario 1 described in Section 3.1.1.1 (glucose uptake rate:
8 mmol gDW−1 h−1,  oxygen  uptake  rate:  ≤ 18.5 mmol gDW−1 h−1).  The  predicted  flux
distribution was compared to solutions generated by two existing implementations of
FBA, the COBRA toolbox  [14,186] and SurreyFBA [185]. The COBRA toolbox was
chosen  because  of  its  high  popularity  in  the  metabolic  modeling  community  (for
instance, a Google Scholar search returns over 440 hits for the string “COBRA toolbox”
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as of  March 2013). Furthermore, the authors of iAF1260 performed their analyses on
the  model  using  the  COBRA  toolbox  and  published  their  FBA  solutions  as
supplementary  material  with  the  original  publication  [24].  SurreyFBA was  chosen
because it  shares  the  design features  of  being both object-oriented  and open-source
software with metano.
The  FBA solution  of  metano was  obtained  using  the  linear  solver  GLPK with  the
objective of maximizing the biomass flux without secondary minimization of total flux.
The solution conforms to all linear and nonlinear bounds within numerical error: No
upper  bounds  were  violated,  and  no  lower  bound  was  violated  by  more  than
4.1×10−17 mmol gDW−1 h−1.  The  average  deviation  from zero  in  the  vector  S∙v (see
Equation 2 on page 9) was below 8.8×10−17 mmol gDW−1 h−1, with a maximum absolute
deviation  of  2.6×10−14 mmol gDW−1 h−1.  The  solution  is  optimal,  as  the  predicted
biomass flux agrees with the solutions of the COBRA toolbox and SurreyFBA to within
10−6 h−1 (both the COBRA toolbox solution and the SurreyFBA solution are rounded to
six digits). A detailed comparison of the three flux distributions is given in Appendix A.
The three flux distributions are in agreement except for alternative pathway use.
It  is  worth  noting  that  of  the  three  implementations  only  SurreyFBA predicts  large
cyclic fluxes through infeasible loops, as the COBRA toolbox implements a secondary
optimization strategy to prevent the occurrence of such fluxes. The strategy used by the
most recent version of the COBRA toolbox has been termed  loopless FBA [103]. It
involves  solving  a  mixed-integer  linear  optimization  problem  instead  of  a  linear
program, which is much more computationally intensive [103,186].
4.4 Flux variability analysis
metano implements the ‘fastFVA’ variant of flux variability analysis [163], where each
optimal solution discovered is used as the starting point of the following optimization
(see Section 3.4 for a brief description). The FBA optimum of the objective function can
be determined in one of three ways: It can either be obtained from an FBA solution
passed as a MetabolicFlux object or a flux file or be computed by performing an FBA
prior to the analysis.
As in FBA, a dead-end analysis is performed as a preprocessing step in order to speed
up the analysis. As any reaction blocked due to dead ends necessarily has a flux of zero,
no  optimization  is  required  in  this  case.  FVA has,  however,  been  implemented  in
metano without the explicit splitting of flux variables that is performed prior to FBA, as
that  would  make  the  formulation  of  the  resulting  optimization  problems  less  clear
without having any benefit.
In contrast  to FBA, arbitrary large bounds of ±100,000 mmol gDW−1 h−1 are used in
FVA in order to ensure that all of the optimization problems are bounded. By using a
sufficiently large (i.e. non-biological) value for the artificial bounds, fluxes with infinite
variability can be identified reliably from the solution alone. Otherwise, it  would be
necessary to query the internal status of the linear program solver to distinguish between
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infeasible and unbounded problems and possible error states. This would be difficult, as
the supported solvers  each use different representations and data  structures for their
internal status.
4.5 MOMA and weighted MOMA
MOMA and wMOMA have been implemented in a common set of Python functions –
the method is selected via an optional parameter: If a vector of weights is supplied,
wMOMA  is  performed,  else  MOMA.  MOMA  and  wMOMA  use  the  CVXOPT
quadratic cone program solver by default, but any quadratic or general nonlinear solver
can be used.
Reducing the stoichiometric matrix prior to analysis is even more important for MOMA
and  wMOMA  than  for  FBA,  because  quadratic  cone  programming  is  more
computationally intensive than linear programming. By default, a dead-end analysis is
performed for the identification of blocked reactions. Alternatively, a more exhaustive
approach is available that involves FVA: Any reaction that is restricted to a flux value of
zero with a flux variability of zero (determined at a relaxed threshold parameter, e.g.
γ = 0.9) can be removed from the stoichiometric matrix.  All  metabolites that are no
longer involved in any reaction can then be removed in a second step. This approach
can potentially identify reactions that are not blocked due to dead ends but nevertheless
cannot  carry  a  flux.  For  instance,  for the  E. coli model  iAF1260 in  scenario 1 (see
Section 3.1.1.1), exhaustive dead-end analysis identifies 234 of the 2,382 reactions as
blocked and 216  of the 1,668 metabolites as dead ends, while FVA reveals that 844
reactions and 628 metabolite nodes can never carry a flux. In this case, the number of
entries in the stoichiometric matrix can be reduced by 60% (compared to 22% when
using dead-end analysis).  This strategy is, however, only applicable when the solution
space of the mutant is a subset of the wild-type solution space. If the mutant scenario
has additional reactions or relaxed constraints, reactions that are blocked in the wild
type are not necessarily blocked in the mutant as well.
As mentioned above, any vector of weights can be used in wMOMA. Per default, the
weight  vector  is  computed  from  a  given  FVA result  according  to  the  decreasing
exponential function described in Section 3.6. If parameter values are not supplied, the
default values of α = 10−6 and β = 0.15 are used.
To  automatically  evaluate  the  results  of  MOMA and  wMOMA on  genome-scale
metabolic  models,  a  script  for  in-silico knockout  analysis  has  been  developed.  It
successively applies MOMA or wMOMA to all scenarios where exactly one reaction is
knocked out, i.e. has its flux constrained to zero. This analysis serves mostly testing and
validation purposes, as it does not use a biological concept of knockouts. In reality, it is
of  course  impossible  to  knock  out  individual  biochemical  reactions.  The  biological
entities  that  can  be  knocked out  are  stretches  of  DNA,  including genes,  regulatory
elements, clusters of genes, and whole plasmids or chromosomes. This difference is
important, as some reactions are catalyzed by more than one enzyme, some reactions
are not gene-associated (e.g. spontaneous reactions), some enzymes catalyze more than
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one  reaction,  and  some  genes  encode  proteins  with  similar  function.  However,  an
automated  analysis  of  all  single-gene  knockouts  would  require  the  accurate
representation of gene-reaction associations, which are  at present  outside the scope of
metano. Gene-reaction associations are best represented in electronic databases, while
metano is specifically designed to operate on ASCII files. It is, however, straightforward
to implement an in-silico analysis of all single-gene knockouts by successively applying
the  methods  of  metano to  scenarios  derived  from  a  more  comprehensive  database
representation (cf. [187]).
The automated knockout analysis implemented in  metano supports three methods for
predicting  the  flux  distribution  for  the  knockout  scenarios:  FBA,  MOMA,  and
wMOMA. While  FBA is  a  less  accurate  tool  for  predicting  the  flux  distribution  in
perturbed networks than MOMA (see Section  3.5), it also has a much lower running
time and can give an upper bound on the possible biomass flux: If FBA already predicts
a knockout to be lethal, that scenario need not be examined using MOMA or wMOMA.
As the analysis of all scenarios where exactly one reaction is knocked out is a very
computationally  intensive  process,  particularly  when  using  MOMA/wMOMA,  the
analysis has been parallelized under the dispatcher-worker paradigm  [188] using  the
Message-Passing Interface (MPI) [178].
4.6 Metabolite flux minimization
Like metano’s implementations of FBA and FVA, the implementation of metabolite flux
minimization in metano employs iterative dead-end analysis as a preprocessing step in
order to speed up the analysis. The flux through any dead-end metabolite or blocked
reaction is necessarily zero due to the steady-state condition. Therefore, all dead ends
and blocked reactions can be omitted in the analysis, which reduces both the number of
optimizations  and  the  dimension  of  each  optimization  problem.  As  described  in
Section 3.9, MFM requires that flux variables be split into non-negative components.
Since the algorithm of MFM is very similar to FVA, it is also amenable to the ‘fastFVA’
strategy, where each optimization is started from the previous optimal solution  [163].
MFM has been implemented with this speedup in metano.
Like FVA, MFM requires the value of the FBA optimum of the objective function. If
this value is not supplied, FBA is performed prior to the analysis.
4.7 Model assertion monitor
The algorithm for automated plausibility checking of metabolic models described in
Section 3.10 has been implemented in metano in the Python class ModelWatcher. This
class defines an assertion monitor, which is associated with a model and can then be
called  repeatedly,  e.g.  to  check  for  biological  plausibility  under  different  growth
scenarios.
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The assertions are either given as a list of strings or as lines in an ASCII file. The
assertions contain symbolic references to reaction fluxes, metabolite fluxes, split ratios,
and the minimum and maximum flux values determined by FVA. These identifiers are
substituted by actual Python variable references prior to evaluation of the assertions.
This substitution is performed via regular expressions [189].
The actual evaluation of assertions is performed by calling Python’s built-in  eval()
function. It should be noted that this allows the execution of arbitrary code inserted in
the assertion file. It is the user’s responsibility to use only Python functions that do not
produce disruptive side effects. While this approach has been deemed acceptable for the
present application, it makes metano’s model assertion monitor unsuitable for execution
in a non-safe environment, such as in a web-based application. Syntax checking and
actual  evaluation of  the assertions  have  been implemented  in  separate  functions,  as
syntax  checks  can  be  performed  without  actually  running  any  potentially
time-consuming numerical analyses on the model.
The  following  symbolic  identifiers  are  defined:  Reaction  fluxes  are  identified  by
reaction  names  as  they  appear  in  the  reaction  file.  By  analogy,  the  flux  through  a
metabolite node is  identified by the corresponding metabolite name.  Split  ratios are
represented  by  the  strings  inratio(<metab>,  <rea>) and outratio(<metab>,
<rea>) respectively, where <metab> is a metabolite name and <rea> is a reaction name.
The  two  symbols  represent  a  producing  (‘inratio’)  or  consuming  (‘outratio’)  flux
through  metabolite  node  <metab> via  reaction  <rea>.  Similarly,  the  maximum and
minimum  values  for  the  flux  through  reaction  <rea>  as  determined  by  FVA are
addressed as min(<rea>) and max(<rea>), respectively.
The  substitution  of  the  symbolic  references  involves  a search  for  non-overlapping
longest matches of reaction and metabolite names. For this to work, no reaction may
have the same name as any metabolite. Processing longest matches first ensures that the
substitution  algorithm  behaves  correctly  for  identifiers  that  are  substrings  of  other
identifiers. For instance, the model iJO1366 contains both the metabolite ‘AMP’ and the
reaction ‘AMP_nucleosidase’.  Processing the  shorter  string before  the longer  would
lead to the nonsensical concatenation of a variable reference to the flux through AMP
and the non-matching string ‘_nucleosidase’.
4.8 Free-energy-based assignment of reaction directions
The computation of the lower and upper bounds of the changes in Gibbs free energies
associated  with  the  reactions  in  a  metabolic  network  and  the  actual  assignment  of
reaction directions have been implemented in two separate programs in metano.
The first script reads in a metabolic model from a reaction file, a list of minimum and
maximum  physiological  concentrations  for  different  metabolites,  a  list  of  Gibbs
energies  of  formation,  and the  temperature  in degrees  Celsius.  The script  computes
lower and upper bounds for the Gibbs free energy changes according to the algorithm
described in Section 3.11. Only those reactions are processed for which Gibbs energies
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of  formation  and  concentration  ranges  are  given  for  each  reactant  and  product.
Equation  11 is not applied directly in the form shown in  Section  3.11.  For reasons of
numerical stability, the term ln(∏
i
c i
sij)  is computed as ∑
i
sij ln c i .
The second script reads a metabolic model from a reaction file and a set of flux bounds
from a scenario file and a list of lower and upper bounds of Gibbs free energy changes
as computed by the first script. It then  creates a new set of flux bounds based on the
Gibbs  free  energy  ranges,  as  described  in  Section  3.11.  The  new  flux  bounds  are
combined with the original bounds and written to a new scenario file, and all changes
and conflicts are reported.
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Existing  studies  on  genome-scale  metabolic  models  tend  to  focus  on  large-scale
analyses of the qualitative model predictions for  various experimental scenarios. The
most common of these analyses are in-silico knockout studies and in-silico analyses of
the  qualitative  metabolic  behavior  depending  on  media  conditions.  In  an  in-silico
knockout analysis, hundreds to thousands of single- or double-gene knockouts are gene-
rated in silico and evaluated with respect to a small number of biological measures, such
as biomass flux, respiration rate, or export rate of a metabolic product  [79,190–193].
The  parameters  that  are  varied  in  studies  assessing  the qualitative  predictions  of  a
metabolic model in different growth scenarios include the carbon source, the nitrogen
source,  and  the  rate  of  oxygen  supply  [77,78,194–196]. Owing  to  its  efficient
implementations (see Sections  4.3 to  4.6),  metano is well suited for such large-scale
studies and has been successfully applied in analyses involving thousands to hundreds
of thousands of simulations [187,197].
In contrast,  the goal  of  the present  study was to  analyze the  quantitative metabolic
behavior  for  one  specific  scenario  in  detail.  Experimental  results,  particularly  from
fluxomics  experiments  and  gene  deletion  studies,  were  employed  for  assessing  the
accuracy of the model’s predictions for the scenario under study. Parts of the results
described and discussed in the following subsection (Section 5.1) have been published
earlier [170].
5.1 Escherichia coli
Flux balance analysis was performed on the model iJO1366, the most recent metabolic
reconstruction of  E. coli, for carbon-limited aerobic growth in a defined high-glucose
medium. The studied growth scenarios are described in detail in Section 3.1.1.2. In the
FBA solution for the original scenario, the biomass flux is 0.85 h−1, the oxygen uptake
rate is 16.5 mmol gDW−1 h−1, and the CO2 emission rate is 18.2 mmol gDW−1 h−1. 552 of
the 2,583 reactions (21%) involving 557 of the 1,805 metabolites (31%) were predicted
to  be  active  (at  a  cutoff  of  10−12 mmol gDW−1 h−1).  Split-ratio  analysis  on  the  FBA
solution revealed that 401 of the 557 metabolites carrying a flux are each produced via a
single reaction and consumed via another single reaction. Thus, these metabolite nodes
are  purely  transitory  in  the  scenario  under  consideration.  Only  the  remaining  156
metabolites (8.6% of all metabolite nodes or 28% of the active metabolites) are branch
points, where fluxes split or join.
5.1.1 Balance sheets of currency metabolites
Inside  the  cell,  chemical  energy  is  transferred  primarily  in  two  forms:  energy-rich
phosphate bonds and strong reducing agents. Energy-rich phosphates that act as cellular
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energy  carriers  include  nucleoside  triphosphates  (most  importantly  ATP)  and
phosphoenolpyruvate (PEP) [55]. Cellular reducing agents include the free nicotinamide
dinucleotides NADH and NADPH, the protein-bound flavin nucleotides FADH2 and
FMNH2, membrane-associated isoprenoid quinols such as ubiquinol and menaquinol,
the tripeptide glutathione,  and redox proteins  such as ferredoxins,  thioredoxins,  and
cytochromes [198]. Most of these reducing agents are either proteins, protein-bound, or
membrane-associated, and many act only in specific pathways such as the detoxification
of free radicals. Only NADH and NADPH act as flexible ‘currency metabolites’.
In order to characterize the energy metabolism as predicted by the model, the balance
sheets of all relevant currency metabolites were compiled using split-ratio analysis on
the FBA solution for the original scenario. The balance sheets (Tables  2 to  9) list for
each  reaction  either  the  pathway  to  which  it  belongs  or  the  biomass  components
produced from the reaction’s main products. As this information was compiled using
branch point analysis, it reflects the actual metabolic fate of the reaction products as
predicted by FBA for the scenario under consideration.
As only two D-amino acids are active in the FBA solution (D-alanine and D-glutamate),
each of which is produced from the respective L-amino acid by a racemase, unmarked
names of amino acids will hereafter be used to denote the L-forms.
ATP
ATP is produced (and consumed) at a rate of 69.7 mmol gDW−1 h−1. The ATP-producing
reactions  are  shown  in  Table  2 along  with  their  relative  contributions.  More  than
three-fifths  of  the total  ATP (61.4%) is  produced in oxidative  phosphorylation.  The
other ATP-producing processes are glycolysis (25.5%), the conversion of acetyl-CoA to
acetate (8.5%), recycling of diphosphate (4.0%), and the TCA cycle (0.7%).
Table  2: Split ratios of ATP-producing fluxes (E. coli). Total flux: 69.7 mmol gDW−1 h−1. Ratios below
0.05% not shown.
Reaction/Enzyme Pathway/Product Ratio
ATP synthase oxidative phosphorylation 61.35%
phosphoglycerate kinase glycolysis 25.47%
acetate kinase acetate export 8.46%
polyphosphate kinase recycling of diphosphate 4.02%
succinyl-CoA synthetase TCA cycle 0.71%
This result conforms to the expectation that under aerobic growth conditions, the vast
majority of ATP is produced via oxidative phosphorylation [199].
48
5 Application to published metabolic models
Table  3: Split ratios of ATP-consuming fluxes (E. coli). Total flux: 69.7 mmol gDW−1 h−1. Ratios below
0.05%  not  shown.  Abbreviations:  AICAR  –  5-aminoimidazole-4-carboxamide  ribotide,  PRPP  –
phosphoribosyl pyrophosphate
Reaction/Enzyme Pathway/Product Ratio
Biomass (incl. GAM) 66.39%
phosphofructokinase glycolysis 8.77%
ATP maintenance requirement NGAM 4.52%
adenylate kinase AMP→ADP 2.73%
acetyl-CoA carboxylase fatty acids 2.68%
AICAR biosynthesis from PRPP (5 reactions) purines 2.67%
glutamine synthetase glutamine 2.13%
aspartate kinase threonine, methionine, lysine, peptidoglycans 1.28%
PRPP synthetase pentose phosphate pathway 1.11%
nucleoside-diphosphate kinase GTP 0.92%
carbamate kinase pyrimidines, arginine, polyamines 0.75%
homoserine kinase threonine 0.65%
nucleoside-diphosphate kinase UTP 0.49%
shikimate kinase shikimate pathway 0.46%
UMP kinase pyrimidines 0.44%
acetylglutamate kinase arginine, polyamines 0.40%
argininosuccinate synthase arginine 0.35%
adenylyl-sulfate kinase sulfur metabolism 0.30%
sulfate adenyltransferase sulfur metabolism 0.30%
guanylate kinase purines 0.29%
GMP synthase purines 0.29%
asparagine synthetase asparagine 0.29%
glutamate 5-kinase proline 0.26%
cytidylate kinase pyrimidines 0.20%
CTP synthase (glutamine) pyrimidines 0.19%
glucose-1-phosphate adenylyltransferase glycogen 0.19%
nucleoside-diphosphate kinase CTP 0.17%
6 reactions in cell wall synthesis peptidoglycans 0.17%
7 reactions in lipopolysaccharide biosynthesis lipopolysaccharide 0.13%
phospholipid export (2×3 reactions) phospholipids 0.11%
ATP phosphoribosyltransferase histidine, purines 0.11%
Table 3 lists the split ratios of the reactions that consume ATP in the scenario under
study. Two-thirds of the ATP (66.2%) is expended as growth-associated maintenance
energy (GAM) in the virtual biomass reaction. Glycolysis also consumes a substantial
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fraction  of  the  total  ATP (8.8%).  In  addition,  4.5%  of  the  ATP  is  consumed  in
non-growth-associated  maintenance  processes  (NGAM),  and  2.7%  is  used  for  the
(re)phosphorylation of AMP to ADP. The major part of the remaining 17.6% is utilized
in  anabolic  pathways,  including amino acid  biosynthesis  (6.2%),  purine metabolism
(3.4%), fatty acid biosynthesis (2.7%), and pyrimidine metabolism (1.2%). 1.6% of the
ATP is converted to the other nucleoside triphosphates GTP (0.9%), UTP (0.5%), and
CTP (0.2%). The synthesis of phosphoribosyl pyrophosphate in the pentose phosphate
pathway consumes 1.1% of the ATP, while 0.6% is used for the assimilation of sulfur,
which is taken up by the cell in the form of sulfate. 0.2% of the ATP enters the biomass
directly (via the biomass reaction), and small fractions are consumed in further anabolic
pathways,  including  those  producing  peptidoglycans,  glycogen,  deoxyribonucleoside
triphosphates, lipopolysaccharide, phospholipids, and various cofactors.
Within the amino acid biosynthetic pathways, glutamine biosynthesis accounts for the
largest  fraction  of  the ATP consumption  (2.1% of  the total  ATP flux),  followed by
threonine (1.3%) and arginine (1.1%). ATP is  further  needed in the biosyntheses of
lysine,  asparagine,  proline,  methionine,  histidine,  and  the  aromatic  amino  acids
phenylalanine, tyrosine, and tryptophan. In addition, cysteine biosynthesis is dependent
on hydrogen sulfide,  which  is  produced from sulfate  via  the  ATP-dependent  sulfur
assimilation pathway.
The  diphosphate  recycling  reaction  (ADP  +  diphosphate  ⇌ ATP  +  phosphate)
regenerates some ‘spent’ ATP. When considering the net ATP balance, it is therefore
necessary  to  subtract  the  flux  through  this  reaction  from  both  sides.  In  addition,
glycolysis  both  consumes  and produces  ATP.  The lower  of  the  two fluxes,  i.e.  the
ATP-consuming  flux  of  6.1 mmol gDW−1 h−1 should  be  subtracted  as  well.  The
remaining, non-cyclic flux through ATP is 60.8 mmol gDW−1 h−1, i.e. the predicted net
ATP production rate is 5.5 moles per mole of glucose.
GTP, UTP, CTP
The total fluxes through the other nucleoside triphosphates are low (GTP: 0.64, UTP:
0.34,  CTP:  0.25 mmol gDW−1 h−1).  Using metabolite  flux  minimization,  these  fluxes
were found to be essential for biomass production – in fact, all three values correspond
to the minimal values necessary for optimal biomass production. However, while the
fluxes through GTP, UTP, and CTP are essential, they are not contributing substantially
to energy metabolism, which is dominated by ATP and phosphoenolpyruvate.
GTP,  UTP,  and  47.1% of  the  CTP are  produced  from ATP and  the  corresponding
diphosphate via nucleoside-diphosphate kinase, while 52.9% of the CTP is produced
from UTP via CTP synthase. The reactions consuming GTP, UTP, and CTP are shown
in Tables 4 to 6 with their respective contributions.
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Table  4: Split ratios of GTP-consuming fluxes (E. coli). Total flux: 0.64 mmol gDW−1 h−1. Ratios below
0.05% not shown.
Reaction/Enzyme Pathway/Product Ratio
adenylosuccinate synthase purines 38.76%
sulfate adenyltransferase sulfur metabolism 33.08%
Biomass 27.91%
GTP cyclohydrolase I folate biosynthesis 0.12%
GTP cyclohydrolase II flavin biosynthesis 0.06%
Table  5: Split ratios of UTP-consuming fluxes (E. coli). Total flux: 0.34 mmol gDW−1 h−1. Ratios below
0.05% not shown.
Reaction/Enzyme Pathway/Product Ratio
CTP synthase CTP 38.90%
Biomass 35.06%
UDP-N-acetylglucosamine diphosphorylase peptidoglycans, lipopolysaccharide 17.88%
UTP-glucose-1-phosphate uridylyltransferase lipopolysaccharide 8.16%
Table  6: Split ratios of CTP-consuming fluxes (E. coli). Total flux: 0.25 mmol gDW−1 h−1. Ratios below
0.05% not shown.
Reaction/Enzyme Pathway/Product Ratio
CDP-diacylglycerol synthetase (3 reactions) phospholipids 45.01%
Biomass 44.21%
3-deoxy-manno-octulosonate cytidylyltransferase lipopolysaccharide 8.33%
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase isoprenoid biosynthesis 2.26%
phosphopantothenate-cysteine ligase coenzyme A 0.20%
38.8% of the GTP is consumed in the de-novo biosynthesis of AMP, 33.1% is used in
sulfur assimilation, while 27.9% enters the biomass. GTP is also the starting molecule in
folate (0.12%) and flavin biosynthesis (0.06%). 38.9% of the total UTP is converted to
CTP,  while  35.1%  enters  the  biomass,  and  13.8%  is  consumed  in  peptidoglycan
biosynthesis. Another 12.2% is utilized for the biosynthesis of lipopolysaccharide. The
main  processes  consuming  CTP  are  phospholipid  biosynthesis  (45.0%),  biomass
formation (44.2%), and lipopolysaccharide biosynthesis (8.3%). Small amounts of CTP
are also needed in isoprenoid (2.2%) and coenzyme A biosynthesis (0.2%).
Phosphoenolpyruvate (PEP)
The flux through PEP is 16.3 mmol gDW−1 h−1. As shown in  Table 7, all PEP is pro-
duced via a single reaction in glycolysis  but consumed in a number of reactions  in
different pathways. FVA was used to verify that for the biomass flux to be optimal, PEP
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cannot be produced via any other way than the enolase reaction. This is expected for
growth on glucose, as PEP production via other reactions (PEP carboxykinase and PEP
synthase, respectively) occurs mainly in gluconeogenesis and is associated with ATP
hydrolysis [200,201].
Table  7: Phosphoenolpyruvate (PEP) balance (E. coli). Total flux: 16.3 mmol gDW−1 h−1. Ratios below
0.05% not shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
enolase glycolysis 100%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
glucose import (phosphotransferase system) glycolysis 67.49%
PEP carboxylase anaplerotic reactions 15.35%
dihydroxyacetone kinase glycolysis 12.99%
3-phosphoshikimate 1-carboxyvinyltransferase shikimate pathway 1.95%
3-deoxy-7-phosphoheptulonate synthase shikimate pathway 1.95%
UDP-N-acetylglucosamine 1-carboxyvinyltransferase peptidoglycans 0.14%
3-deoxy-8-phosphooctulonate synthase lipopolysaccharide 0.13%
E. coli uses a phosphotransferase system for the uptake and phosphorylation of mono-
and oligosaccharides. In the process, PEP is converted to pyruvate. In the FBA solution
for the original scenario, the phosphotransferase system accounts for two-thirds of the
total PEP flux (67.5%). Anaplerotic replenishing of the TCA cycle via PEP carboxylase
accounts for the second largest fraction (15.4%). 13.0% of the PEP is consumed in the
phosphorylation of dihydroxyacetone to dihydroxyacetone phosphate. In the shikimate
pathway, PEP is consumed in two reactions. Together they consume 3.9% of the total
PEP.  In  addition,  smaller  fractions  of  PEP  are  consumed  in  the  biosynthesis  of
peptidoglycans and lipopolysaccharide.
As the phosphotransferase system is the main mode of glucose uptake in E. coli [202],
the large PEP flux through the phosphotransferase system is expected for a scenario
with rapid glucose uptake.
In contrast, the high flux through dihydroxyacetone (DHA) kinase predicted by FBA is
unexpected.  The  flux  through  DHA  is  2.1 mmol gDW−1 h−1,  99.7%  of  which  is
converted to dihydroxyacetone phosphate by DHA kinase. DHA, while being a usable
carbon source [203], is not known as an intracellular metabolite in E. coli except in the
degradation of glycerol  [204,205]. In the FBA solution, glycerol degradation accounts
for  only  0.26%  of  the  DHA flux.  FVA confirms  that  the  flux  through  glycerol
dehydrogenase  has  a  tight  range  of  4–19 µmol gDW−1 h−1 under  the  constraint  of
optimal  biomass  production.  100%  of  the  DHA is  produced  from  the  cleavage  of
fructose 6-phosphate (F6P) to glyceraldehyde 3-phosphate and DHA by the enzyme F6P
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aldolase. While the F6P aldolase reaction is active in the FBA solution, FVA revealed
that it need not be active for optimal growth. In addition, the minimum flux through
DHA required for optimal growth is 5.5 µmol gDW−1 h−1, as computed via MFM.
F6P aldolase was described in E. coli in 2000 [206]. However, nothing is known about
its function or expression in vivo. Glycolysis in E. coli has been studied for more than
seven  decades  and  is  known  to  proceed  via  the  Embden-Meyerhof-Parnas  path-
way  [207]. It  involves  the  phosphorylation  of  F6P to  fructose  1,6-bisphosphate  via
phosphofructokinase and the cleavage of fructose 1,6-bisphosphate to glyceraldehyde
3-phosphate and dihydroxyacetone phosphate via fructose-bisphosphate aldolase [200].
In the model, F6P aldolase is an alternative to fructose-bisphosphate aldolase because
the reaction pair F6P aldolase + DHA kinase is stoichiometrically equivalent to the pair
phosphofructokinase  +  fructose-bisphosphate  aldolase  except  for  using  a  different
phosphorylating agent (PEP instead of ATP). As noted above, this alternative pathway
has, however, never been observed in vivo. Moreover, the discoverers of F6P aldolase
note  that  the  catalyzed  reaction  is  10 kJ mol−1 more  endergonic  than  the  reaction
catalyzed by fructose-bisphosphate aldolase [206]. The reaction is therefore unlikely to
proceed in the cleavage direction under the conditions found in the cell.
Therefore,  the  model’s  predictions  would  conform  more  closely  to  experimental
observations if the F6P aldolase reaction were removed or at least constrained to the
condensation direction. An FBA with cleavage of F6P disallowed (via an upper bound
of zero on the F6P aldolase flux) yielded a flux distribution where 99.3% of all F6P is
converted to fructose 1,6-bisphosphate via phosphofructokinase. The flux distribution in
this case corresponds to the Embden-Meyerhof-Parnas pathway as it is described for
E. coli.
Net balance of glycolysis
As glycolysis in  E. coli produces both ATP and PEP as energy-rich phosphates, a net
balance can be compiled by combining the balance sheets for these two metabolites. In
the FBA solution for the original scenario, glycolysis (including the phosphotransferase
system)  generates  1.6  molecules  of  ATP and 1.5  PEP per  molecule  of  glucose  and
consumes 0.6 ATP and 1.2 PEP. Hence, the net balance is positive with an output of
1.1 ATP and 0.3 PEP per glucose molecule (all values rounded to two significant digits).
In the FBA solution, glycolysis thus operates at 67.4% of its theoretical maximum yield
of 2 molecules of ATP or PEP per molecule of glucose  [55], while one-third of the
metabolic flux (32.6%) branches from the superpathway of glycolysis and the pentose
phosphate pathway towards anabolic pathways.
NADH
In  the  FBA solution  for  the  original  scenario,  the  rate  of  NADH  production  and
consumption is 33.7 mmol gDW−1 h−1. The split ratios are shown in Table 8. Nearly 85%
of the total  NADH is  produced in glycolysis  (52.7%) and the  subsequent  oxidative
decarboxylation of pyruvate to acetyl-CoA (32.1%). Another 8.1% is generated in the
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TCA cycle.  The  remaining  NADH  arises  as  a  byproduct  of  various  amino  acid
biosyntheses (6.2%), purine biosynthesis (0.6%), and folate metabolism (0.1%).
Table 8: NADH balance (E. coli). Total flux: 33.7 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
glyceraldehyde-3-phosphate dehydrogenase glycolysis 52.74%
pyruvate dehydrogenase glycolysis/TCA cycle 32.14%
malate dehydrogenase TCA cycle 5.35%
phosphoglycerate dehydrogenase serine 4.31%
2-oxoglutarate dehydrogenase TCA cycle 2.78%
3-isopropylmalate dehydrogenase leucine 1.11%
Inosine monophosphate (IMP) dehydrogenase purines 0.60%
histidinol dehydrogenase histidine 0.47%
prephenate dehydrogenase tyrosine 0.34%
glycine cleavage system folate metabolism 0.14%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
NADH dehydrogenase oxidative phosphorylation 94.48%
enoyl-[acyl-carrier-protein] reductase (11 reactions) fatty acids 5.10%
methylenetetrahydrofolate reductase methionine 0.40%
NADH  is  used  almost  exclusively  for  the  generation  of  ATP  via  oxidative
phosphorylation (94.5%). Of the pathways accounting for at least 0.05% of the NADH
flux, only the biosyntheses of fatty acids (5.1%) and the amino acid methionine (0.4%)
use NADH as reducing agent.
These results are in agreement with the general principle that in aerobically growing
cells, NADH is chiefly used for ATP generation, while NADPH is used as reducing
agent  in  anabolic  pathways  [55].  Furthermore,  when  growing  aerobically  on
carbohydrates, cells are expected to produce NADH primarily via glycolysis and the
TCA cycle [55].
NADPH and thioredoxin
The  flux  through  NADPH  is  13.9 mmol gDW−1 h−1.  The  reactions  that  produce  or
consume NADPH are shown in  Table 9 along with their split ratios. While the flux
through NADPH is less than half the NADH flux, NADPH is consumed in many more
reactions than NADH. In the predicted flux distribution, NADPH stems mainly from the
oxidative branch of the pentose phosphate pathway (PPP), which accounts for 80.7% of
the  NADPH-producing  flux.  13.4% is  generated  in  the  TCA cycle  via  the  enzyme
54
5 Application to published metabolic models
isocitrate dehydrogenase, and the remaining 5.9% arises as a byproduct in association
with purine metabolism.
Table 9: NADPH balance (E. coli). Total flux: 13.9 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
glucose 6-phosphate dehydrogenase pentose phosphate pathway 40.35%
phosphogluconate dehydrogenase pentose phosphate pathway 40.35%
isocitrate dehydrogenase TCA cycle 13.40%
methylenetetrahydrofolate dehydrogenase purines 5.89%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
glutamate dehydrogenase glutamate 51.65%
3-oxoacyl-[acyl-carrier-protein] reductase 
(11 reactions) fatty acids 13.41%
ketol-acid reductoisomerase (2 reactions) valine, leucine, isoleucine, coenzyme A 6.95%
aspartate semialdehyde dehydrogenase threonine, methionine, lysine, peptidoglycans 6.43%
sulfite reductase sulfur metabolism 4.57%
homoserine dehydrogenase threonine, methionine 4.21%
shikimate dehydrogenase shikimate pathway 2.28%
dihydrodipicolinate reductase lysine, peptidoglycans 2.22%
thioredoxin reductase conversions to other redox carriers 2.14%
N-acetyl-γ-glutamyl-phosphate reductase arginine, polyamines 2.01%
glutamate 5-semialdehyde dehydrogenase proline 1.32%
pyrroline 5-carboxylate reductase proline 1.32%
glycerol 3-phosphate dehydrogenase phospholipids 1.03%
UDP-N-acetylenolpyruvoylglucosamine 
reductase peptidoglycans 0.17%
dihydrofolate reductase folate metabolism 0.16%
dTDP-4-dehydrorhamnose reductase lipopolysaccharide 0.05%
In the FBA solution for the original scenario, NADPH is used in 33 reactions with a flux
of more than 0.1 µmol gDW−1 h−1. More than 90% of the NADPH is consumed in only
two groups of pathways – amino acid biosynthesis  (77.8%) and fatty acid synthesis
(13.4%). The provision of glutamate alone accounts for 51.7% of the total  NADPH
consumption. The other amino acid biosynthetic pathways with direct use of NADPH
are  those  of  threonine  (6.5% of  the  total  NADPH),  lysine  (4.1%),  leucine  (2.7%),
proline (2.6%), valine (2.5%), methionine (1.9%), arginine (1.8%), isoleucine (1.7%),
phenylalanine (1.1%), tyrosine (0.8%), and tryptophan (0.3%). The biosyntheses of all
three  branched-chain  amino  acids  together  consume  7.0%,  and  those  of  the  three
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aromatic amino acids combined account for 2.3%. Moreover, NADPH is consumed in
sulfur  assimilation  (4.6%);  the  provision  of  reduced  thioredoxin  (2.1%);  the
biosynthesis of phospholipids (1.0%), polyamines, peptidoglycans, lipopolysaccharide,
and various cofactors; and folate metabolism (0.16%).
The majority of the reduced thioredoxin is likewise used in sulfur assimilation (71.1%),
while  28.9% is  consumed  in  the  biosynthesis  of  deoxyribonucleotides.  In  the  FBA
solution, thioredoxin reductase (EC 1.6.4.5), which uses NADPH as electron donor, is
the  only  source  of  reduced  thioredoxin.  The  flux  through  reduced  thioredoxin  is
0.30 mmol gDW−1 h−1.
The predicted ratios of the NADPH-producing fluxes are in disagreement with in-vivo
values  for  E. coli grown  aerobically  on  glucose  that  were  determined  by  13C  flux
analysis: While 35–45% of the NADPH stems from the oxidative PPP, another 35–45%
is produced by a proton-translocating transhydrogenase, and 20–25% is generated by
isocitrate  dehydrogenase  [208].  The  transhydrogenase  PntAB  (EC 1.6.1.2)  is  a
membrane-integral protein that converts NADP+ and NADH to NADPH and NAD+ at
the cost of proton flux from the periplasm to the cytosol. Activity of this enzyme thus
reduces  the  number  of  protons  available  for  ATP  generation  in  oxidative  phos-
phorylation.  This energy cost,  which induces an increase in respiration, is likely the
reason why, according to FVA, at optimal biomass flux, no transhydrogenase activity is
possible in the model. The experimental results and an FVA for optimal biomass flux
agree that there is no significant NADPH production via malic enzyme (EC 1.1.1.40) in
the studied scenario [208].
In an exploratory attempt to reconcile the model’s predictions with the experimental
observations, FBA was performed for an alternative scenario, which differs from the
original scenario in the lower bound of the transhydrogenase flux (5 mmol gDW−1 h−1
instead  of  zero).  The  FBA  solution  for  the  alternative  scenario  reproduces
experimentally measured values for the growth rate and the rates of CO2 emission and
O2 uptake similarly well as the FBA solution for the original scenario (see Appendix B).
In  contrast  to  the  solution  for  the  original  scenario,  the  ratios  between
NADPH-producing  reactions  predicted  by  FBA  for  the  alternative  scenario  are
consistent with the experimental results  [208]: 37% is produced in the oxidative PPP,
36%  results  from  transhydrogenase  activity,  and  21%  is  produced  by  isocitrate
dehydrogenase.
The observation that NADPH is involved in many more reactions than NADH while
having a lower total flux than NADH conforms as well to the paradigm that NADH is
used primarily in energy metabolism while NADPH is used as electron donor in redox
reactions in anabolic pathways [55].
The predictions for thioredoxin correspond to known metabolic roles of thioredoxin and
thioredoxin reductase  [209]. However, MFM revealed that in the model, flux through
thioredoxin  is  not  essential  for  optimal  aerobic  growth  on  glucose  (see  also
Section  5.1.4).  The  reason  is  that  the  model  contains  alternatives  to  the  reactions
involving  thioredoxins.  The  alternative  reactions  use  other  reducing  agents,  mainly
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NADPH and reduced glutathione. Thioredoxins are known to be redundant in  E. coli
growing under steady-state conditions – trxA trxC double mutants are phenotypically
inconspicuous  under  non-stress  conditions  [210]. Thioredoxins  may,  however,  be
essential for the oxidative stress response [211]. As the response to physiological stress
is an inherently non-steady-state process  [212], FBA is not applicable to the study of
such conditions.
5.1.2 Selected branch points
As  mentioned  above,  only  156  metabolites  (8.6%  of  the  metabolite  nodes  in  the
network) are branch points. In this subsection, selected branch points are analyzed in
detail.  The  following  two  goals  were  pursued  in  the  analyses  presented  here:  To
elucidate  the metabolic  roles of the selected metabolites and to  identify the relative
contributions of the biochemical pathways branching or joining in the respective branch
points. All these analyses are scenario-specific as they were performed on a specific
simulation scenario – the original scenario for model iJO1366, unless otherwise noted.
Table  10:  Split  ratios  of  2-oxoglutarate  (E. coli).  Total  flux:
8.12 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
aspartate transaminase aspartate 29.99%
isocitrate dehydrogenase TCA cycle 22.96%
phosphoserine transaminase serine 17.85%
L-alanine transaminase alanine 5.78%
leucine transaminase leucine 4.61%
valine transaminase valine 4.33%
succinyldiaminopimelate transaminase lysine, peptidoglycans 3.80%
acetylornithine transaminase arginine, polyamines 3.45%
isoleucine transaminase isoleucine 2.97%
phenylalanine transaminase phenylalanine 1.89%
tyrosine transaminase tyrosine 1.41%
histidinol-phosphate transaminase histidine 0.97%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
glutamate dehydrogenase glutamate 88.48%
2-oxoglutarate dehydrogenase TCA cycle 11.51%
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2-Oxoglutarate
The total flux through 2-oxoglutarate is 8.1 mmol gDW−1 h−1. The corresponding split
ratios are shown in Table 10.
The  ratios  of  the  producing  fluxes  reveal  that  77.0% of  the  total  2-oxoglutarate  is
produced as a byproduct in various transamination reactions. In each of these reactions,
a transaminase (EC class 2.6.1) transfers the amino group of glutamate to an acceptor
molecule, yielding 2-oxoglutarate as a byproduct. In this context, 2-oxoglutarate can be
thought of as ‘spent glutamate’.  Only 23.0% is synthesized via the TCA cycle.  The
transaminase reactions form a cycle with glutamate dehydrogenase (EC 1.4.1.4), which
produces  glutamate  from  2-oxoglutarate  and  ammonia  at  the  expense  of  NADPH
oxidation.  In  the  scenario  under  consideration,  88.5% of  the  total  2-oxoglutarate  is
consumed  by  this  reaction,  and  only  11.5%  is  metabolized  in  the  TCA cycle  via
2-oxoglutarate dehydrogenase.
A net balance can be compiled by subtracting the cyclic flux of 6.3 mmol gDW−1 h−1
from both sides. In this net balance, 100% of the 2-oxoglutarate is produced in the TCA
cycle, and 50.1% is converted to succinyl-CoA in the TCA cycle, while 49.9% is used to
produce glutamate.
Glutamate
Table 11 lists the ratios of the fluxes producing and consuming glutamate. The split
ratios reveal the presence of a second transamination cycle in which the amino-group
donor is glutamine, which is converted to glutamate in the process.
85.0%  is  produced  from  2-oxoglutarate,  while  15.0%  stems  from  transamination
reactions with glutamine as amino-group donor. 74.0% is used as amino-group donor by
other transamination reactions, while 17.6% is converted to glutamine.
Table  11: Split  ratios  of  glutamate (E. coli).  Total  flux:  8.46 mmol gDW−1 h−1.  Ratios  below
0.05% not shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
glutamate dehydrogenase TCA cycle 85.02%
amidophosphoribosyltransferase purines 4.40%
phosphoribosylformylglycinamidine synthase purines 4.40%
GMP synthase purines 2.39%
CTP synthase CTP 1.57%
imidazole-glycerol-3-phosphate synthase histidine, purines 0.93%
glutamine-fructose-6-phosphate transaminase peptidoglycans, lipopolysaccharide 0.72%
anthranilate synthase tryptophan 0.56%
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Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
aspartate transaminase aspartate 28.82%
glutamine synthetase glutamine 17.57%
phosphoserine transaminase serine 17.15%
L-alanine transaminase alanine 5.55%
leucine transaminase leucine 4.43%
valine transaminase valine 4.16%
succinyldiaminopimelate transaminase lysine, peptidoglycans 3.65%
N-acetylglutamate synthase arginine, polyamines 3.31%
acetylornithine transaminase arginine, polyamines 3.31%
isoleucine transaminase isoleucine 2.85%
Biomass 2.59%
glutamate 5-kinase proline 2.17%
phenylalanine transaminase phenylalanine 1.82%
tyrosine transaminase tyrosine 1.36%
histidinol-phosphate transaminase histidine 0.93%
glutamate racemase peptidoglycans 0.28%
glutamyl-tRNA synthetase cobalamin, heme 0.05%
Again, a net balance can be compiled by subtracting all fluxes in the two transamination
cycles. The split ratios of the net flux of 0.93 mmol gDW−1 h−1 are shown in Table 12.
The net production of glutamate results only from glutamate dehydrogenase.
Table  12: Split ratios of glutamate discounting transamination cycles.
Total flux: 0.93 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Producing fluxes
Reaction Pathway Ratio
glutamate dehydrogenase TCA cycle 100%
Consuming fluxes
Reaction Pathway Ratio
N-acetylglutamate synthase arginine, polyamines 30.10%
glutamine synthetase glutamine 23.51%
Biomass 23.51%
glutamate 5-kinase proline 19.75%
glutamate racemase peptidoglycans 2.54%
glutamyl-tRNA synthetase cobalamin, heme 0.49%
dihydrofolate synthase folate metabolism 0.08%
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The  largest  part  of  the  non-circulating  glutamate  is  converted  to  arginine  (26.4%).
23.5% is converted to glutamine, and another 23.5% enters the biomass directly. 19.8%
is converted to proline, which, like arginine and the non-circulating glutamine, enters
the biomass  as  a  precursor  for  protein synthesis.  Smaller  parts  are  used in  the bio-
synthesis of polyamines (3.7%), peptidoglycans (2.5%), and various cofactors.
For metabolites that are less promiscuous than the ones discussed so far, i.e. produced
and  consumed  in  a  smaller  number  of  reactions,  the  split  ratios  can  be  analyzed
graphically with full metabolic context using branch point analysis.
Glucose 6-phosphate (G6P)
Figure 13 shows the extended metabolic context of glucose 6-phosphate (G6P).  The
figure was created using AMEBA with a maximum depth of two (see Section 3.8). All
G6P is produced by a phosphotransferase system, which transports glucose into the cell
and simultaneously phosphorylates it using phosphoenolpyruvate (PEP) as phosphate
and energy donor. As can be seen in Figure 13, this process accounts for the majority of
both  the  PEP consumption  and  the  pyruvate  formation.  In  effect,  the  first  step  of
glycolysis, glucose uptake and phosphorylation, and the last step, dephosphorylation of
PEP to pyruvate, are relatively strongly coupled in the scenario under consideration via
the phosphotransferase system [213].
Figure  13: Split ratios of glucose 6-phosphate and adjacent nodes (E. coli). Green: Metabolite nodes,
yellow: enzyme nodes. Numbers in metabolite nodes are total flux in mmol gDW−1 h−1. Edge labels are
split ratios as fractions of the flux through the adjacent metabolite node.
G6P is the first point after glucose uptake where metabolic fluxes split. In the studied
scenario, the majority of the G6P (51.1%) enters the pentose phosphate pathway (PPP),
while 47.4% is metabolized via glycolysis. 1.5% is converted to glucose 1-phosphate,
which is used for the synthesis of glycogen (79.1%) and lipopolysaccharide (20.9%).
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Figure  14:  Metabolite  fluxes  and split  ratios  within the  superpathway of  glycolysis  and the pentose
phosphate pathway (E. coli).  Green: Metabolite nodes, yellow: enzyme nodes.  Numbers in metabolite
nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the
adjacent metabolite node.
The flux through G6P is 11.0 mmol gDW−1 h−1, the same as the glucose uptake rate. This
corresponds to 66.0 mmol gDW−1 h−1 of carbon atoms. The flux through PEP, which is
produced exclusively in lower glycolysis, is 16.3 mmol gDW−1 h−1, which corresponds
to a carbon flux of 48.9 mmol gDW−1 h−1. This means that 74.1% of the carbon taken up
via the phosphotransferase system reaches lower glycolysis. Hence, while more than
half  of  the  G6P initially  enters  the  PPP,  a  large  part  of  the  carbon  returns  to  the
glycolytic pathway via transketolase and transaldolase. This can be seen  in detail in a
branch point analysis of the superpathway formed by glycolysis and the PPP, which is
shown in Figure 14.
The unexpectedly high flux entering the PPP is explained by the fact that in the model,
the enzymes glucose 6-phosphate dehydrogenase (EC 1.1.1.49) and phosphogluconate
dehydrogenase (EC 1.1.1.44) of the oxidative part of the PPP constitute the cheapest
way to produce NADPH. In the alternative scenario, where a substantial fraction of the
NADPH is  produced  via  transhydrogenase  (EC 1.6.1.2),  only  23.1% of  the  G6P is
predicted  to  enter  the  PPP,  while  75.4%  is  converted  to  fructose  6-phosphate  in
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glycolysis. In this scenario, the carbon loss via the oxidative PPP is lower than in the
original scenario, and 78.8% of the total carbon from glucose reaches PEP (flux through
PEP: 17.3 mmol gDW−1 h−1, 100% produced via enolase).
Acetate
The fluxes consuming and producing acetate are shown with one additional level of
metabolic context in  Figure 15. The total flux through acetate is 6.4 mmol gDW−1 h−1,
which corresponds to the fixed acetate export flux. All of the acetate is exported via
acetate/proton symport.
Figure 15: Split ratios of acetate and adjacent nodes (E. coli). Green: Metabolite nodes, yellow: enzyme
nodes. Numbers in metabolite nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios as
fractions of the flux through the adjacent metabolite node.
While small fractions of acetate arise as a byproduct in arginine metabolism (4.4%),
cysteine  biosynthesis  (3.3%),  and  the  formation  of  lipopolysaccharide  (0.2%),  the
majority (92.1%) is produced from acetyl-CoA via phosphotransacetylase (EC 2.3.1.8)
and acetate kinase (EC 2.7.2.1). In fact, more than half of the total acetyl-CoA (54.5%)
is converted to acetate in this way.
If no acetate export flux is enforced, i.e. the corresponding constraint is disabled in the
scenario file, the reactions of acetate kinase and phosphotransacetylase are predicted by
FVA to  proceed  in  the  opposite  direction,  i.e.  recycling  the  acetate  formed  as  a
byproduct to the central carbon metabolism. This means that in the original scenario,
acetate is only produced from acetyl-CoA to satisfy the high demand of acetate imposed
by forced secretion. According to FVA, this pathway for acetate production is cheapest
with respect to the objective of maximizing biomass output.
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5.1.3 Metabolic cycles and metabolite pools
As has already been seen in the example of the superpathway of glycolysis and the
pentose phosphate pathway shown in  Figure 14, branch point analysis (BPA) allows
simultaneously analyzing all fluxes in a particular metabolic context. BPA was applied
to the study of selected metabolic cycles and metabolite pools.
TCA cycle
The fluxes in the TCA cycle, as predicted by FBA for the scenario under study, are
shown  in  Figure  16.  In  the  original  scenario,  only  about  one-sixth  of  the  total
acetyl-CoA is metabolized via the TCA cycle. As mentioned above, the largest part of
the acetyl-CoA is converted to acetate, which is then secreted.
Figure 16: Metabolic fluxes and split ratios in the TCA cycle (E. coli). Green: Metabolite nodes, yellow:
enzyme nodes. Numbers in metabolite nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios
as fractions of the flux through the adjacent metabolite node.
The path from citrate synthase to 2-oxoglutarate is linear, i.e. all of the citrate produced
by  citrate  synthase  is  converted  to  2-oxoglutarate.  As  discussed  in  Section  5.1.2,
2-oxoglutarate is a branch point: While about 50.1% of the 2-oxoglutarate produced in
the TCA cycle is metabolized within the TCA cycle, the remaining 49.9% is converted
to glutamate, which is the starting molecule for several anabolic pathways.
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All of the succinyl-CoA, which is generated from 2-oxoglutarate in the TCA cycle, is
further  converted  to  succinate,  52.7%  within  the  TCA  cycle,  33.0%  in  lysine
metabolism,  and  14.3%  in  methionine  biosynthesis.  100%  of  the  succinate  is
subsequently  converted  to  fumarate  via  succinate  dehydrogenase,  but  this  reaction
accounts  for  only  52.0% of  the  fumarate  production.  Nearly  all  of  the  fumarate  is
converted to malate, virtually all of which is then oxidized to oxaloacetate. In the FBA
solution for the original scenario, only 41.8% of the oxaloacetate is produced in the
TCA cycle,  while  the  majority  (58.1%)  is  generated  anaplerotically  from phospho-
enolpyruvate.
Oxaloacetate  is  the  second point  in  the  TCA cycle  where  the  metabolic  flux  splits
between  the  catabolic  cycle  and  anabolic  pathways.  56.6%  of  the  oxaloacetate  is
transaminated to aspartate,  which,  like glutamate,  is the starting molecule in several
biosynthetic pathways. However, much of the carbon flux initially directed to aspartate
formation is returned to oxaloacetate, as was revealed in a further branch point analysis
of the full metabolic context of aspartate and oxaloacetate.
Aspartate transamination cycle
The cycle between aspartate and oxaloacetate identified by BPA, which is shown in
Figure 17, consists of four steps, of which two are shared with the TCA cycle: The
aspartate generated from oxaloacetate transfers its amino group to different acceptors in
arginine and purine metabolism. In each case,  fumarate  is  formed  and subsequently
converted back to oxaloacetate in two reactions of the TCA cycle.
Figure  17:  Cycle  between  aspartate  and  oxaloacetate  (E. coli).  Green:  Metabolite  nodes,  yellow:
enzyme nodes.  Numbers in metabolite nodes are total flux in mmol gDW−1 h−1.  Edge labels are split
ratios as fractions of the flux through the adjacent metabolite node.
This  third  transamination  cycle  carries  a  combined  flux  of  0.87 mmol gDW−1 h−1.
Subtracting this flux from both sides of the oxaloacetate balance yields a net balance, in
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which 54.3% of the non-circulating oxaloacetate is metabolized in the TCA cycle, while
45.7% is used for the provision of aspartate for anabolic pathways.  In the corrected
balance, an even larger fraction of the oxaloacetate (72.8%) is produced anaplerotically,
while only 27.2% is formed in the TCA cycle.
Comparison of predicted TCA cycle fluxes with experimental data
The prediction that 54% of the acetyl-CoA is converted to acetate for secretion is in
fairly good agreement with experimental results: Fischer et al. [154] obtained a range of
55–59% using 13C tracer analysis. In contrast, the experimentally determined values for
the fraction of acetyl-CoA entering the TCA cycle (25–30%) and the flux through the
TCA cycle (27–33% of the glucose uptake rate) could not be reproduced by FBA for the
original scenario. In the predicted flux distribution, only 17% of the acetyl-CoA enters
the TCA cycle. Moreover, the flux through isocitrate dehydrogenase is only 17% of the
glucose uptake rate.
Considerably larger fluxes in the TCA cycle were obtained when performing FBA for
the  alternative  scenario,  where  the  flux  through  transhydrogenase  is  fixed  at
5 mmol gDW−1 h−1. In this scenario, the predicted flux through isocitrate dehydrogenase
is  2.9 mmol gDW−1 h−1,  which  corresponds  to  26% of  the  glucose  uptake  rate.  This
value is much closer to the experimentally determined range of 27–33%. As a result of
the larger flux through the TCA cycle, the fraction of NADH that is generated in the
TCA cycle is also increased (12.9% as opposed to 8.1% in the original scenario). At
24.8% the fraction of acetyl-CoA entering the TCA cycle is also much closer to the
experimentally determined range of 25–30% than the value predicted for the original
scenario (17.2%).
Tetrahydrofolate pool
Tetrahydrofolate (THFA) is an important carrier of activated one-carbon groups. It can
also act as a reducing agent. The fluxes in the folate-dependent one-carbon pool are
shown in metabolic context in Figure 18.
The total flux through THFA is 0.98 mmol gDW−1 h−1. 99.92% of the THFA circulates,
and only 0.08% is produced via  de-novo synthesis. As the dihydrofolate moiety, once
synthesized, is unchanged in all metabolic reactions in the model, de-novo synthesis is
only active to the extent needed to compensate for the THFA derivatives lost via the
biomass reaction. While a small fraction is directly converted to 10-formyl-THFA in the
ATP-dependent reassimilation of formate via formate-THFA ligase, nearly 99.8% of the
THFA is  converted  to  5,10-methylene-THFA as  the  primary  activated  form.  5,10-
methylene-THFA is  generated  from  THFA via  enzymatic  cleavage  of  either  serine
(94.8% of the THFA flux) or glycine (4.9%). 84.0% of the 5,10-methylene-THFA is
subsequently  converted  to  10-formyl-THFA,  while  13.8%  is  reduced  to  5-methyl-
THFA. 10-formyl-THFA is consumed in two reactions in purine metabolism, where it
donates a formyl group. Virtually all of the 5-methyl-THFA is consumed in the last step
of methionine biosynthesis, where the activated methyl group is transferred to the thiol
group of  L-homocysteine.  The remaining fractions  of  the 5,10-methylene-THFA are
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used for the synthesis of dTMP (2.2%) and coenzyme A (0.05%). In the first step of
coenzyme A biosynthesis, 5,10-methylene-THFA donates a methylene group, while in
the synthesis of dTMP from dUMP, it transfers both the activated methylene group and
two electrons and is thus converted to dihydrofolate. The dihydrofolate is then reduced
back to THFA.
Figure  18:  Metabolite  fluxes  and  split  ratios  within  the  tetrahydrofolate  pool  (E. coli).  Green:
Metabolite  nodes,  yellow:  enzyme  nodes.  Numbers  in  metabolite  nodes  are  total  flux  in
mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the adjacent metabolite
node.
5.1.4 Essentiality of metabolite nodes
Metabolite  flux  minimization  (MFM)  was  performed  for  the  original  scenario  to
identify metabolites that are essential, i.e. those that must necessarily carry a non-zero
flux for growth to be optimal. Of the 557 metabolite nodes carrying a flux, 548 (98%)
were identified as essential.  Table 13 shows the nine metabolites that are active in the
FBA solution  but  were  predicted  by  MFM to  be  nonessential.  In  the  model,  these
metabolites lie on pathways that are not essential for biomass formation in the scenario
under consideration. The low number of nonessential metabolites likely results from the
large number of constraints present in the studied scenario. Similarly, only 76 of the 552
active  reactions  were  predicted  by  FVA to  be  nonessential,  while  all  other  active
reactions must have a non-zero flux in order for the biomass flux to be optimal.
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Table 13: Metabolites carrying a flux but predicted to be nonessential (E. coli). The right
column lists the number of reactions in which each metabolite appears in the network.
Metabolite Number of reactions
adenosine 7
α-D-ribose 1-phosphate 7
fructose 1,6-bisphosphate 4
glycine[periplasm] 4
hydroxypyruvate 3
H+[extracellular] 6
thioredoxin (reduced) 10
thioredoxin (oxidized) 10
[cell wall precursor of two linked disaccharide 
pentapeptide and tetrapeptide murein units] 3
In the predicted flux distribution for the studied scenario, the active reactions involving
adenosine  and α-D-ribose  1-phosphate  are  part  of  an adenine salvage  pathway.  The
model contains an alternative route, where adenine is converted to AMP in one reaction
step instead of two.
In the model, flux through fructose 1,6-bisphosphate is not required for optimal growth
because  of  the  sedoheptulose  bisphosphate  bypass.  In  this  pathway,  which  was
originally  described in  2009 for  transaldolase-deficient  E. coli strains,  sedoheptulose
7-phosphate is degraded to erythrose 4-phosphate and dihydroxyacetone phosphate by
phosphofructokinase and fructose-bisphosphate aldolase  [214]. The following reaction
sequences allowed by the model are stoichiometrically equivalent:
I (glycolysis, active in FBA solution):
phosphofructokinase : ATP + fructose 6-phosphate → ADP + fructose 1,6-bisphosphate + H+
fructose-bisphosphate_aldolase : fructose 1,6-bisphosphate → dihydroxyacetone phosphate + 
glyceraldehyde 3-phosphate
II (transaldolase + sedoheptulose bisphosphate bypass):
transaldolase : glyceraldehyde 3-phosphate + sedoheptulose 7-phosphate ← erythrose 4-phosphate + 
fructose 6-phosphate
phosphofructokinase_(s7p) : ATP + sedoheptulose 7-phosphate → ADP + H+ + sedoheptulose 
1,7-bisphosphate
Sedoheptulose_1,7-bisphosphate_D-glyceraldehyde-3-phosphate-lyase :
sedoheptulose 1,7-bisphosphate → dihydroxyacetone phosphate + erythrose 4-phosphate
As noted  in  Section  5.1.1,  glycolysis  in  E. coli has  been studied extensively  and is
known to proceed via the classical Embden-Meyerhof-Parnas pathway. The conversion
of fructose 6-phosphate to fructose 1,6-bisphosphate is a central step in this ubiquitous
pathway,  which  is  tightly  regulated  [200].  Therefore,  it  is  highly  unlikely  that  an
alternative pathway, which was only discovered in 2009, should play a significant role
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in  the  wild  type.  Indeed,  activity  in  this  pathway  has  only  been  observed  in
transaldolase-deficient  mutants  [214].  As  this  pathway  uses  the  glycolytic  enzymes
phosphofructokinase  and  fructose-bisphosphate  aldolase,  whose  affinity  for  the
sedoheptulose  phosphates  is  probably  dramatically  lower  than  that  for  the
corresponding  fructose  phosphates,  the  bypass  reactions  are  unlikely  to  take  place
unless  there  is  an  accumulation  of  sedoheptulose  7-phosphate.  Hence,  the  model’s
predictions when specifically studying the wild type could be made more accurate by
disallowing flux through the bypass reactions.
Periplasmic  glycine  only  occurs  as  an  intermediate  in  the  following  sequence  of
transport reactions:
glycine_reversible_transport_via_proton_symport_(periplasm) : glycine[p] + H+[p] ← glycine + H+
glycine_transport_in_via_sodium_symport_(periplasm) : glycine[p] + Na+[p] → glycine + Na+
calcium_/_sodium_antiporter_(1_1) : Ca2+ + Na+[p] ← Na+ + Ca2+[p]
The net effect of this reaction sequence is the simultaneous import of calcium ions and
export of protons. While the Na+/Ca2+ antiporter is the only calcium importer available
in the model, proton and sodium symporters with the same stoichiometry exist for a
variety of organic anions, which can thus replace the first two reactions of the transport
sequence. Alternatives include glycolate, acetate, and glutamate.
The  two  active  reactions  involving  hydroxypyruvate,  which  are  catalyzed  by
hydroxypyruvate isomerase and hydroxypyruvate reductase (NADH), can be replaced
by the single reaction catalyzed by tartronate  semialdehyde reductase,  in  which this
intermediate does not occur.
In  the  FBA  solution,  excess  protons  produced  by  metabolic  reactions  are  first
transported to the periplasm via the complexes of the electron transport chain and then
secreted to the extracellular space. Alternatively, these protons can, however, also be
converted to water in the periplasm via the following reaction, which is catalyzed by a
ferroxidase (EC 1.16.3.1):
4 Fe2+ + 4 H+ + 1 O2 → 4 Fe3+ + 2 H2O
In order to convert all excess protons to water, the rate of Fe2+ uptake has to increase by
14.0 mmol gDW−1 h−1, and the Fe3+ secretion rate has to increase by the same amount.
This extreme rate, which is equivalent to a mass flux of 0.85 grams of iron per gram dry
weight per hour, is highly unrealistic, especially as the Fe3+ produced in the reaction is
barely soluble at pH 7 [215]. Hence, this process should be disallowed in the model by
constraining the Fe3+ secretion rate to zero (or a value close to zero). The only reason
why this possibility to freely import electrons does not have a more dramatic effect on
the model’s predictions is that the model does not contain any reaction by which the
electrons could be transferred to a cytosolic redox carrier.
Thioredoxin occurs in ten reactions in the network, seven of which can have a non-zero
flux value according to FVA. However, the model contains stoichiometric alternatives
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to all of these reactions, which use different reducing agents. Therefore, thioredoxin is
predicted to be nonessential for optimal growth, both in its reduced and in its oxidized
form.
Menaquinone-8,  which  is  not  active  in  the  examined  FBA solution,  is  the  most
promiscuous nonessential metabolite. It occurs in twenty-three reactions in the network,
none of which needs to  be active for optimal  growth.  FVA identified nine of these
reactions as being able to carry a flux.
Table  14:  Intracellular  metabolites  with  the  largest  minimum  fluxes  (E. coli).  Shown  are  the
minimum fluxes required for optimal growth.
Metabolite Minimum flux Metabolite Minimum flux
H+ 239.2 NADP+ 13.9
H2O 108.1 NADPH 13.9
ADP 69.7 pyruvate 13.3
ATP 69.7 coenzyme A 11.8
phosphate 66.9 glucose 6-phosphate 11.0
NAD+ 33.7 acetyl-CoA 10.8
NADH 33.7 ammonium 9.4
ubiquinol-8 33.0 L-glutamate 8.5
ubiquinone-8 33.0 dihydroxyacetone phosphate 8.2
CO2 23.5 2-oxoglutarate 8.1
glyceraldehyde 3-phosphate 17.8 fructose 6-phosphate 6.6
3-phospho-D-glycerate 17.7 acetate 6.4
1,3-bisphospho-D-glycerate 17.7 acetyl phosphate 5.9
O2 16.5 6-phospho-D-gluconate 5.6
2-phospho-D-glycerate 16.3 6-phospho-D-glucono-1,5-lactone 5.6
phosphoenolpyruvate 16.3 D-ribulose 5-phosphate 5.6
The thirty-two intracellular metabolites with the highest minimum flux sums are shown
in Table 14. They include five ubiquitous cofactor or currency metabolites, each in the
active and depleted forms (ATP/ADP, NADH/NAD+,  ubiquinol/ubiquinone, NADPH/
NADP+, and acetyl-CoA/coenzyme A), as well as five very small compounds (H+, H2O,
phosphate,  CO2,  and  ammonium).  This  set  further  contains  nine  intermediates  of
glycolysis and three from the pentose phosphate pathway, all from the oxidative part.
The glycolytic intermediates have a high minimum flux because all carbon taken up as
glucose must initially go through glycolysis, and fluxes split from glycolysis to other
pathways only gradually. The large required flux in the first metabolites of the pentose
phosphate pathway is explained by the fact that this pathway is the least expensive route
in the model for producing NADPH. The remaining five metabolites with high required
fluxes are O2, glutamate, 2-oxoglutarate, acetate, and acetyl phosphate. A high oxygen
flux is expected for a rapid aerobic growth scenario, and the large required flux through
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glutamate and 2-oxoglutarate is due to the transamination cycle involving these meta-
bolites. The high minimum fluxes through acetate and acetyl phosphate result from the
forced acetate secretion.
An alternative view on minimum required metabolite fluxes is presented in  Table 15,
which shows the twenty largest minimum carbon fluxes for intracellular non-cofactor
metabolites. The carbon flux through a metabolite is the product of the metabolite flux
and the number of carbon atoms in the compound. In this ranking, glucose 6-phosphate
appears at the top instead of the eighth position, as all carbon taken up by the cell has to
pass  through  this  intermediate.  The  list  contains  another  nine  metabolites  from
glycolysis and five intermediates from the pentose phosphate pathway. The other five
metabolites  with  high  required  carbon  fluxes  are  glutamate,  2-oxoglutarate,  CO2,
oxaloacetate, and acetate. Oxaloacetate has a large required flux because it is involved
in a transamination cycle, as detailed above.
Table 15: Metabolites with the largest essential carbon fluxes (E. coli). Fluxes are in mmol gDW−1 h−1.
Metabolite C atoms Minimum flux Minimum C flux
glucose 6-phosphate 6 11 66
glyceraldehyde 3-phosphate 3 17.75 53.26
3-phospho-D-glycerate 3 17.75 53.24
1,3-bisphospho-D-glycerate 3 17.75 53.24
2-phospho-D-glycerate 3 16.3 48.89
phosphoenolpyruvate 3 16.3 48.89
L-glutamate 5 8.46 42.28
2-oxoglutarate 5 8.12 40.62
pyruvate 3 13.3 39.9
fructose 6-phosphate 6 6.59 39.55
6-phospho-D-gluconate 6 5.62 33.7
6-phospho-D-glucono-1,5-lactone 6 5.62 33.7
D-ribulose 5-phosphate 5 5.62 28.08
dihydroxyacetone phosphate 3 8.23 24.68
CO2 1 23.5 23.5
acetyl-CoA 2* 10.82 21.64
oxaloacetate 4 4.3 17.21
D-xylulose 5-phosphate 5 3.09 15.47
acetate 2 6.4 12.8
D-ribose 5-phosphate 5 2.5 12.5
* discounting coenzyme A moiety
70
5 Application to published metabolic models
5.2 Thermotoga maritima
For  T. maritima, FBA was performed on the scenario defined by the set of upper and
lower bounds given in the SBML file of the model (see Section 3.1.2 for details). This
scenario describes anaerobic growth on glucose as the sole carbon source. At a glucose
uptake  rate  of 10.0 mmol gDW−1 h−1,  the  predicted  growth  rate  is  0.36 h−1,  and  the
model  exports  CO2 at  a  rate  of  16.5 mmol gDW−1 h−1,  acetate  at  a  rate  of
15.4 mmol gDW−1 h−1, and hydrogen (H2) at a rate of 33.2 mmol gDW−1 h−1. This means
that 51% of the carbon taken up as glucose is  secreted as acetate, and another 27% is
converted to CO2. Only 21% of the carbon is incorporated into biomass. In the FBA
solution  for the studied scenario, 273 of the 645 reactions (42%) have a flux with an
absolute value above 10−12 mmol gDW−1 h−1.  The subnetwork spanned by these active
reactions contains 276 of the 564 metabolites (49%). Of these 276 metabolites, only 86
(15.2% of all metabolite nodes or 31% of the active metabolites) are branch points. The
remaining 190 metabolite nodes lie on unbranched paths.
In  accordance  with  the  differences  in  ecology  between  the  two  organisms,  the
T. maritima model  exhibits  qualitatively  different  behavior  compared  to the  E. coli
models: As T. maritima is an obligate anaerobe, there is no oxygen uptake. In addition,
T. maritima does  not  possess  a  phosphotransferase  system  [216,217]. Consequently,
98.4%  of  the  phosphoenolpyruvate  is  converted  to  pyruvate  via  pyruvate  kinase
(EC 2.7.1.40).  In  the  model,  the  only  usable  form  of  sulfur  is  elemental  sulfur.
Therefore, the much more energy-intensive activation and reduction of sulfate is not
observed in the FBA solution. In fact, the sulfate reduction pathway is absent from the
model and the underlying genome annotation.
T. maritima generates energy by fermentation.  In the FBA solution, ATP synthase and
all enzymes associated with the electron transfer chain are inactive. Excess intracellular
protons are removed via an acetate/proton symporter (80.8%), which accounts for 100%
of the acetate export, and a proton-exporting ATPase  (19.2%),  which  hydrolyzes one
molecule of ATP per proton.  The TCA cycle operates as a branched pathway in the
studied flux distribution: The forward branch converts citrate to glutamate, while the
reverse pathway transforms oxaloacetate to aspartate via fumarate.
5.2.1 ATP balance
The split  ratios  of  the ATP-producing fluxes  are  shown in  Table 16.  The total  flux
through  ATP is  52.5 mmol gDW−1 h−1.  71.0% is  produced  in  glycolysis,  and  29.0%
stems  from  acetate  fermentation.  These  results  are  in  agreement  with  the  general
observation  that  in  the  fermentative  metabolism of  carbohydrates,  ATP is  produced
primarily via substrate-level phosphorylation [200,218].
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Table  16: Split ratios of ATP-producing fluxes (T. maritima). Total flux:  52.5 mmol gDW−1 h−1.  Ratios
below 0.05% not shown.
Reaction/Enzyme Pathway/Product Ratio
phosphoglycerate kinase glycolysis 35.79%
pyruvate kinase glycolysis 35.21%
acetate kinase acetate fermentation 28.97%
The ATP-consuming reactions and their flux split ratios are shown in  Table 17. The
growth-associated  maintenance  requirement  (GAM) accounts  for  only  31.2% of  the
ATP-consuming flux (E. coli iJO1366:  66.2%),  while non-growth-associated energy-
dependent processes are not represented in the T. maritima model iTZ478. The largest
fraction of the ATP is  consumed in the processes of glucose uptake and glycolysis,
which together account for 53.1% of the total ATP-consuming flux. Glucose uptake is
more expensive than in E. coli, as T. maritima lacks a phosphotransferase system (PTS)
and  employs primary active transport via an ABC transporter instead.  While  the PTS
simultaneously imports and phosphorylates glucose  using  phosphoenolpyruvate as the
energy-rich phosphate donor, the ABC transporter hydrolyzes one molecule of ATP just
to  transport one  molecule  of  glucose  into  the  cell.  In  the  cytosol, glucose  is  then
phosphorylated via a hexokinase at the expense of a second molecule of ATP.
3.5% of the ATP is consumed by a proton-translocating ATPase, which is used to export
excess intracellular protons to the medium. Like in E. coli, notable fractions of the ATP
are  consumed in  the  processes  of  amino acid  biosynthesis  (3.6%),  the  provision of
purine  and pyrimidine  nucleotides  (2.2%  and  0.8%,  respectively),  and the (re)phos-
phorylation of AMP to ADP (2.1%). In the FBA solution, 1.5% of the ATP is used for
the  synthesis  of  oxaloacetate  from  pyruvate  via  pyruvate  carboxylase  (EC 6.4.1.1).
Furthermore, the provision of phosphoribosyl pyrophosphate in the pentose phosphate
pathway accounts for 1.1% of the ATP consumption.
Smaller amounts of ATP are converted to dGTP (0.5%) and UTP (0.2%). Fatty acid
biosynthesis accounts for only 0.1% of the ATP consumption (E. coli iJO1366: 2.7%).
Another 0.1% of the ATP enters the biomass directly. Further small amounts of ATP are
consumed  in  folate  metabolism  and  the  biosyntheses  of  glycogen,  peptidoglycans,
polyamines, isoprenoid precursors, and various cofactors. In contrast to the E. coli flux
distribution analyzed in the previous section, no ATP is consumed in sulfur metabolism,
as the simulation scenario for T. maritima includes elemental sulfur as the sole source of
sulfur (E. coli: sulfate).
As in the E. coli flux distribution, the fluxes through the other nucleoside triphosphates
GTP, UTP, and CTP are low (0.20, 0.11, and 0.05 mmol gDW−1 h−1, respectively), and
they do not strongly contribute to energy metabolism. In the studied scenario, it is not
necessary to explicitly examine phosphoenolpyruvate as an energy metabolite, as 98.4%
is  converted  to  ATP via  pyruvate  kinase.  The  remainder  is  consumed  in  metabolic
reactions where its primary role is not that of an energy donor.
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Table  17: Split ratios of ATP-consuming fluxes (T. maritima). Total flux: 52.5 mmol gDW−1 h−1. Ratios
below 0.05% not shown. Abbreviations: AICAR – 5-aminoimidazole-4-carboxamide ribotide,  PRPP –
phosphoribosyl pyrophosphate
Reaction/Enzyme Pathway/Product Ratio
Biomass (incl. GAM) 31.29%
D-glucose transport via ABC system glucose import 19.03%
hexokinase glycolysis 19.02%
phosphofructokinase glycolysis 15.07%
H+-exporting ATPase export of excess protons 3.48%
adenylate kinase AMP→ADP 2.11%
glutamine synthetase glutamine 1.65%
pyruvate carboxylase anaplerotic reactions 1.53%
AICAR biosynthesis from PRPP (4 reactions) purines 1.33%
PRPP synthetase pentose phosphate pathway 1.11%
carbamoyl-phosphate synthase (glutamine-hydrolyzing) pyrimidines, arginine 0.81%
guanylate kinase purines 0.65%
nucleoside-diphosphate kinase dGTP 0.48%
shikimate kinase shikimate pathway 0.28%
aspartate kinase lysine 0.24%
uridylate kinase pyrimidines 0.23%
acetylglutamate kinase arginine, polyamines 0.22%
nucleoside-diphosphate kinase UTP 0.22%
argininosuccinate synthase, reversible arginine 0.19%
GMP synthase purines 0.19%
glutamate 5-kinase proline 0.14%
acetyl-CoA carboxylase fatty acids 0.13%
glucose-1-phosphate adenylyltransferase glycogen 0.11%
3 reactions in folate metabolism folate metabolism 0.10%
5 reactions in cell wall biosynthesis peptidoglycans 0.09%
CTP synthase (glutamine) pyrimidines 0.09%
ATP phosphoribosyltransferase reversible histidine, purines 0.06%
5.2.2 Balance sheets of redox carriers
Fermentation differs from respiration in the terminal acceptor of the electrons generated
in the oxidative breakdown of  a reduced carbon source. While respiration utilizes an
exogenous electron acceptor such as molecular oxygen, nitrate, or sulfate, the electrons
are  transferred  to  an  endogenous acceptor  in  fermentation  [55]. In  the  fermentative
catabolism of  carbohydrates,  the  terminal  electron  acceptor  is  usually  derived  from
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pyruvate  [200].  This difference should be reflected in the balance sheets of the redox
carriers. The balance sheets for NADH and NADPH are shown in Tables 18 and 19.
Table  18:  NADH  balance  (T. maritima).  Total  flux:  19.3 mmol gDW−1 h−1.  Ratios  below  0.05%  not
shown. Abbreviations: IMP – inosine monophosphate
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
glyceraldehyde-3-phosphate dehydrogenase glycolysis 97.52%
3-isopropylmalate dehydrogenase leucine 0.80%
dihydroorotic acid dehydrogenase pyrimidines 0.58%
IMP dehydrogenase purines 0.52%
histidinol dehydrogenase histidine 0.34%
prephenate dehydrogenase tyrosine 0.24%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
NAD-linked hydrogenase hydrogen formation 89.12%
glutamate dehydrogenase (NAD) glutamate 6.13%
malate dehydrogenase aspartate (reverse TCA cycle) 3.17%
dihydrodipicolinate reductase (NADH) lysine 0.66%
glycine cleavage system glycine 0.46%
methylenetetrahydrofolate reductase methionine 0.38%
In the FBA solution, the total flux through NADH is 19.3 mmol gDW−1 h−1. 97.5% of
the NADH is produced in glycolysis, while the remaining NADH arises as a byproduct
in various anabolic pathways. 89.1% is used to reduce intracellular protons to molecular
hydrogen, which is exported. The remaining NADH is consumed in the biosyntheses of
the amino acids glutamate (6.1%), aspartate (3.2%), lysine (0.7%), glycine (0.5%), and
methionine (0.4%).
As expected,  NADH is  primarily  formed in  glycolysis.  The NADH then has  to  be
reoxidized to NAD+.  In the model, this reoxidation occurs  primarily  via the following
hydrogenase reaction:
NADH + H+ → NAD+ + H2.
Intracellular  protons  thus  serve  as  an endogenous  electron  acceptor  in  the  scenario
under consideration.  This  particular  reaction is, however, thermodynamically unfavor-
able owing to the significantly lower reduction potential of the pair 2 H+/H2 (−0.42 V)
compared to NAD+/NADH (−0.32 V).
In 2009, the same year the model was published, it was discovered that in T. maritima,
electrons  are  transferred  from  NADH  to  H+ in  a  synergistic  process  involving a
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ferredoxin with  the much lower reduction potential  of −0.453 V as a second electron
donor [219]. The hydrogenase complex catalyzes the net reaction
NADH + 2 ferredoxin[red] + 3 H+ → NAD+ + 2 ferredoxin[ox] + 2 H2 [219].
In the model,  the two  hydrogenase  reactions  are  not  directly coupled.  As shown in
Figure 19, their flux ratio is close to 1:1, however.
Figure 19: Flux split ratios of the two hydrogen-forming reactions in the FBA solution for T. maritima.
Green:  Metabolite  nodes,  yellow:  enzyme  nodes.  Numbers  in  metabolite  nodes  are  total  flux  in
mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the adjacent metabolite
node.
Reduced ferredoxin is produced in the conversion of pyruvate to acetyl-CoA, which is
catalyzed by pyruvate synthase (EC 1.2.7.1):
coenzyme A + ferredoxin[ox] + pyruvate  ⇌ acetyl-CoA + CO2 + ferredoxin[red] + H+.
Table 19 shows the NADPH-producing reactions along with their flux split ratios. At
1.5 mmol gDW−1 h−1, the total flux through NADPH is only 7.7% of the NADH flux
(E. coli iJO1366: 41.4%). In the FBA solution, 48.5% of the NADPH is produced in the
oxidative pentose phosphate pathway, while 26.9% is generated by isocitrate dehydro-
genase in the formation of glutamate from citrate. 24.6% arises as a byproduct in purine
metabolism.
The high relative contribution  of  purine metabolism to NADPH production  is  most
likely due to the low overall flux through NADPH, which in turn is induced by the low
demand for NADPH in the model: Glutamate dehydrogenase, which accounts for over
50% of the NADPH demand in E. coli is replaced by an NADH-dependent form in the
T. maritima model. In addition, the amino acids threonine and methionine, whose bio-
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syntheses account for a substantial fraction of the NADPH consumption in E. coli, are
synthesized via non-NADPH-dependent pathways in the T. maritima model.
Table  19:  NADPH  balance  (T. maritima).  Total  flux:  1.5 mmol gDW−1 h−1.  Ratios  below  0.05%  not
shown.
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
isocitrate dehydrogenase TCA cycle 26.90%
methylenetetrahydrofolate dehydrogenase purines 24.60%
glucose 6-phosphate dehydrogenase pentose phosphate pathway 24.25%
phosphogluconate dehydrogenase pentose phosphate pathway 24.25%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
ketol-acid reductoisomerase (2 reactions) valine, leucine, isoleucine, coenzyme A 26.87%
thioredoxin reductase synthesis of deoxyribonucleotides 18.66%
shikimate dehydrogenase shikimate pathway 9.96%
fatty acid biosynthesis (4 reactions) fatty acids 9.14%
aspartate semialdehyde dehydrogenase lysine 8.57%
N-acetyl-γ-glutamyl-phosphate reductase arginine, polyamines 7.83%
sulfide dehydrogenase sulfur metabolism 5.88%
glutamate 5-semialdehyde dehydrogenase proline 5.09%
pyrroline 5-carboxylate reductase proline 5.09%
dihydrofolate reductase folate metabolism 1.21%
UDP-N-acetylenolpyruvoylglucosamine reductase peptidoglycans 0.67%
thymidylate synthase dTMP 0.60%
Furthermore, the fraction of fatty acids per gram dry weight seems to be much lower in
the  T. maritima model than in  E. coli.  Like in  E. coli,  NADPH is used as a reducing
agent  in  a  wide  variety  of  anabolic  pathways:  60.6%  is  consumed  in  amino  acid
biosynthesis, 19.3% in the provision of deoxyribonucleotides, 9.1% in fatty acid bio-
synthesis, 5.9% in the reduction of sulfur, 2.4% in folate metabolism, and 1.0% in the
formation  of  polyamines.  Smaller  fractions  are  consumed  in  the  biosyntheses  of
isoprenoid precursors and coenzyme A.
5.2.3 Biosyntheses involving reversed degradation pathways
In the FBA solution, a conspicuously large amount of ATP is  used to  phosphorylate
dGDP to dGTP. The reason for this was discovered by exploring the fate of dGTP via
branch point analysis:  While 3.7% enters the biomass as a  building block of DNA,
96.3% is dephosphorylated in two steps to deoxyguanosine, which is then converted to
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deoxyribose  1-phosphate  and  guanine  via  purine-nucleoside  phosphorylase
(EC 2.4.2.1).  While  the  guanine  is  salvaged  into  GMP via  guanine  phosphoribosyl-
transferase  (EC 2.4.2.8),  the deoxyribose  1-phosphate is converted to glyceraldehyde
3-phosphate and acetaldehyde via the action of phosphopentomutase  (EC 5.4.2.7) and
deoxyribose-phosphate  aldolase  (EC 4.1.2.4).  The  acetaldehyde  is  then  used  by
threonine aldolase (EC 4.1.2.48) to convert glycine to threonine.
Threonine aldolase is known to be involved in the degradation of threonine [200]. From
in-vitro studies, the corresponding reaction is known to be reversible  [220].  However,
no organism is known to rely exclusively on this reaction for the provision of threonine,
and  no  biosynthetic  pathway  involving  threonine  aldolase  has  been  described.  The
structure and substrate specificity of the threonine aldolase of  T. maritima have been
studied in detail. The corresponding publication  [221] reports high pairwise sequence
identities to threonine aldolases from organisms such as  E. coli,  which are known to
produce threonine from homoserine via the usual biosynthetic pathway (see [200] for a
detailed description).
In the model, threonine aldolase is the only possible way to produce threonine – if its
flux is restricted to the cleavage direction, a non-zero biomass flux is no longer possible.
In view of the current knowledge about threonine aldolase, both general and specific to
T. maritima,  this seems to be an error in the model. In the modeling process, it would
have been much more parsimonious to assume the standard biosynthetic pathway even
in the absence of  specific  evidence than to  postulate  a  novel  route  of  biosynthesis,
especially if that route incorporates an enzyme that has highly similar homologs known
to be active in a degradation pathway.
An exploratory series of branch point analyses starting from the balance sheets of ATP
(Table 17) and ammonium (not shown) revealed several degradation reactions, which
are used in biosynthetic routes in the model. Table 20 lists these reactions.
Table 20: Reactions known to occur in degradation pathways but involved in the biosynthesis of biomass
precursors  in  the  FBA solution  for  T. maritima.  Reactions  are  written  in  the  degradation  direction.
Reactions marked with a dagger (†) are the only possible way  in the model  to produce  the respective
compound.
Enzyme (named as in model) EC number Reaction
threonine aldolase † 4.1.2.48 L-threonine ⇌ glycine + acetaldehyde
L-serine deaminase † 4.3.1.17 L-serine ⇌ pyruvate + ammonium
L-aspartase 4.3.1.1 L-aspartate ⇌ fumarate + ammonium
O-succinylhomoserine lyase 
(elimination) 2.5.1.48
O-succinyl-L-homoserine + H2O ⇌
2-oxobutanoate + H+ + ammonium + succinate
dCMP deaminase 3.5.4.12 dCMP + H+ + H2O ⇌ dUMP + ammonium
glucosamine-6-phosphate deaminase 3.5.99.6 D-glucosamine 6-phosphate + H2O ⇌D-fructose 6-phosphate + ammonium
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The only way for the model to produce the proteinogenic amino acid serine is by using
the  degradation  reaction  catalyzed  by  L-serine  deaminase  (EC 4.3.1.17)  in  reverse.
Serine  biosynthesis  usually starts  from  3-phosphoglycerate  and  proceeds  via  the
intermediate  3-phosphohydroxypyruvate  (see  [200] for  a  detailed  description).  An
alternative non-phosphorylated route had been discussed for a few decades, but was
ultimately dismissed as a ‘fallacy’ [222]. Consequently, serine biosynthesis via L-serine
deaminase is likely an error in the model. L-Serine deaminase is the only way for the
model to produce serine, as confirmed by an FBA performed with the flux through this
reaction constrained to the deamination direction. The unusual biosynthetic pathways of
serine and threonine are not discussed by the authors of the model.
In  addition,  the  model  contains  ‘shortcuts’  for  the  production  of  aspartate,
O-succinyl-L-homoserine,  dCMP,  and  D-glucosamine  6-phosphate that  involve
degradation reactions. If these reactions (shown in Table 20) are blocked by appropriate
flux constraints, the biomass flux decreases slightly (by 0.2% when constraining all four
reactions), but biomass production is still possible.
In the model, aspartate is produced preferentially from fumarate and ammonium via
aspartase, which is known to occur primarily in the degradation of aspartate. Aspartate
is usually produced from oxaloacetate via aspartate transaminase, which uses glutamate
as the amino group donor  [200].  This reaction is more costly, as the regeneration of
glutamate from 2-oxoglutarate consumes NADPH or NADH, respectively (see the first
two subsections in Section 5.1.2).
Similarly,  O-succinyl-L-homoserine is  produced  preferentially  via  an  elimination
reaction catalyzed by O-succinyl-L-homoserine succinate-lyase (EC 2.5.1.48, synonym:
cystathionine  gamma-synthase).  In  the reaction,  which  is  shown  in  Table  20,
O-succinyl-L-homoserine  is  cleaved  into  2-oxobutanoate,  succinate,  and  ammonia.
However, in the model, O-succinyl-L-homoserine  can also be formed from the three
smaller molecules in the reverse reaction, which seems unlikely from both enthalpic and
entropic  considerations.  The  reaction,  which  occurs  during  the  biosynthesis  of
methionine,  is  a  cheaper  alternative  to  the  standard  reactions,  which  produce
O-succinyl-L-homoserine  or  alternatively  O-acetyl-L-homoserine  from L-homoserine
and succinyl-CoA or acetyl-CoA, respectively.
In the model, dCMP is formed from dUMP and ammonium via dCMP deaminase, and
D-glucosamine 6-phosphate is produced by glucosamine-6-phosphate deaminase from
D-fructose  6-phosphate  and  ammonium.  These  two  reactions  also  bypass  energy-
dependent biosyntheses. If dCMP deaminase is constrained to the degradation direction,
dCDP is  formed  from  CDP at  the  expense  of  thioredoxin  oxidation  in  a  reaction
catalyzed by ribonucleoside-diphosphate reductase. Similarly, if the reaction of glucosa-
mine-6-phosphate deaminase is constrained to the degradation direction, D-glucosamine
6-phosphate  is  generated  from  D-fructose  6-phosphate  via  a  transaminase  using
glutamine as the amino-group donor.
The  impact of these modeling errors is twofold: The reversibility of the degradation
reactions for serine and threonine obfuscates the fact that the biosyntheses of these two
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proteinogenic amino acids have not been modeled. The reversibility of the other four
reactions listed in Table 20 introduces unlikely alternative reactions to enzymes known
(from other organisms) to be involved in the biosyntheses of the respective compounds.
In addition, they lead to quantitative effects in energy metabolism, lowering the demand
for ATP, NADH, and NADPH per unit of biomass. These effects are low for the last
three reactions as methionine, dCDP, and D-glucosamine 6-phosphate do not carry high
fluxes at optimal biomass production. However, the flux through aspartate in the FBA
solution  is  relatively  high  at  1.0 mmol gDW−1 h−1 (at  a  biomass  flux  of  0.36 h−1).
Together with the fact that the transamination of aspartate to asparagine and the energy
demand of non-growth associated processes have been omitted from the model,  this
likely leads to a considerable underestimation of the cellular energy consumption by the
model.
Because of the gaps identified in amino acid biosynthesis and the  overly far-reaching
metabolic capabilities of the model, a more detailed analysis was not deemed useful. In
order  for the  model  to make  accurate  predictions  of the  metabolic  phenotype  of
T. maritima under different conditions, these issues have to be addressed through careful
manual curation and refinement of the model.
5.3 Performance of wMOMA vs. MOMA on a small genome-scale model
A preliminary analysis was performed to assess the predictive quality of wMOMA in
comparison to MOMA. To keep computation times low, the methods were applied to all
single-reaction  knockouts  in  a  small  genome-scale  metabolic  model.  The  model
iMO1056 of  Pseudomonas  aeruginosa PAO1  [79] was  chosen for  this  analysis.  At
1,005 reactions and 874 metabolite nodes  it  is considerably smaller than any of the
E. coli models.  All simulations were performed with the minimal medium constraints
provided in the same file as the model (aerobic growth on glucose, glucose uptake rate:
10 mmol gDW−1 h−1,  see  Section  3.1.3).  For  this  scenario,  FBA predicted  a  specific
growth rate of 1.05 h−1.  385 metabolites are dead ends in this scenario, leading to 369
blocked reactions. Using the automated knockout analysis implemented in metano, the
growth rate of each single-reaction knockout mutant was predicted by FBA, MOMA,
and wMOMA in turn. As noted in Section 4.5, FBA gives an upper limit for the biomass
flux that is possible in the mutant network.
An overview of the results of this preliminary analysis  is shown in Figure 20. For the
636  reactions  that  were  not  blocked  due  to  dead  ends  (and  thus  predicted  to  be
nonessential by FBA, MOMA, and wMOMA alike), the predictions of FBA differed
strongest from those of the other methods. All three methods predicted the knockouts of
about 230 reactions (FBA: 229, MOMA: 236, wMOMA: 234) to be  definitely lethal
(biomass flux < 1% of the wild-type optimum). In addition, the knockouts of more than
340 reactions  (FBA: 367, MOMA: 342, wMOMA: 348)  were predicted by all  three
methods to  have no effect on the growth rate  (biomass flux  > 99% of the wild-type
optimum).
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Figure  20: Histogram of the predicted biomass flux for each single-reaction knockout relative to FBA
optimum for the wild-type. 369 reactions that are blocked due to dead ends were excluded.
The predictions of MOMA and wMOMA with respect to the biomass flux differed for
very few cases only, as can be seen in Figure 21. The difference was less than 10−6 % of
the wild-type optimum for the knockouts of 533 of the 636 non-blocked reactions. A
difference of more than 10% of the wild-type optimum was found for only 12 single-
reaction knockouts.  Of these, a difference of more than 20% (but less than 50%) was
found for  only  3  cases:  proton-translocating  NADH dehydrogenase  and the  proton-
translocating  cytochrome  complexes  cytochrome c  oxidase  and  ubiquinone-cyto-
chrome c  reductase.  Unfortunately,  experimental  information  about  these  knockouts,
including whether the mutants are viable at all, was not available. As all three of these
proteins  are  involved  in  the  respiratory  chain  and  P. aeruginosa is  an  obligate
respirer [144], the effects of the mutations are likely pronounced.
Figure  21:  Histogram of  the  difference  in  predicted  biomass  flux  between  MOMA and  wMOMA
expressed as a percentage of the wild-type FBA optimum. Scenarios with a difference below 10−6 % not
shown.
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As MOMA and wMOMA make very similar predictions for most scenarios, the quality
of their predictions cannot be easily evaluated. In particular, such an evaluation would
require  a  model  that  has  been  very thoroughly  validated  and  refined.  Moreover,
high-quality  in-vivo flux data are needed. In addition to differences in the predicted
biomass flux, further criteria could be used to identify knockouts for which MOMA and
wMOMA  make  qualitatively  different  predictions.  Examples  of  such  criteria  are
differences in the predicted CO2 secretion rate, the summed absolute flux through all
reactions in the network,  and the ratio of CO2 export and biomass flux. Furthermore,
flux distributions predicted by MOMA and wMOMA for the same scenario could be
classified as qualitatively different if a reaction flux has opposite signs in the two flux
distributions or if a reaction is active in one flux distribution but inactive in the other.
The question which method makes the better predictions for specific scenarios will have
to be explored in a follow-up study. Nevertheless, wMOMA is more theoretically sound
than MOMA, as fluxes that cannot be accurately predicted via FBA (as evidenced by
their very high variability in FVA) do not need to be faithfully reproduced by the mutant
network in wMOMA, in contrast to MOMA.
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6 metano as a tool for model reconstruction
While the preceding chapters focused on the uses of metano in the analysis of metabolic
models and predicted flux distributions, the present chapter will outline the roles that
metano can play in the process of model construction and refinement. Figure 22 gives
an overview of the iterative process of the reconstruction of genome-scale metabolic
networks. This cycle can be seen as a specialization of the more general cycle of data-
and hypothesis-driven modeling in systems biology shown in  Figure 1 in Section  2.1
(page 6).
Figure 22: The roles of metano and other software tools developed in our group in the iterative cycle of
genome-based metabolic modeling.
6.1 Background: From the genome to a network model
As the tools implemented in metano operate only on stoichiometric metabolic models,
they are not applicable in the first stages of network reconstruction. To provide a rough
outline  of  the modeling process,  these early  stages  will  briefly  be described in  this
section. These stages correspond to the right-hand side of the cycle shown in Figure 22.
As  noted  in  Section  2.5.1,  the  process  of  metabolic  modeling  always  starts  from a
genome  annotation.  This  annotation  is  usually  compiled  by  combining  various
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annotation sources. The program EnzymeDetector, which was developed in our group,
combines  data  from different  biological  databases with  in-silico predictions  of gene
functions  [105].  The  computational  methods  used  for  enzyme  function  prediction
include  a  BLAST-based  homology  search  [105] and  the  hierarchical  pattern-based
function assignment BrEPS [109].
In the next step, a list of catalyzed reactions is created from the list of annotated enzyme
functions. Different electronic databases can be used for the assignment of biochemical
reactions to enzyme functions. The database BKM-react [223], which was developed in
our  group,  is  an  integrated  database  of  biochemical  reactions  compiled  from the
databases BRENDA [106], KEGG [107], and MetaCyc [224]. Based on the initial list of
metabolic  reactions,  both  enzyme-catalyzed  and  spontaneous,  a  raw  model  can  be
constructed.  In  the  construction  of  stoichiometric  models,  it  is  important  that  all
reactions satisfy the condition of mass balance (see Section 2.3). As the stoichiometry
of  each  reaction  included  in BKM-react  has  been  verified  [223], this  database  is
particularly well suited for metabolic modeling.
The raw model can be supplemented with reactions that are required for the reachability
of known biomass components. Different strategies exist for this process, which has
been  termed  ‘gap  filling’,  including  graph-based  approaches  and  mathematical
optimization  strategies.  The  program gapFiller,  which  was  developed  in  our  group,
exemplifies the graph-based strategy  [225], while the MetaFlux tool  employs mixed-
integer linear programming [226].
In order to obtain a complete ‘simulation-ready’ metabolic model, compartments have
to be defined, and transport and exchange reactions have to be added to the model (see
Section 2.3.3). In addition, a biomass reaction has to be formulated (see Section 2.3.5).
To date, these steps cannot be performed in an automated fashion.
6.2 Getting the model to ‘run’
Once an initial network model with biomass, transport, and exchange reactions has been
constructed,  metano can be used to analyze the model’s capabilities and to fit model
parameters. In the first stage, the model is refined with the goal to obtain a steady-state
flux distribution, i.e. to make the  FBA optimization problem feasible. The problem is
infeasible,  i.e. the solution space is empty, if no flux vector exists that simultaneously
satisfies all equality and  inequality constraints. For instance, the substrate or oxygen
uptake  rate  might  be  too  low  to  satisfy  the  non-growth-associated  maintenance
requirement (NGAM). Other common causes of infeasibility are missing transport or
exchange reactions and gaps in pathways leading to biomass precursors. At this stage,
dead-end  analysis can  be  a  valuable  tool  for  identifying  gaps  in  the  network.  If
metabolites that are known intermediates in a biosynthetic pathway are dead ends in the
model, this might indicate a gap in the pathway.  Dead-end analysis can also identify
problems resulting  from inconsistent  use  of  metabolite  identifiers  (e.g.  if  molecular
oxygen is labeled ‘oxygen’ in some reactions and ‘O2’ in others).
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A further common occurrence at this stage of modeling is that while the solution space
of FBA is not empty, a non-zero biomass flux is not possible. This is usually the result
of  unintended  stoichiometric  coupling  between  reactions.  An  example  is  shown  in
Figure 23.
Figure 23: An example of stoichiometric coupling: In this network, the reactions labeled 'v1' and 'v3' are
stoichiometrically coupled via the cofactor metabolites Q and Q*.
In  this  network,  the  reactions  labeled  with  the  flux  variables  v1 and  v3 are
stoichiometrically coupled so that, depending on notation, either v1 = v3 or v1 = −v3, and
b1 = v5 = 0. The reason for this is a missing pathway synthesizing or degrading either Q
or Q*. As neither Q nor Q* can be produced or consumed outside the reactions v1 and
v3, the two reaction fluxes must cancel each other out in steady state. Consequently, it is
impossible to add matter to the cycle A–B–C–D via flux b1 or remove matter via flux v5.
In practice, this phenomenon can occur, e.g., when cofactor biosynthetic pathways still
contain gaps.
If  it  is  possible  for  the  objective  function in  FBA to  assume a  non-zero value,  the
solution space might not be bounded (except possibly for an artificial upper bound on
the objective function). The cause for this is either a lack of constraints on substrate
uptake rates or the presence of a reaction violating mass balance,  which allows the
production  of  matter  out  of  nothing.  The  first  case can  easily  be  discovered  by
examining the boundary fluxes in the FBA solution. In the latter case, the problematic
reaction can be identified by tracing back from any metabolite with an implausibly high
flux using split-ratio analysis or its graphical extension branch point analysis (BPA).
Once a finite, non-zero biomass flux is obtained in FBA, the fitting of model parameters
to  thermodynamic  constraints  and experimental  data  can  begin.  If  the  physiological
ranges of intracellular metabolite concentrations are known, they can be used for the
free-energy-based assignment of reaction directions. In the FBA solution, boundary
fluxes should  be  closely  examined  for  plausibility.  If  an  energy-rich metabolite  is
secreted, this might indicate an error in the model. Possibly, a reaction metabolizing the
exported compound is missing in this case. Unexpected behavior can be traced back to
its immediate cause using split-ratio analysis and/or BPA. At this stage, FVA can also
be useful for the identification of overly far-reaching capabilities by examining for each
flux variable whether it can be zero and whether it must be zero in the studied scenario.
For  instance,  in  a  model  of  an  obligate  aerobe,  growth  should  be  dependent  on  a
non-zero oxygen uptake rate.
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6.3 Model refinement
Metabolic modeling is a cyclic process (see Figure 22), where new reactions are added
as new metabolic functions are found – either in an updated genome annotation or by
experimental observation.  By monitoring assertions  via  metano’s tool for  automated
plausibility checking at every step of the modeling process, it is possible to determine
if  a  change  to the  model  leads  to  a  qualitative  change  in  the  predicted  metabolic
behavior.  Seemingly  small  changes  in  the  model  can  alter  the  model’s  predictions
dramatically.  For  instance,  if  a  transporter  is  introduced  that  is  not  constrained,
unlimited substrate uptake and thus unlimited growth may be possible. To give another
example,  a  single added reaction  may lead to  a  biologically  infeasible  ‘shortcut’ in
existing pathways.
Finally, systematic metabolite-centric analyses like those described in Sections 5.1 and
5.2 can be used to fit model predictions to experimental results.
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In  this  work,  a  collection  of  software  tools  for  the  reconstruction  and  analysis  of
metabolic models has been developed.  The software package  metano implements  the
established  computational  methods  of  flux  balance  analysis  (FBA),  flux  variability
analysis  (FVA),  minimization  of  metabolic  adjustment  (MOMA),  dead-end analysis,
and the free-energy-based prediction of reaction directionality.  Within this  framework,
several new methods and extensions of existing algorithms have been implemented, to
wit weighted  MOMA (wMOMA),  split-ratio  analysis,  metabolite  flux  minimization
(MFM), and the automated plausibility checking of metabolic models.  With its broad
selection of computational methods,  metano is a useful tool to assist in the process of
metabolic  reconstruction  and to  perform in-depth  analyses  of  metabolic  models  and
their predicted behavior in different growth scenarios.
The distribution of metano as open source allows anyone to use the software (under the
terms of the GNU General Public License) and to adapt it to their specific requirements.
In this way, metano serves as a reference implementation of the algorithms developed in
this work. The object-oriented design of the software ensures easy maintainability and
extensibility. metano has been implemented in such a way as to be easy to use for users
with different technical backgrounds: On the one hand, it is written in the widely-used
Python  programming  language  and  provided  in  the  form  of  Python  classes  and
functions.  This permits easy adaptation of the software to  different requirements  by
users with basic programming skills. On the other hand, metano is provided in the form
of  stand-alone  Python  programs,  and  it  supports  the  popular  SBML format  for  the
exchange  of  metabolic  models.  These  features  allow  metabolic  modelers  without
programming experience to quickly apply the methods implemented in metano to their
models.
In the design of metano,  great attention was paid to efficiency. In the implementations
of FBA, FVA, MOMA/wMOMA, and MFM, iterative dead-end analysis is performed as
a  preprocessing  step  in  order  to  reduce  the  dimension of  the  solution  space  of  the
respective  optimization  problems.  The  implementations  of  FVA and  MFM,  which
optimize different objective functions in the same solution space, employ the ‘fastFVA’
strategy, where each optimization is launched from the solution of the previous  one.
MOMA/wMOMA have been implemented with the option to perform an FVA-based
reduction of the steady-state solution space as an alternative preprocessing step, which
can speed up the analysis even more than a dead-end analysis. Due to its good run-time
behavior,  metano has  been  successfully  applied  to  large-scale  analyses  involving
thousands or even hundreds of thousands of simulations [187,197].
The implementation  of  FBA in  metano is  one  of  the first  to  allow unbounded flux
variables  in the optimization. As has been argued in Section  4.3 and demonstrated on
the example of the E. coli model iAF1260, unproductive fluxes through stoichiometri-
cally balanced cycles do not occur in this implementation. metano FBA hence does not
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require special treatment of thermodynamically infeasible loops. Therefore, it is more
computationally efficient than existing implementations, which often use mixed-integer
linear programming to secondarily preclude cyclic flux through such loops.
Weighted MOMA (wMOMA) is a variant of MOMA, which is introduced in this thesis
and has been implemented in metano. In contrast to MOMA, it is much less sensitive to
the  choice  of  reference  vector  from  the  optimal  FBA solution  space.  While  the
preliminary analysis described in Section 5.3 failed to clearly identify an experimentally
verifiable scenario  where  the  two  methods  make  substantially  different  predictions,
wMOMA is more theoretically sound than MOMA. FBA returns arbitrary values for
variables  that  are  not  sharply  constrained  by the  optimization  problem.  Using  such
arbitrary values as reference is obviously always wrong.
metano uses the same data structures and functions for both MOMA and wMOMA. As
most of the code  is  shared between the two methods, improvements in one method
become available in the other instantaneously. This shared code is easier to maintain
than duplicated code. The use of shared code is made possible by the fact that  the two
methods  differ only  in  the  weighting  scheme  (uniform  in  MOMA and  linear  in
wMOMA).
In this  work,  it  has  further  been  shown how the automated plausibility  checking of
metabolic models is made possible by the formalization of expectations with respect to
model  behavior.  The  formalization  proposed  here  takes  the  form of  assertions,  i.e.
Boolean expressions which evaluate to  True for the expected case.  A procedure for
sequentially  testing  a  series  of  assertions  has  been  implemented  in  metano.  The
resulting program can be used in the process of model construction and refinement to
ensure that any unexpected model behavior enabled by a modification or extension of
the model is discovered as soon as it arises.
The  methods  of  split-ratio  analysis  and  metabolite  flux  minimization,  which  were
developed in this work, establish a metabolite-centric view on flux distributions. This
metabolite-centric  view  allows  a  more  meaningful  biological  interpretation  of  flux
distributions than is possible from the reaction fluxes alone. It thus complements the
classical reaction-centric framework.
The detailed analyses presented in Section  5.1.2 serve to illustrate the power of split-
ratio analysis and its graphical extension branch point analysis (BPA): While split-ratio
analysis merely post-processes an FBA solution, it yields all split ratios and metabolite
fluxes in the system at a glance. Both the tabular output of split-ratio analysis and, in
particular, the interactive graphical output of BPA allow analyzing reaction fluxes in a
natural context. The context for interpreting the flux through any particular reaction is
provided by considering not the absolute  flux  value in mmol gDW−1 h−1, but rather its
share of  the total flux  through each of the  metabolites consumed or produced by the
reaction.
Split-ratio analysis and BPA allow the scenario-specific assignment of metabolic roles:
For instance, the energy balance of Escherichia coli cannot be fully understood without
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considering  phosphoenolpyruvate  (PEP).  In  contrast,  in  Thermotoga  maritima,  PEP
mostly acts as a catabolic intermediate, which is used to generate pyruvate and ATP.
Using split-ratio  analysis,  metabolites  can  be  classified,  e.g.,  as  mere  biomass
components,  energy or  redox carriers,  group donors,  and mere  byproducts.  To give
another example,  in  T. maritima,  the  reducing  equivalent  NADH  acts  mostly  as  a
catabolic  byproduct,  as  its  chemical  potential  is  used  for  the  largest  part  to  reduce
intracellular protons to hydrogen, which does not contribute to biomass formation.
The  metabolite-centric  analyses  of  the  two  very  different  scenarios  of  aerobically
growing E. coli and strictly anaerobic T. maritima illustrate that the energy metabolism
under a particular set of environmental conditions can be characterized in terms of the
balance sheets of a very small number of currency metabolites.  These balance sheets
can be used to assess the biological plausibility of a model’s predictions even when
organism-specific  experimental  data  are  scarce.  This  is  due  to  the  fact  that  energy
metabolism tends to proceed along variations of only a few well-understood pathways,
depending  almost  exclusively  on  the  organism’s  ecology  (phototrophic  vs.  chemo-
trophic, anaerobic vs. aerobic, etc.).
Moreover,  as only a  fraction of  the reactions in  a  model  is  active in  any particular
scenario  and  most  of  the  active  metabolite  nodes  are  purely  transitory,  a  full
metabolite-centric analysis will likely never need to consider more than a few hundred
metabolite nodes.
By  studying  the  split  ratios  of  branch  points  at  the  intersection  of  catabolism and
anabolism, such as 2-oxoglutarate and oxaloacetate, it is possible to explore the balance
between  energy  generation  and  biomass  production  for  each  pathway.  Shifting  this
balance  is  crucial  in  metabolic  engineering:  If  the  goal  is  the  overproduction  and
secretion of a metabolite of interest, it is not sufficient to overexpress enzymes on the
pathway  leading  to  product  formation.  Rather,  an  optimal  balance  has  to  be  found
between product formation,  energy generation, and growth [227,228]. Thus, split-ratio
analysis can be used to guide the process of metabolic engineering.
The analyses of metabolite pools and metabolic cycles presented in Section 5.1.3 are not
easily possible with other methods than branch point analysis: The presence of cyclic
fluxes  is  neither  evident  in  the  reaction  fluxes  nor  in  the  balance  sheets  of  single
metabolites, but can only be seen in a larger metabolic context. Similarly, metabolite
pools, which are depleted and replenished via various reactions from different pathways
can only be understood in a larger metabolic context. This context is defined by all
activated  and  depleted  forms  of  a  pool  metabolite,  which  have  to  be  examined
simultaneously along with all reactions in which they are involved. This is powerfully
illustrated by the analysis of the tetrahydrofolate (THFA) pool, which is defined by the
activated  forms  5,10-methylene-THFA,  5-methyl-THFA,  5,10-methenyl-THFA,  and
10-formyl-THFA and the depleted forms THFA and dihydrofolate.
Metabolite flux minimization is a second metabolite-centric method developed in this
work and implemented in metano.  As demonstrated in Section 5.1.4, it is a useful tool
for  efficiently  assessing  the  essentiality  of  metabolite  nodes  for  optimal  biomass
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production. In addition, a ranking of metabolite nodes by their required flux under the
goal of optimal biomass production can give further insights into the global metabolic
behavior. Studies of metabolite essentiality are not possible in a purely reaction-centric
framework. In the example of the E. coli model iJO1366, it is not apparent from the flux
variabilities  of  the  ten  reactions  involving thioredoxin  or  the  twenty-three  reactions
involving menaquinone-8 that flux through neither of these metabolites is required for
optimal biomass production in the studied scenario.
The  detailed  metabolite-centric  analyses  of  the  published  genome-scale  metabolic
models  iJO1366  and  iTZ478  presented  in  Sections  5.1 and  5.2 revealed  several
prospects for model refinement. From the balance sheets of energy metabolites, it was
discovered that in the E. coli model  iJO1366,  the reaction pair  fructose-6-phosphate
(F6P) aldolase + dihydroxyacetone kinase can partially replace the usual reaction pair of
phosphofructokinase + fructose-bisphosphate aldolase in glycolysis. As this  involves
activity of F6P aldolase in the strongly endergonic cleavage direction and activity of
this enzyme in either direction has never been observed in vivo, this alternative route in
glycolysis  should be disallowed in the model.  This  would remove ambiguity in the
model’s predictions and thus improve accuracy for most scenarios.
In the systematic survey of the split ratios of all energy metabolites, a discrepancy was
found  between  the  predicted  and  experimentally  determined  NADPH  balance  for
E. coli growing aerobically on glucose. The discrepancy could be resolved completely
by introducing a forced flux through proton-translocating transhydrogenase.
Two further  possibilities for refinement  of the model iJO1366 were identified in an
analysis of metabolite essentiality using metabolite flux minimization. Firstly, it  was
discovered that  in  the model,  excess intracellular protons can  be converted  to water
using molecular oxygen and electrons donated by Fe2+ ions, which are oxidized to Fe3+
in the process.  As this  entails  iron uptake and secretion at  an extreme rate and the
solubility of the produced Fe3+ ions is low, this reaction should also be blocked in the
model  to  eliminate  ambiguity  and  improve  accuracy.  Secondly,  fructose  1,6-
bisphosphate  is  predicted  to  be  nonessential  in  the  model  for  optimal  biomass
production under aerobic growth on glucose. The reason was found in the sedoheptulose
bisphosphate  bypass,  which  can  completely  replace  the  standard  reactions  of
phosphofructokinase  and  fructose-bisphosphate  aldolase.  However,  this  alternative
metabolic route has only been described for transaldolase-deficient mutants, and it uses
the same enzymes as the standard glycolytic path. Therefore, it should be disallowed
when specifically studying the wild type.
As the authors of  the  T. maritima model  iTZ478  themselves  note,  the model  is  not
accurate  enough  to  allow  quantitative  predictions.  Obvious  limitations  are that
non-growth-associated processes are not represented in the model, that the formation of
asparagine has not been modeled, and that the value of the substrate uptake rate seems
to  have  been  selected  arbitrarily.  By  analyzing  the  split  ratios  of  high-energy
metabolites  such  as  ATP and  small  low-energy  metabolites  such  as  ammonium  as
predicted  for  the  studied  scenario, further  unexpected  metabolic  capabilities  were
discovered: Several reactions known only from degradation pathways were found to be
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involved in the biosynthesis of biomass precursors, where they operate in the reverse
direction. In particular, the proteinogenic amino acids serine and threonine can only be
produced via reversed degradation pathways. As no in-vivo evidence exists for any of
these  reversed  pathways,  they  must  be  considered  errors  in  the  model.  Four  other
degradation reactions operating in the reverse direction were found to act as ‘shortcuts’,
which bypass the standard biosynthetic pathways.
These results illustrate that the metabolite-centric analysis of flux distributions made
possible  by  algorithms implemented  in  metano is  a  new and  powerful  tool  for  the
reconstruction and refinement of genome-scale metabolic models. Using the metabolite-
centric framework developed in this work, possibilities for model refinement could be
identified even in the model iJO1366, which is  the result  of more than a decade of
genome annotation and metabolic modeling.
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Symbols and abbreviations
 gDW Gram dry weight of biomass
 lb Vector of lower bounds on the reaction fluxes
 ub Vector of upper bounds on the reaction fluxes
 S Stoichiometric matrix
 v Vector of reaction fluxes
vBM Biomass flux (flux through the virtual biomass reaction)
 Z(v) A function in the fluxes v used as objective function in FBA
 Zopt, FBA The optimal value of the objective function determined by FBA
ABC transporter ATP-binding cassette transporter
BPA Branch point analysis
CoA Coenzyme A
DHA Dihydroxyacetone
F6P Fructose 6-phosphate
FBA Flux balance analysis
FVA Flux variability analysis
G6P Glucose 6-phosphate
GAM Growth-associated maintenance requirement
MFM Metabolite flux minimization
MOMA Minimization of metabolic adjustment
NGAM Non-growth-associated maintenance requirement
PEP Phosphoenolpyruvate
PPP Pentose phosphate pathway
PTS Phosphotransferase system
ROOM Regulatory on/off minimization
SBML Systems biology markup language
TCA cycle Tricarboxylic acid cycle
THFA Tetrahydrofolate
wMOMA Weighted minimization of metabolic adjustment
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Appendix A:  Comparison  of  FBA  solutions  from
different software tools
FBA was performed on the E. coli model iAF1260 for scenario 1 (glucose uptake rate:
8 mmol gDW−1 h−1,  oxygen uptake  rate:  ≤ 18.5 mmol gDW−1 h−1;  see  Section  3.1.1.1)
using  metano or SurreyFBA [185] (the latter via its JyMet graphical user interface).
Both  FBA solutions  were  then  compared  to  the  flux  distribution  published  by  the
authors  of  iAF1260  (downloaded  from  the  supplementary  material  of  the
publication  [24]),  which  was generated  by the  FBA implementation  in  the  COBRA
toolbox [14].
The three FBA solutions agree for 2,301 of the 2,382 reactions in the network, which
includes 234 reactions blocked due to dead ends. Only slightly more than 400 reactions
are  active  in  any FBA solution  (at  a  cutoff  of  10−12 mmol gDW−1 h−1;  metano:  403,
COBRA toolbox: 403, SurreyFBA: 416). All three implementations predict the same
biomass  flux of  0.7367 h−1,  which means that  all  three solutions  are  indeed optimal
(agreement within 10−6 h−1; COBRA toolbox and SurreyFBA solutions are rounded to
six digits).  All  three software tools predict an oxygen exchange flux well  above the
lower  bound  of  −18.5 mmol gDW−1 h−1 defined  in  the  scenario,  i.e.  growth  is  only
limited by carbon availability and not by oxygen supply. There is no export of acetate in
any of the three FBA solutions.
The 81 reactions for which differences were present between at least two flux distri-
butions  are  shown in  Table 21.  In  contrast  to  the  other  tools,  SurreyFBA predicted
extremely high fluxes for 19 reactions in infeasible loops (first 19 rows in  Table 21,
marked in red). Cyclic fluxes through infeasible loops do not occur in the solutions of
metano and the COBRA toolbox. While for 81 reactions there is no agreement between
all three tools, there are only 10 cases where no two solutions agree. The predictions of
metano agree in 25 cases with the COBRA toolbox (marked in purple in Table 21) and
in 22 cases  with  SurreyFBA (marked in green),  while  SurreyFBA and the COBRA
toolbox agree for 23 reactions (marked in yellow). The differences are explained by
alternative pathway use, towards which the FBA objective, maximization of biomass
flux,  is  blind.  To  give  an  example,  the  following  two  sets  of  reactions  are
stoichiometrically equivalent:
I (active in COBRA toolbox solution):
R_phosphoribosylpyrophosphate_synthetase : ATP + ribose 5-phosphate → AMP + H+ + phosphoribosyl 
pyrophosphate
R_adenylate_kinase : AMP + ATP → 2 ADP
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II (active in metano solution):
R_ribose_1_5_bisphosphokinase : ATP + ribose 1,5-bisphosphate → ADP + phosphoribosyl 
pyrophosphate
R_ribose_1_phosphokinase : ATP + ribose 1-phosphate → ADP + H+ + ribose 1,5-bisphosphate
R_phosphopentomutase : ribose 1-phosphate ← ribose 5-phosphate
Table  21:  Differences  in  the  flux  distributions  predicted  by  three  different  implementations  of  FBA
(metano,  COBRA toolbox,  SurreyFBA) for  the model  iAF1260, scenario 1 (see Section 3.1.1.1).  Flux
values are in mmol gDW−1 h−1. All three FBA solutions agree for any reaction not shown.
Reaction metano COBRAtoolbox SurreyFBA
R_adentylate_kinase__GTP_ 0.9816 0 -999999
R_nucleoside_diphosphate_kinase__ATPGDP_ 1.5420 0.5604 -999998
R_adenosine_transport_in_via_proton_symport__reversible__
periplasm_ 0 0 -999999
R_inosine_transport_in_via_proton_symport__periplasm_ 0 0 999999
R_thymidine_transport_in_via_proton_symport__reversible__
periplasm_ 0 0 -999999
R_isochorismate_synthase 0 0 -999999
R_glucose_transport_via_diffusion__extracellular_to_periplas
m_ 8.0 8.0 -999991
R_Isochorismate_Synthase 0 0 999999
R_D_glucoseMaltotriose_transport_via_diffusion__extracellul
ar_to_periplasm__irreversible 0 0 999999
R_inosine_transport_in_via_proton_symport__reversible__per
iplasm_ 0 0 -999999
R_adenosine_transport_in_via_proton_symport__periplasm_ 0 0 999999
R_thymidine_transport_in_via_proton_symport__periplasm_ 0 0 999999
R_Valine_pyruvate_aminotransferase 0 0 999999
R_L_alanine_transaminase -0.4294 -0.4294 -999999
R_phosphoribosylpyrophosphate_synthetase 0 0.6866 -999998
R_phosphopentomutase -0.6866 0 -999999
R_ribose_1_phosphokinase 0.6863 0 999999
R_ribose_1_5_bisphosphokinase 0.6863 0 999999
R_valine_transaminase -0.3118 -0.3118 999998
R_adenylate_kinase 0 1.6682 1.6682
R_fructose_6_phosphate_aldolase 1.0269 1.0269 0
R_pyruvate_kinase 0 0 1.0269
R_Dihydroxyacetone_phosphotransferase 1.0269 1.0269 0
R_fructose_bisphosphate_aldolase 5.1642 5.1642 6.1912
R_phosphofructokinase 5.1642 5.1642 6.1912
R_beta_ketoacyl_ACP_synthase__2_ 0.2621 0.2621 0
R_Acetyl_CoA_ACP_transacylase 0 0 0.2621
R_beta_ketoacyl_ACP_synthase 0 0 0.2621
R_thioredoxin_reductase__NADPH_ 0.2598 0 0.2598
R_fumarate_reductase_001 0 0.2437 0.2459
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Reaction metano COBRAtoolbox SurreyFBA
R_succinate_dehydrogenase__irreversible_ 3.7291 3.9750 3.9750
R_dihydroorotic_acid__menaquinone_8_ 0 0.2437 0.2437
R_dihydoorotic_acid_dehydrogenase__quinone8_ 0.2437 0 0
R_glutaredoxin_reductase 0 0.2206 0
R_glutathione_oxidoreductase 0 0.2206 0
R_phosphoadenylyl_sulfate_reductase__glutaredoxin_ 0 0.1815 0
R_phosphoadenylyl_sulfate_reductase__thioredoxin_ 0.1815 0 0.1815
R_flavodoxin_reductase__NADPH_ 0 0.0392 0
R_ribonucleoside_triphosphate_reductase__CTP___flavodoxi
n_ 0 0.0199 0
R_ribonucleoside_diphosphate_reductase__GDP___glutaredo
xin_ 0 0.0199 0
R_nucleoside_diphosphate_kinase__ATPCDP_ 0.1134 0.1333 0.1134
R_nucleoside_diphosphate_kinase__ATPdCDP_ 0.0199 0 0.0199
R_ribonucleoside_diphosphate_reductase__CDP_ 0.0199 0 0.0199
R_ribonucleoside_diphosphate_reductase__GDP_ 0.0199 0 0.0199
R_ribonucleoside_diphosphate_reductase__UDP_ 0.0193 0 0.0193
R_ribonucleoside_diphosphate_reductase__ADP_ 0.0193 0 0.0193
R_nucleoside_diphosphate_kinase__ATPdADP_ 0.0193 0 0.0193
R_ribonucleoside_triphosphate_reductase__ATP___flavodoxin
_ 0 0.0193 0
R_ribonucleoside_diphosphate_reductase__UDP___glutaredo
xin_ 0 0.0193 0
R_iron__II__transport_via_diffusion__extracellular_to_peripla
sm_ 0.0108 0.0056 0.0056
R_Fe2_exchange -0.0108 -0.0056 -0.0056
R_Fe3_exchange 0 -0.0052 -0.0052
R_iron__III__transport_via_diffusion__extracellular_to_peripl
asm_ 0 0.0052 0.0052
R_H_exchange 6.7609 6.7661 6.7661
R_proton_transport_via_diffusion__extracellular_to_periplasm
_ -6.7609 -6.7661 -6.7661
R_glycolate_transport_via_sodium_symport__periplasm_ 0 0.0035 0
R_glycolate_transport_via_proton_symport__reversible__peri
plasm_ 0 -0.0035 0
R_acetate_reversible_transport_via_proton_symport__periplas
m_ -0.0035 0 0
R_NaAcetate_symport__periplasm_ 0.0035 0 0
R_L_proline_reversible_transport_via_proton_symport__perip
lasm_ 0 0 -0.0035
R_NaProline_L_symporter__periplasm_ 0 0 0.0035
R_H2O_transport_via_diffusion__extracellular_to_periplasm_ -37.2402 -37.2376 -37.2376
R_H2O_exchange 37.2402 37.2376 37.2376
R_L_aspartate_oxidase_001 0.0017 0 0
R_L_aspartate_oxidase_002 0 0 0.0017
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Reaction metano COBRAtoolbox SurreyFBA
R_L_aspartate_oxidase_003 0 0.0017 0
R_isopentenyl_diphosphate_D_isomerase 0 0.0002 -0.0016
R_1_hydroxy_2_methyl_2__E__butenyl_4_diphosphate_redu
ctase__ipdp_ 0.0016 0.0018 0
R_1_hydroxy_2_methyl_2__E__butenyl_4_diphosphate_redu
ctase__dmpp_ 0.0002 0 0.0018
R_ferroxidase 0.0013 0 0
R_oxygen_transport_via_diffusion__extracellular_to_periplas
m_ 16.2669 16.2656 16.2656
R_O2_exchange -16.2669 -16.2656 -16.2656
R_fumarate_reductase_002 0 0.0005 0
R_Glycolate_oxidase_003 0 0.0005 0
R_Glycolate_oxidase_001 0.0005 0 0
R_Glycolate_oxidase_002 0 0 0.0005
R_polyphosphate_kinase_002 -2.2961 -2.2964 -2.2964
R_adenine_phosphoribosyltransferase 0 0.0003 0.0003
R_purine_nucleoside_phosphorylase__Adenosine_ -0.0003 0 0
R_adenosine_kinase 0.0003 0 0
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Appendix B:  FBA on  E. coli model  iJO1366  for  the
alternative scenario
FBA was performed for the alternative scenario described in Section  3.1.1.2. Like the
original scenario, it describes a continuous growth environment with a constant glucose
uptake  rate  of  11.0 mmol gDW−1 h−1,  and  a  forced  acetate  secretion  rate  of
6.4 mmol gDW−1 h−1. Oxygen can be taken up from the environment at an arbitrary rate.
The alternative scenario differs from the original scenario in a forced flux of (at least)
5 mmol gDW−1 h−1 through  the  reaction  catalyzed  by  proton-translocating  trans-
hydrogenase (EC 1.6.1.2). The values for the glucose uptake rate, oxygen uptake rate,
growth rate, acetate secretion rate, and CO2 emission rate predicted by FBA under the
two scenarios are shown in Table 22 along with experimentally determined values from
a 13C tracer analysis [154].
Table  22: Key flux  values  predicted  by  FBA for  the  original  and alternative scenarios  described  in
Section  3.1.1.2 compared  to  experimentally  determined  values.  Experimental  values  were  taken
from [154]. The experimental values, which were obtained during growth in a bioreactor in continuous
mode, are given with standard deviation from triplicate experiments. Growth rate is given in h−1, all other
fluxes in mmol gDW−1 h−1.
Experimental values FBA (original scenario) FBA (alternative scenario)
glucose uptake rate 11.0 ± 0.5 11.0 (fixed) 11.0 (fixed)
oxygen uptake rate 18.2 ± 0.8 16.5 16.7
growth rate 0.82 ± 0.02 0.85 0.85
CO2 secretion rate 18.6 ± 0.5 18.2 18.4
acetate secretion rate 6.4 ± 1 6.4 (fixed) 6.4 (fixed)
At the given values for the glucose uptake rate and the acetate secretion rate, the FBA
solutions for the two scenarios both accurately predict the CO2 emission rate and the
growth rate,  while both yield somewhat too low values for the oxygen uptake rate.
While FBA predicts nearly identical values for these key fluxes under the two scenarios,
the predicted oxygen uptake rate is slightly higher (and thus closer to the experimentally
determined value) in the alternative scenario.
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